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The human body is protected against pathogens such as viruses, bacteria, 
and parasites by the constantly alert immune system. This sophisticated 
defense system is guaranteed by finely orchestrated interactions among 
different cell types, which belong to either the innate or the adaptive immune 
system. The innate immunity is regulated by cells like macrophages, natural 
killer (NK) cells, granulocytes, and monocytes that interact with pathogens 
locally and in a non-specific manner. The adaptive immunity is based on T 
and B lymphocytes that specifically recognize a certain pathogenic antigen 
(Ag) and build up an immunological memory, which will provide a faster and 
enhanced reaction upon restimulation with the same Ag. At the interface 
between innate and adaptive immunity are the dendritic cells (DCs). These 
highly specialized cells take up and process Ag at the periphery and then 
migrate to the lymph nodes, where they present Ag-derived peptides to 
resting lymphocytes, thereby initiating an immune response. 
 
 
Monocytes and Dendritic Cells 
 
Monocytes are large motile, amoeboid, phagocytic cells with an indented nucleus. 
They derive from bone marrow precursors and are the blood representative of the 
mononuclear phagocyte system. Monocytes remain in the blood for a short time 
(about 24 hours mean half-life) and then exit the blood stream to enter body tissues, 
where many of them spontaneously differentiate into macrophages (Furth, 1988). 
However, in steady state there is no net accumulation of macrophages in peripheral 
tissues, therefore either monocytes that entry into tissue are just sufficient to replace 
dying macrophages, or monocytes only transiently reside in the tissues (Furth, 
1988). 
Interestingly, monocytes can differentiate also into dendritic cells (DC) (Fig.1).  
 
 
 
Figure 1. In vitro, DCs can be obtained from monocytes purified from peripheral 
blood. After 6 days of culture in a cocktail of IL-4 and GM-CSF, monocytes differentiate into 
immature DC that are highly capable of capture antigens. Stimulation of immature DC with 
activating agents (such as bacterial LPS or PGE2 and TNFa) induce maturation of DCs. These 
mature DCs have a reduced antigen capture capacity but are very effective in antigen 
presentation and therefore T cell stimulation. 
 
Chapter 1 
 12 
 
This can occur under physiological conditions, in an in vitro assay where monocytes 
traverse endothelial monolayers in the basal-to-apical direction (reverse 
transmigration) without addition of exogenous chemokines (Randolph et al., 1998). 
In addition, monocytes differentiate into DC in culture, upon treatment with cocktails 
of specific cytokines, such as IL-4 and GM-CSF (Romani et al., 1994). 
DC are a group of bone-marrow-derived leukocytes that are specialized for the 
uptake, processing, transport and presentation of Ag to T lymphocytes (Banchereau 
and Steinman, 1998). At a stage called immature, DC reside in peripheral tissues 
continuously sampling the antigenic environment. When they encounter microbial 
products or tissue damage, DC get activated and start migrating towards the lymph 
nodes. While migrating, DC become mature, process the captured Ag and present 
Ag-derived peptides complexed to major histocompatibility complex (MHC) molecules 
on their surface. Meanwhile, DC upregulate the co-stimulatory molecules required for 
effective interaction with and activation of T cells. Once in the lymph node, the 
mature DC efficiently trigger an immune response by stimulating any T cell bearing a 
receptor that is specific for any of the Ag-peptide/MHC complexes present on the DC 
surface (Fig.2). In this way, very small numbers of mature activated DC are highly 
efficient at generating strong immune responses against pathogens or endogenous 
tumors. 
The functional plasticity of DC is also guaranteed by the existance of distinct DC 
subsets that may perform different functions at different sites. In vitro studies 
indicated that human hematopoietic stem cells can differentiate into two different DC 
precursors: a myeloid precursor that further differentiates into Langerhans cells, 
interstitial DC, and myeloid DC (Shortman and Liu, 2002), and a lymphoid precursor 
from which plasmacytoid DC derive (Spits et al., 2000).  
 
 
 
Figure 2. Life cycle of DCs. Hematopoietic stem cells differentiate in progenitor cells, which 
migrate via blood to peripheral tissues to differentiate into immature DCs that patrol for 
foreign antigens. Upon antigen uptake, DC process antigens, mature, and migrate to the T 
cell area of the draining lymph node. There, interaction of DC with naïve T cells occurs and 
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subsequent activation of T cells induces activated T cells to migrate from the lymph node to 
the peripheral tissues and eliminate the antigen. 
 
 
However, since the number of DC that can be directly isolated from blood or tissue is 
very low, monocytes are routinely used in the laboratory to produce sufficient 
amount of DC, as already mentioned above (Romani et al., 1994). These monocyte-
derived DC are commonly used as cell model, although their relation with in vivo 
existing DC is still unclear. 
Recently, it has been proposed that DC are not only involved in the generation of an 
immune response but also in the maintenance of tolerance to self-antigens 
(Roncarolo et al., 2001; Steinman et al., 2000). The emerging model is that 
quiescent DC (moderate surface level of MHCII and co-stimulatory molecules, Ag-
uptake capacity, low activation state) that bear self-antigens are required for the 
continuous maintenance of self-tolerance, whereas immune responses occur when 
invading pathogens provide danger signals that trigger DC activation (Shortman and 
Heath, 2001). 
The plasma membrane of DC displays a specific set of cell surface molecules that 
must change dynamically along with the specific alterations occurring in the 
development from immature to mature or quiescent DC. 
Some of these receptors recognize various stimuli and vary from lectin-domain 
scavenger receptors, such as C-type lectin-like receptors, to the Toll-like receptors 
(TLRs). Other receptors belong to the integrin family and are involved in cell 
adhesion, regulating the interaction of DC with other cell types, such as endothelial 
cells and lymphocytes (Fig. 3). 
 
 
 
Figure 3. DCs are equipped with a broad set of adhesion receptors expressed at 
the cell membrane. These receptors mediate the interactions of DCs with other cell types 
(such as T or endothelial cells), with components of the extra-cellular matrix (such as 
fibronectin, collagen, and laminin), and with different microorganisms. 
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Integrins and integrin-associated proteins in the immune system 
The adhesive processes of leukocytes have been subject of numerous studies. These 
bone-marrow derived cells with diverse form and function circulate in the blood in a 
resting state of low adhesiveness. They display a particular pattern of adhesion 
receptors that can change in a signal- and time-dependent manner. 
While some of these receptors, among which β1 integrins, are present also in other 
cell types, the β2 and β7 integrins are exclusively expressed on the cell surface of 
leukocytes (Hynes, 1992). A list of integrins expressed on the cell surface of 
leukocytes is represented in Table 1. 
 
 Table 1. Integrins expressed on leukocytes 
Integrins Ligands 
β1 
   α1β1 (VLA-1) 
   α2β1 (VLA-2) 
   α3β1 (VLA-3) 
   α4β1 (VLA-4) 
   α5β1 (VLA-5) 
   α6β1 (VLA-6) 
 
β2 
   αLβ2 (LFA-1) 
   αMβ2 (Mac-1, CR3) 
   αXβ2 (P150,95) 
   αDβ2 
 
β7 
   α4β7 
   αEβ7 
 
ECM 
ECM 
ECM 
ECM, VCAM-1 
ECM 
ECM 
 
 
ICAMs 
ICAMs, soluble ligands (incl. heparin, C3bi, LPS) 
soluble ligands (incl. LPS, fibrinogen) 
ICAM-3 
 
 
ECM, MadCAM-1, VCAM-1 
E-cadherin 
 
 
The β2 integrins family comprehends four members (Harris et al., 2000), αLβ2 
(CD11a/CD18; LFA-1), αMβ2 (CD11b/CD18; MAC-1), αXβ2 (CD11c/CD18; p150,95), 
and αDβ2 (CD11d/CD18). Each of the β2 integrins recognizes one or more members 
of the intercellular adhesion molecule (ICAM) family (Harris et al., 2000). In addition, 
αLβ2 binds to JAM-1, expressed at the tight junction of resting endothelium 
(Ostermann et al., 2002), and αDβ2 binds to vascular cell adhesion molecule-1 
(VCAM-1) (Van der Vieren et al., 1999), while αMβ2 and αXβ2 can also interact with 
polysaccharides (Wright et al., 1989) (Ingalls and Golenbock, 1995). The RGD motif, 
a critical feature in many integrin ligands, is not required for ligands of the β2 
integrins family. The most extensively studied member of this family is αLβ2. This 
integrin mediates leukocyte migration across the endothelium both during normal 
lymphocyte recirculation and in response to inflammatory signals (van Kooyk et al., 
1989). αLβ2 has also been shown to be involved in the formation of the 
“immunological synapse”, the contact site between T lymphocytes and antigen 
presenting cells (Grakoui et al., 1999). 
The β7 integrins are specifically expressed by distinct subsets of T lymphocytes and 
in the murine immune system they can be found also on subsets of skin-derived 
dendritic cells (DCs) in peripheral lymph nodes (Pribila et al., 2004). This family 
consists of only two members: α4β7, expressed on a subset of memory CD4+ and 
CD8+ T lymphocytes, which binds to the mucosal addressin cell adhesion molecule 
(MAdCAM-1) (Rott et al., 1996), and αEβ7, which interacts with epithelial-specific 
cadherin (E-cadherin) (Cepek et al., 1993; Higgins et al., 1998).Integrins play 
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important roles in various phases of the immune response by mediating cell-
pathogen, cell-cell, and cell-extracellular matrix interactions. They are not merely 
‘sticky’ receptors, but deliver ‘outside-in’ signals across the cell membrane by 
establishing cis associations with other receptors on the same cell, thus forming 
multi-molecular assemblies (Fig. 4).  
 
 
 
Figure 4. β2 integrins and interacting proteins in the immune system. Integrins are 
involved in cell-cell interactions (A), cell-endothelium interactions (B) and cell-pathogen 
interactions (C). Interacting proteins are involved in activation of integrins, signal 
transduction and cytoskeletal rearrangement.  
 
 
Several integrin-associated proteins have been identified that can modulate integrin 
function in different ways: by altering the affinity of the integrin for the ligand by 
directly altering integrin conformation; by multimerization and recruitment of  
additional integrin receptors to form integrin clusters; or by the association of 
integrins with other molecules to form an active signaling complex that also acquires 
increased ligand binding potential. 
Most integrin-associated proteins identified so far do not share any common 
structural relationship (see Table 2). Both GPI-anchored, trans-membrane or 
cytoplasmic proteins have been reported to associate with integrins (Brown, 2002; 
Hemler, 1998; Porter and Hogg, 1998).  
The association of integrins with GPI-linked proteins has raised the question whether 
integrin function could be modulated by the lipid microenvironment on the cell 
membrane. Indeed, evidence is increasing showing that lipid microdomains enriched 
in glycosphingolipids and cholesterol, also known as lipid rafts (see paragraph 
“Plasma membrane organization”) provide scaffolding platforms where different 
types of receptors – including integrins – having similar affinity for a certain lipid 
microenvironment, can meet and subsequently mediate specific signaling events. In 
general, the involvement of integrins in membrane supramolecular complexes 
constituted by proteins as well as specific lipids is an emerging area of research 
particularly important in the immune system. 
Chapter 1 
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Table 2. Integrin-binding proteins 
 
Name Function Integrin Reference 
 
α-actinin 
talin 
myosin-X 
cytohesin-1 
 
 
FAK 
 
RapL 
Rack1 
 
WAIT-1 
Paxillin 
RanBPM 
 
 
JAB-1 
 
 
Calnexin 
 
 
Calreticulin 
 
 
 
ProMMP-2, -9  
 
 
uPAR 
 
 
FcγRIIIB 
CD14 
 
CD9, CD53, 
CD63, CD81, 
CD82, CD151 
 
16K H-ATPase 
 
Kv1.3 
 
 
CD44 
DNAM-1 
 
EWI-2 
 
actin-bundling protein 
actin-binding protein 
motor protein 
ARF guanine 
nucleotide exchange 
factor 
focal adhesion 
associated kinase 
Rap1 interactor 
activated PKC 
receptor 
WD protein 
intracellular adaptor 
molecular scaffold 
protein 
 
Jun activating binding 
protein-1 
 
calcium-binding 
chaperone in ER 
membrane 
calcium-binding 
chaperone in ER 
lumen 
 
pro-matrix metallo 
proteases 
 
urokinase-type 
plasminogen activator 
receptor 
IgG Fc receptor 
LPS-binding protein 
 
Tetraspannins 
 
 
 
ATP-driven proton 
transporter 
voltage-gated 
K+channel 
 
adhesion receptor 
transmembrane 
protein 
transmembrane 
protein 
 
β1, β2 
β1, β2, β7 
β1 
β2 
 
 
β1, β2 
 
αL 
β1, β2 
 
α4β7, αEβ7 
α4β1 
β1, β2 
 
 
β2 
 
 
β1 
 
 
α 
 
 
 
β2 
 
 
αLβ2, αMβ2 
 
 
αMβ2 
αMβ2 
 
β2, α4β1, 
α5β1 
 
 
β1 
 
β1 
 
 
α4β1 
αLβ2 
 
α4β1 
 
(Otey et al., 1990), (Pavalko and LaRoche, 1993) 
(Calderwood et al., 1999; Tadokoro et al., 2003) 
(Zhang et al., 2004)  
(Geiger et al., 2000) 
 
 
(Schaller et al., 1995) 
 
(Katagiri et al., 2003) 
(Liliental and Chang, 1998) 
 
(Rietzler et al., 1998) 
(Hyduk et al., 2004) 
(Denti et al., 2004) 
 
 
(Bianchi et al., 2000) 
 
 
(Lenter and Vestweber, 1994) 
 
 
 
(Rojiani et al., 1991) 
 
 
 
(Stefanidakis et al., 2003) 
 
 
(Xue et al., 1994) 
 
 
(Xia et al., 2002b) 
(Zarewych et al., 1996) 
 
(Rubinstein et al., 1994) 
 
 
(Skinner and Wildeman, 1999) 
 
(Levite et al., 2000) 
 
 
(Nandi et al., 2004) 
(Shibuya et al., 2003) 
 
(Kolesnikova et al., 2004) 
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Antigen recognition 
A central element in immunity is the recognition of invading pathogens by 
leukocytes. Leukocytes can be broadly divided into lymphocytes and phagocytes. 
Phagocytes (monocytes, macrophages, and granulocytes) form the ‘first line’ of 
defense and are equipped with a variety of pathogen uptake receptors including Fc 
receptors (FcR), complement receptors, among which CR3 (the αMβ2 integrin also 
known as Mac-1) and CR4 (the αXβ2 integrin also known as p150/95), and more 
recently discovered carbohydrate-binding proteins (such as C-type lectins and 
scavenger receptors). As discussed above, cross-talk between associating FcR and 
αMβ2 or αXβ2 enhances their functional activity (Ortiz-Stern and Rosales, 2003). 
Using Fluorescence Resonance Energy Transfer (FRET), which allows detection of 
interacting molecules within 10 nm distance, FcRIIIB was shown to interact with 
αMβ2 on neutrophils membrane (Todd and Petty, 1997). In fact, since FcRIIIB is a 
GPI-anchored molecule without intracellular portion, it completely depends on lateral 
association with αMβ2 for signal transduction. This association is invaluable to 
effectively promote antibody-dependent phagocytosis of opsonized microorganisms 
(Todd and Petty, 1997). Similarly, it has recently been shown that an interaction 
between FcγRIII and αMβ2 enhances binding to iC3b, a critical complement-3 
fragment that opsonizes pathogens and apoptotic cells after complement activation, 
on monocytes (Preynat-Seauve et al., 2004). This interaction is lost during monocyte 
differentiation into DCs (Steinman, 1991), potent antigen-presenting cells, where 
binding of iC3b via αMβ2 is impaired (Preynat-Seauve et al., 2004). 
Another GPI-linked molecule that associates with αMβ2 is CD14. This protein binds to  
bacterial lipopolysaccharide and subsequently associates with αMβ2 contributing to 
the generation of proinflammatory cytokines. Interestingly, this association occurs 
only in cell that circulate in the blood and is lost upon adhesion on a substrate, 
emphasizing the dynamic nature of these lateral interactions (Todd and Petty, 1997).  
The integrin αMβ2 is involved in pathogen recognition by mediating adhesion of 
lymphocytes to the fungus Candida albicans (Forsyth and Mathews, 2002). This 
interaction occurs via cooperation between the I domain of the α subunit and the 
lectin-like domain of the β2 chain. The αMβ2-mediated adhesion of lymphocytes to 
C.albicans is a fundamental prerequisite to trigger the antifungal effect of 
lymphocytes and to inhibit hyphal growth of this pathogenic fungus (Forsyth and 
Mathews, 2002). 
Several other microorganisms have also been shown to exploit this β2 integrin to 
gain access into the host cells. For example, interaction between αMβ2 and 
Histoplasma capsulatum, Blastomyces dermatitidis (Newman et al., 1995), 
Mycobacterium tuberculosis (Cywes et al., 1996), and Leishmania sp. (Russell and 
Wright, 1988) have been documented. 
Another member of the β2 integrin family, αLβ2, has been shown to mediate the 
attachment of bacteria to the host cell. More specifically, the periodontopathogenic 
organism, Porphyromonas gingivalis, possess fimbriae on its cell surface that mediate 
adherence to human monocytes. The bacterium uses these fimbriae to bind CD14, 
Toll-like receptor-2 and the αL subunit, thereby inducing production of 
proinflammatory cytokines, such as IL-6. The interaction does not seem to depend 
on the intact αLβ2 dimer, since antibodies against αL, but not β2, inhibited IL-6 
production on monocytes after challenge with P.gingivalis (Ogawa et al., 2002). The 
same integrin also contributes to cell-to-cell transmission of HIV-1 by interacting with 
virus-anchored host ICAM-1 (Bounou et al., 2004; Hioe et al., 2001). In this way, 
virus dissemination exploits interactions between host molecules that are 
incorporated within HIV-1 and their natural counter-receptors. 
A further example of viruses exploiting integrins to gain entry to host cell is the 
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human parvovirus B19 that requires activation of α5β1 for internalization (Weigel-
Kelley et al., 2003). The major cell surface receptor for this virus is the blood group P 
antigen, which only allows binding but not internalization. Replication of the 
pathogenic parvovirus B19 is restricted to erythroid progenitor cells. Mature red 
blood cells, which express high levels of P antigen but not the α5β1 integrin, bind 
parvovirus but do not allow viral entry. By contrast, primary human erythroid 
progenitor cells express high levels of both P antigen and α5β1 which facilitate β1 
integrin-mediated entry of parvovirus B19 (Weigel-Kelley et al., 2003).    
 
 
Antigen presentation 
A stable interaction between a T lymphocyte and an antigen-presenting cell (APC) is 
a prerequisite to effectively trigger the signaling cascade for T cell activation and 
effector function (Miller et al., 2002). 
The sole interaction between TCR and peptide/MHC complex is not strong enough to 
mediate this stable interaction. The αLβ2 integrin, highly expressed on T cells, and 
its counter receptor ICAM-1, present on the surface of APCs, are key mediators of 
this interaction (van Kooyk et al., 1989). More specifically, αLβ2, together with the 
integrin-associated cytoskeletal protein talin, forms an external ring surrounding a 
central area rich in TCR, thus participating to the establishment of the immunological 
synapse (IS) during antigen-dependent interactions with APCs (Monks et al., 1998). 
After 1 hour of conjugation, the TCR disappears from the IS, while clustered αLβ2 is 
present up to 4 hours (Lee et al., 2002). This suggests that prolonged localization of 
αLβ2 at the T cell-APC facilitates molecular engagements at the contact site 
necessary for complete T cell activation, which results in T cell proliferation and 
enhancement of IL-2 production. Besides stabilizing the T cell-APC contact, αLβ2 can 
provide costimulatory signals, other than CD28, that support and promote TCR-
induced T cell activation (Abraham and Miller, 2001; Van Seventer et al., 1990). As 
such, αLβ2 modulates IL-2 transcription level by interacting with Jun-activating 
binding protein 1 (JAB-1) (Bianchi et al., 2000). JAB-1 colocalizes with αLβ2 at the 
cell surface by associating to the integrin cytoplasmic tails. The activation of αLβ2 
induces phosphorylation of the β2 integrin chain and subsequent release of JAB-1. 
The nuclear pool of JAB-1 increases and binding of c-Jun-containing activator 
protein-1 (AP-1)-complexes to their DNA consensus site is enhanced, resulting in 
activation of AP-1-driven transcription (Bianchi et al., 2000). Along the same line, a 
second cytoplasmic protein, cytohesin-1 (Cyh-1), contributes to αLβ2-mediated 
costimulation in a JAB-1 independent manner (Perez et al., 2003). Cyh-1, a guanine-
nucleotide exchange factor originally identified as dynamic regulator of αLβ2 function 
in leukocyte arrest on endothelium (Weber et al., 2001), is able to mediate Erk1/2 
activation that is required for IL-2 production. The underlaying mechanism is based 
on physical interactions between the C-terminal PH domain of Cyh-1 and the β2 
cytoplasmic tail of αLβ2, which results in enhanced clustering of the integrin at the 
cell surface and strengthening of ICAM-1 binding both in monocytic and lymphocytic 
cell lines (Weber et al., 2001).  
An additional partner of αLβ2 that contributes to costimulatory signals is the 
leukocyte adhesion molecule DNAM-1 (CD226) (Shibuya et al., 2003). Upon 
stimulation of peripheral blood T lymphocytes by anti-CD3, physical association 
between αLβ2 and DNAM-1 has been reported. Once associated, cross-linking of 
LFA-1 induces Fyn-mediated tyrosine phosphorylation of DNAM-1. This complex of 
αLβ2, DNAM-1 and Fyn is found at the IS both in CD4+ and CD8+ T cells. However, 
while in CD4+ T cells this complex colocalizes with lipid rafts, on CD8+ T cells the 
αLβ2-mediated costimulatory signal seems lipid raft independent (Shibuya et al., 
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2003). The relevance of this different involvement of lipid rafts in the different T cell 
subsets however remains unclear. 
Interestingly, when DNAM-1 is recruited into lipid rafts, it can associate with another 
αLβ2 interacting protein: the small GTPase Rap-1 (Ralston et al., 2004). The 
constitutively active form of Rap-1 (Rap1V12) increases both affinity and avidity of 
LFA-1 for ICAM-1, thereby regulating adhesion strength between T cell and APC 
(Sebzda et al., 2002). This occurs by association of Rap-1 with its effector RAPL 
(Katagiri et al., 2003). Identified by yeast two-hybrid screening, RAPL was found to 
associate with the constitutively active Rap1V12, but not with inactive Rap-1, and to 
coimmunoprecipitate with αLβ2 in cells expressing Rap1V12 (Katagiri et al., 2003). 
Moreover, in vivo RAPL has been reported to colocalize with αLβ2 at membrane 
protrusions and at the IS, thereby perhaps controlling spatial regulation of  αLβ2 
(Katagiri et al., 2003).  
The interaction of αLβ2 with several partners at the IS triggers multiple lymphocyte 
signaling pathways that eventually will lead to proper T cell activation and expansion. 
 
 
Leukocyte migration 
Resting T lymphocytes continuously circulate between blood and lymph nodes, 
waiting for the right APC to provide the proper stimulus. This constant movement of 
naïve T cells ensures that the immune system continuously surveys for as many 
different intruders as possible. The ability of naïve T cells to enter lymph nodes or 
tissues relays on sets of adhesion molecules that are used in a specific time- and 
space-dependent manner (Butcher et al., 1999). Although the majority of integrins 
on unstimulated T cells exist in an inactive state, a small subset of integrins are in a 
high-affinity state and are particularly important for spontaneous adhesion to 
endothelium (Chen et al., 1999). Under shear flow, the initial interaction of T cells 
with endothelium consists in rolling of the T cells on the endothelial surface. Besides 
selectins, also the integrin α4β1 contributes by establishing quick low-affinity 
interactions with its counter receptor VCAM-1 (Berlin et al., 1995). While affinity 
modulation does not seem to play any role in regulating tethering and rolling, sub-
second induction of α4β1 clustering at the leukocyte-substrate contact zone, upon 
chemokine stimulation, enhances leukocyte avidity to VCAM-1 (Grabovsky et al., 
2000). This α4β1-mediated transient rolling is a pre-requisite for firm adhesion to 
and migration through the endothelial barrier for lymphocytes as well as monocytes. 
Recently, it has been shown that the lateral association of α4β1 with the tetraspanin 
CD81 is critical for rapid adhesion strengthening in monocytes and primary murine B 
cells interacting with VCAM-1 under shear flow (Feigelson et al., 2003).  
Most recent studies show that α4β1 can also mediate firm adhesion of human 
lymphoid cells onto endothelium by forming a bimolecular complex with CD44 (Nandi 
et al., 2004). This receptor mediates rolling of activated T cells on hyaluronan on 
endothelial cells. By both co-immunoprecipitation and transfection studies, it was 
shown that CD44 specifically associates with α4β1 and not with αLβ2, and that its 
cytoplasmic tail is essential for this interaction. Lack of the cytoplasmic tail of CD44 
abrogates the α4β1 function, inhibiting in vivo lymphocyte trafficking to sites of 
inflammation (Nandi et al., 2004). Engagement of α4β1 with VCAM-1 increases 
binding between αLβ2 and ICAM-1 (Chan et al., 2000). More specifically, this α4β1-
mediated enhancement of αLβ2 adhesiveness requires the presence of urokinase 
receptor (uPAR; CD87) as activation transducer on leukocytes cell membrane (May et 
al., 2000). This GPI-linked receptor can, besides its role in the fibrinolytic system, 
upregulate cell adhesion by forming a multimeric receptor complex where tyrosine 
kinase as well as β2 integrins localize (Bohuslav et al., 1995). In this way, the α4 
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integrin which mediates rolling also stimulates the β2 integrins to initiate firm 
adhesion and transmigration. 
The αLβ2-ICAM-1 pair mediates migration of T cells across the endothelium by 
stabilizing the formation of a docking structure between T and endothelial cells 
(Barreiro et al., 2002). Recently, the junctional adhesion molecule-1 (JAM-1) was 
shown to be a ligand of the integrin αLβ2 during T cell transmigration (Ostermann et 
al., 2002).  
T cells must not only cross the endothelium but must also migrate through the 
perivascular basement membrane into the tissue or lymph node.     
The integrin α4β1 promotes cell migration and antagonizes cell spreading. In 
particular, the association of the cytoplasmic protein paxillin to the cytoplasmic tail of 
α4 is essential for α4β1-mediated inhibition of cell spreading (Liu et al., 1999). In 
fact, α4-paxillin interaction promotes focal adhesion kinase (FAK) phosphorylation, 
which in turn is essential for integrin-dependent cell migration and disassembly of 
focal adhesions (Liu et al., 1999). It has been already mentioned that α4β1-CD81 
complexes strengthen the adhesion to VCAM-1 under shear flow. Recently, another 
cell-surface partner of α4β1, the 4 immunoglobulin domains trans-membrane protein 
EWI-2, has been documented to regulate α4β1-mediated inhibition of cell spreading 
rather than interaction with VCAM-1 under shear flow (Kolesnikova et al., 2004). 
EWI-2 sequesters α4β1-CD81 complexes into larger α4β1-CD81-EWI-2 complexes, 
thereby limiting the availability of α4β1 to spread and ruffle on VCAM-1 (Kolesnikova 
et al., 2004).  
Cells move by coordinating the generation of protrusions (lamellipodia) at the front of 
the cell, which lead to new attachments, and the detachment of previous adhesions 
at the rear of the cell. The integrin αLβ2 has been also shown to mediate T cell 
migration on ICAM-1 by influencing the acto-myosin cytoskeleton dynamic 
organization. This occurs by a compartmentalized regulation of myosin light chain 
kinase (MLCK) and Rho kinase (ROCK), at the leading edge and at the trailing edge, 
respectively (Smith et al., 2003). The coordination between these two kinases 
mediates the forward movement of the migrating T cells. 
Interestingly, not only integrins influence the cytoskeleton organization, but the 
cytoskeleton also modulates integrin activity. The specific binding of the cytoskeletal 
protein talin to integrin β subunit cytoplasmic tail leads to conformational 
rearrangements of integrin extracellular domains, thereby increasing the affinity for 
the ligand (Tadokoro et al., 2003). FRET measurements between cyan fluorescent 
protein- and yellow fluorescent protein-fused αL and β2 provided in vivo evidence for 
α−β tail associations in the inactive form that are disrupted or rearranged after talin 
binding and subsequent integrin activation (Kim et al., 2003). The unconventional 
myosin-X (Myo10) is an actin-based motor protein that was recently shown by yeast 
two-hybrid to interact with integrin β subunit cytoplasmic tail (Zhang et al., 2004). 
Knock-down of Myo10 by short interfering RNA impaired integrin function in cell 
adhesion, whereas overexpression of Myo10 stimulated filopodia formation and 
elongation in an integrin-dependent fashion. Moreover, Myo10 is also able to 
relocalize β1 integrins at the tips of the filopodia (Zhang et al., 2004).  Both talin and 
Myo10 bind to the β chain cytoplasmic tail NPXY motif, which is conserved in six of 
eight human β integrin cytoplasmic domains (including β1, β2, and β7), and the 
interaction is mediated by the FERM domain present on both talin and Myo10 
(Tadokoro et al., 2003; Zhang et al., 2004). A tight control of these interactions is 
fundamental to regulate integrin-mediated adhesion and migration. 
Although the mechanism regulating integrin-mediated migration can be common for 
almost all integrins, the integrin repertoire, responsible for different ligand specificity, 
expressed on the cell surface by each immune cell specifically determines the 
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migration routes towards tissues and/or lymph nodes. In this way, integrins 
collaborate with other families of receptors involved in homing, such as selectins and 
chemokine receptors. Recent in vivo studies showed an impaired Th2, but not Th1, 
effector homing to lungs in allergen-challenged β2-null mice (Lee et al., 2003a). 
Moreover, in the spleen, αLβ2 and α4β1 integrins function together to promote both 
T and B cells transit from the marginal zone into white pulp cords (Lo et al., 2003).  
β7 integrins are differentially expressed on two subsets of memory T lymphocytes, 
αEβ7HIα4β7LO and αEβ7LOα4β7HI a, and regulate their trafficking to mucosal sites 
(Rott et al., 1996). In particular, α4β7 is expressed on a distinct subset of memory 
CD4 and CD8 T cells and directs their trafficking to intestinal sites of inflammation, 
while αEβ7 is present on intraepithelial lymphocytes, where it mediates their 
retention between intestinal epithelial cells, and on CD4+CD25+ and CD4+CD25- 
regulatory T cells (Treg) (Lehmann et al., 2002; Rott et al., 1996). The importance of 
β7 integrins in lymphocyte migration into gut-associated lymphoid organs is shown 
by the phenotype of L-selectin/β7 integrin double knock-out mice. In these animals, 
more than 95% lymphocytes were unable to attach to high endothelial venules of 
Peyer’s patches and other lymphoid tissues (Steeber et al., 1998). Using a yeast 
interaction trap screen, a human WD repeat protein, termed WAIT-1, was isolated 
that interacts with the integrin β7 cytoplasmic tail (Rietzler et al., 1998). WAIT-1 also 
binds to the cytoplasmic domains of α4 and αE but not to those of integrin β1, β2, 
and αL subunits. This association of WAIT-1 and β7 integrin was confirmed by 
coprecipitation, and the binding site for WAIT-1 was mapped to a short membrane-
proximal region of the β7 cytoplasmic tail. How this interaction modulates the binding 
capacity of β7 integrins is at present unknown. 
In conclusion, the multitude of integrin mediated interactions illustrates the 
importance of these receptors for the immune system, not only to facilitate migration 
but also to assist in mediating antigen specific signals by stabilizing cell-cell 
interactions. 
 
 
C-type Lectins and lectin-like Receptors 
Cells of the immune system are equipped with many animal lectin and lectin like 
receptors (carbohydrate-binding proteins) many of which are of eminent importance 
for their function. Genomic approaches to define leucocytes in more molecular terms 
have during the past two years led to the identification of a series of genes that 
encode lectin or lectin- like receptors (LLRs) (Figdor et al., 2002; Kogelberg and 
Feizi, 2001). Many of these lectins are members of the calcium dependent C-type 
lectin family (Table 3) and recognize their ligands through the structurally related Ca 
(2+)-dependent carbohydrate-recognition domains (C-type CRDs). A well-defined 
subset, the selectins, primarily function as cell adhesion receptors that play an 
important role in homing of leukocytes. The binding specificity of selectin cell 
adhesion molecules results from an extended binding site within a single CRD. While 
cell-cell contact by recognition of endogenous ligands is a prominent function of both 
selectins and lectin like NK receptors (not discussed here), others are specialized in 
recognition of pathogens and therefore resemble the ancient pattern recognition 
molecules – the Toll like receptor (TLR) family  – that are thought to recognize 
foreign ligands during early phases of the immune response. 
 
 
 
                                                 
a HI and LO indicate high and low expression level, respectively. 
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Pathogen recognition by soluble collectins such as serum mannose-binding protein 
and pulmonary surfactant proteins, but also the macrophage cell-surface mannose 
receptor, is affected by binding of terminal monosaccharide residues characteristic of 
bacterial and fungal cell surfaces. The broad selectivity of the monosaccharide-
binding site and the geometrical arrangement of multiple CRDs in the intact lectins 
may explain their ability to mediate discrimination between self and non-self. 
 
 
C-type lectin-like receptors in leukocyte trafficking. 
The selectins – a family that consists of only three members (E-, L-, and P- selectin) 
- form the prototype C-type LLRs that mediate adhesion and homing to the 
peripheral tissues. Both E- and P selectin are expressed on activated endothelium 
and have been demonstrated to play a major role in lymphocyte extravasation 
(Fig.5).  
 
 
 
 
Figure 5. C-type lectin-like receptors (LLRs) and their dual function. LLRs have an 
important function in mediating contact (DC-T cell contact, T cell activation/co-stimulation) 
between leukocytes and the endothelium (homing). In addition LLRs expressed by DC are 
pathogen recognition receptors, a function they share with TLRs.   
 
 
Sialyl-lewis X (SLeX) is the predominant carbohydrate recognized by E- or P selectin. 
GlyCAM-1 and CD34 expressed at low levels on endothelium can bind to L- selectin. 
More recently LOX-1, originally identified as an endothelial scavenger receptor with a 
C-type LLR structure, was shown to support rolling and adhesion of mononuclear 
leukocytes (Hayashida et al., 2002) as well as of platelets (Kakutani et al., 2000) to 
endothelium. As such LOX-1 plays an important role in leukocyte extravasation upon 
inflammatory stimuli (Honjo et al., 2003). 
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Similarly, the macrophage mannose receptor (MMR) parallels members of the 
selectin family. Through its cysteine-rich domain, MMR can bind to other 
macrophages in marginal zones of the spleen, and to B cells in germinal centers. 
These are thought to direct MMR-bearing cells toward germinal centers during an 
immune response. The finding that several classes of carbohydrates bind MMR 
provides a mechanism for regulating the trafficking and function of MMR-bearing 
cells (Leteux et al., 2000). Recently, MMR was identified on human lymphatic 
endothelium to mediate binding of lymphocytes through L-selectin (Irjala et al., 
2001). Interestingly, MMR is absent on high endothelial venules, indicating that L-
selectin exploits distinct ligands to mediate binding at sites of lymphocyte entrance 
and exit within lymph nodes. Also dermal microvascular endothelial cells express the 
MMR (Groger et al., 2000) and has been associated with the scavenger function of 
MMR, thus providing a first example of the dual function of some of the LLRs (Fig.5). 
Further evidence for a role of C-type lectins in trafficking of dendritic cells comes 
from the observation that ICAM-2, constitutively expressed by endothelium supports 
tethering and rolling of cells expressing DC-SIGN (Geijtenbeek et al., 2000a). DC-
SIGN-ICAM-2 interactions regulate chemokine-induced transmigration of DC across 
both resting and activated endothelium in vitro, indicating that DC-SIGN - next to its 
capacity to bind pathogens (Geijtenbeek et al., 2000a) like HIV-1 - is central to this 
unusual trafficking capacity of DC (Engering et al., 2002a; Geijtenbeek et al., 2000a). 
 
 
Antigen Presenting Cell -T cell interactions. 
Proliferation of leukocytes after antigenic stimulation is always associated with dense 
APC-T cell clusters. There is increasing evidence that also here C-type LLR mediated 
interactions are of importance. We previously showed that DC-SIGN is highly 
expressed on DC, binds ICAM-3, and mediates transient adhesion with T cells 
(Geijtenbeek et al., 2000c). DC-SIGN supports early, antigen non-specific, contact 
between DC and T cells, enabling T cell receptor engagement by stabilization of the 
DC-T cell contact zone (Geijtenbeek et al., 2000c). Interestingly, two other C-type 
LLRs, Dectin-1 (Ariizumi et al., 2000) and DCAL-1 (Ryan et al., 2002), both expressed 
by macrophages and DC, have been proposed to bind T cells as well. His-tagged 
fusion-proteins of both proteins bind to the surface of T cells and promote their 
proliferation in the presence of anti-CD3 antibodies. This suggests that Dectin-1 and 
DCAL-1 on DC bind to as yet undefined cellular ligands on T cells, thereby delivering 
T cell co-stimulatory signals.  
 
 
Antigen uptake by C-type lectin-like receptors. 
Next to the role in cell adhesion several C-type LLRs participate in pathogen 
recognition and uptake. Besides the classical MMR, which is known to act as an 
endocytic receptor, also DEC205 (Mahnke et al., 2000), BDCA-2 (Dzionek et al., 
2001) and DC-SIGN (Engering et al., 2002b; Schjetne et al., 2002) have recently 
been demonstrated to mediate antigen uptake.  
While the MMR delivers antigen to the early endosomes and recycles to the surface, 
DEC-205, BDCA-2 and DC-SIGN deliver antigens to late endosomes or lysosomes 
where they are degraded. Besides the tyrosine based coated pit sequence uptake 
motif present in MMR (table 3), the cytoplasmic domains of DEC 205, BDCA-2, CLEC-
1 and DC-SIGN contain an additional triacidic cluster important for targeting to 
proteolytic vacuoles (Mahnke et al., 2000). Furthermore, a di-leucine motif (Table 3) 
present in the cytoplasmic domain of DC-SIGN is essential for internalization 
(Engering et al., 2002b). The liver sinusoidal endothelial cell associated homologue of 
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DC-SIGN - designated L-SIGN - has the same ligand binding specificities as DC-SIGN 
(Bashirova et al., 2001), but is not expressed by DC. Liver sinusoids are specialized 
capillary vessels characterized by the presence of resident macrophages adhering to 
the liver sinusoidal endothelial cells. The interactions between liver sinusoid 
endothelial cells (LSEC) and leukocytes require expression of adhesion molecules on 
the cell surfaces and appear to constitute a central mechanism of peripheral immune 
surveillance in the liver. MMR and now also L-SIGN are known to be expressed on 
LSEC and may mediate the clearance of many potentially antigenic proteins from the 
circulation, in a manner similar to DC in lymphoid organs. 
 
 
Antigen sensing by Toll-like receptors 
The Toll-like receptor (TLR) family is known as a series of evolutionary highly 
conserved surface receptors that recognize pathogen-associated molecular patterns 
(PAMPs) displayed at the cell surface of micro-organisms (Fig.6). These receptors are 
referred to as pattern-recognition receptors (PRRs) and recognize bacterial 
lipopolysaccharides, peptidoglycans, unmethylated CpG motifs of bacterial DNA or 
double stranded RNA of viruses.  
 
 
 
Figure 6. Toll-like receptors and their respective pathogen-associated molecular patterns. 
 
 
Some TLRs have been shown to form heterodimers, thus broadening their pattern-
recognition potential. For example, TLR-2 must associate with TLR-1 to mediate 
recognition of the triacylated bacterial lipopeptides Pam3CSK4 (Takeuchi et al., 
2000), while cooperation of TLR-2 with TLR-6 leads to recognition of the diacylated 
mycobacterial lipopetide MALP-2 (Takeuchi et al., 2001). Association of TLR-2 with 
an unknown member of the family is necessary for recognition of peptidoglycan 
(Imler and Zheng, 2004). 
TLRs are related to the Drosophila toll receptor family (Akira, 2003) and provide an 
intriguing link between innate and adaptive immunity because of their role in DC 
activation and maturation(Medzhitov and Janeway, 2002). In DCs and macrophages, 
signals through TLRs induce the release of cytokines, such as interferons (IFNs) and 
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IL-12, and the upregulation of accessory molecules for efficient stimulation of T cells 
(Jarrossay et al., 2001). 
In addition to microbial molecules, recent reports showed that also endogenous 
agonists such as heat-shock proteins, inflammatory mediators or extracellular matrix 
fragments can activate TLRs (Biragyn et al., 2002; Johnson et al., 2002; Vabulas et 
al., 2002). TLRs have different localization in the cell. While the majority is expressed 
on the cell surface, TLR9, which recognize internalized CpG DNA, is found in the 
cytoplasm (e.g., TLR-9). Upon stimulation, TLRs activate the transcription factors NF-
kB and AP1, generally leading to the production of inflammatory cytokines, such as 
TNFα and IL-6, and up-regulation of costimulatory molecules CD80 and CD86 on 
DCs(Medzhitov, 2001). Although the majority of TLRs can signal through the 
cytoplasmic factor MyD88 (Takeuchi et al., 2000), at least two members (e.g., TLR-3 
and TLR-4) do not exclusively depend on MyD88 for signaling (Kawai et al., 2001). In 
fact, activation of TLR-4 can trigger cytokine production as well as costimulatory 
molecule induction through MyD88-dependent pathway, while it can stimulate IFN-
inducible gene expression and caspase activation in a Myd88-independent manner 
(Akira et al., 2001). 
Although overexpression studies as well as specific the use of knock-out mice have 
revealed important information about the function of TLRs and have identified 
several microbial components able to activate TLRs, it is still unknown how TLRs 
recognize their ligands. Moreover, it is still unclear whether abnormal TLRs activation 
by endogenous ligands is involved in immunological disorders such as autoimmune 
diseases or chronic inflammatory responses. 
 
 
C-type lectin-like and Toll-like receptors are both pathogen recognition receptors. 
While TLRs mainly act to alert DC, overwhelming evidence now shows that C-type 
LLRs can operate as constituents of the powerful antigen capture and uptake 
mechanism of macrophages and DC as discussed above. As such, like TLRs, LLRs 
recognize PAMPs. Evidence is emerging that LLRs not only play a role as phagocytic 
Pattern Recognition Receptors, but also may synergize or antagonize TLR signals. 
For example, both TLR-4 and several LLRs bind fungi. Dectin-1, the β-glucan 
receptor, mediates attachment and uptake of fungi exploiting its ITAM motif. In 
addition, Candida albicans binds well to MMR (d'Ostiani et al., 2000). TLR-4 deficient 
mice show an enhanced infection rate of C.albicans (Netea et al., 2002). While MMR 
deficient mice show deficient clearing of serum proteins, they do not suffer from 
systemic Candida infections (Lee et al., 2003b; Netea et al., 2002), likely due to 
redundancy in LLRs. 
The C-type lectin BDCA-2 is expressed by plasmacytoid DC, a subset of DC that upon 
viral infection produce IFNs, inducing innate antiviral immunity (Dzionek et al., 
2002). Cross-linking of BDCA-2 using antibodies induces Ca2+ mobilization as well as 
tyrosine phosphorylation of cellular proteins. Moreover, IFN secretion induced by 
various stimuli, such as influenza virus and bacterial DNA, is inhibited by 
simultaneous ligation of BDCA-2, indicating that this lectin modulates signaling of 
TLRs as well. A natural ligand of BDCA-2 has not yet been identified. Also 
mycobacteria can simultaneously interact with TLRs and C-type lectins. Binding of 
mycobacterial lipoproteins to TLRs on DC triggers production of IL-12, essential to 
initiate immune responses to eliminate intracellular mycobacteria (Tsuji et al., 2000). 
Interestingly, several groups recently showed that mycobacterium-derived 
mannosylated lipoarabinomannans (ManLAMs) binds to DC via MMR and DC-SIGN 
and inhibit TLR-mediated IL-12 production (Cooper et al., 2002; Geijtenbeek et al., 
2003; Maeda et al., 2003; Tailleux et al., 2003). These observations suggest that 
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simultaneous binding of mycobacterium components to both MMR, DC-SIGN and 
TLRs may skew the immune system from a protective Th1 response towards a 
tolerogenic Th2 response facilitating immune escape of mycobacteria, demonstrating 
the critical balance between TLR and LLR signals. 
 
 
C-type LLRs specificity as a consequence of differences in ligand glycosylation. 
Several studies report on the importance of glycosylation through transferases and 
how inflammation induced transferase activity can dramatically alter the homing 
behavior of cells. 
L-selectin mediates rolling of lymphocytes on high endothelial venules (HEVs) in 
secondary lymphoid organs by interacting with HEV ligands GlyCAM-1, CD34, and 
podocalyxin. These ligands must be sialylated, fucosylated, and sulfated for optimal 
recognition by L-selectin. In particular glycosyltransferases are responsible for 
formation of branched structures on O-glycans on GlyCAM-1 and CD34 (Bistrup et 
al., 1999).  
While the Gal-6-sulfotransferase shows a wide tissue distribution, GlcNAc-6-
sulfotransferase is highly restricted to HEVs, thereby contributing to different homing 
profiles. Furthermore, whereas endothelial expression of sialyl-LewisX (SLeX) or sulfo 
SLeX glycans in postcapillary venules is either absent or low, strong expression is 
observed in inflamed tissue to recruit leukocytes (Kannagi, 2002). Renkonen et al. 
(2002) show that essentially every organ carries its own pattern of SLeX or sulfo SLeX 
glycans, suggesting that each organ has its own unique glycans code responsible for 
organ selective leukocyte traffic. Their observations also emphasize the major impact 
of small differences in glycosylation on leukocyte homing (Renkonen et al., 2002). 
Moreover, leukocytes from P-selectin glycoprotein ligand-1 (PSGL-1) deficient (PSGL-
1-/-) mice show impaired rolling (Sperandio et al., 2001). Similarly, Core 2 beta1-6-
N-glucosaminyltransferase (C2GlcNAcT-I) deficient mice (core 2(-/-)) show 
dramatically reduced leukocyte rolling due to severely impaired binding of P-selectin 
to PSGL-1 (Xia et al., 2002a), not only demonstrating that PSGL-1 is a major E-/P-
selectin ligand, but also that proper glycosylation is essential. 
As well as inflammatory cytokines, cytokines such as IL-2 and IL-15, secreted during 
productive immune responses, induce transferase activity resulting in altered 
glycosylation of PSGL-1 (Carlow et al., 2001), reinforcing the concept that the 
cytokine milieu directly affects the lymphocyte homing properties. 
Similar to the selectins, ligand binding in the type II C-type lectin group also depends 
on subtle differences in the arrangements of carbohydrate residues and their 
branching. For example, MMR, but not DC-SIGN (Engering et al., 2002b), recognizes 
end-standing single mannose moieties, whereas DC-SIGN has higher affinity for more 
complex mannose residues in specific arrangements (Feinberg et al., 2001; Mitchell 
et al., 2001). Thus, even when C-type lectins share a CRD site and bind mannose-
containing structures, their counter structures differ in carbohydrate branching and 
spacing, creating unique sets of carbohydrate recognition profiles on DC. This is 
illustrated in Fig.7 where different forms of the Lewis X blood group antigen result in 
binding to completely different C-type lectin-like receptors. The cysteine-rich domain 
of the macrophage mannose receptor (MMR) recognizes sulfated oligosaccharides of 
LeX (Leteux et al., 2000); DC-SIGN recognizes the unsialylated form of LeX 
(Appelmelk et al., 2003) and P- and E- selectin have an affinity for both.  
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Multimerization of C-type LLRs. 
Several C-type LLRs are thought to form multimeric complexes, ranging from dimers 
to tetramers. This is one possibility to increase binding of ligands containing 
repetitive sugar moieties (Mitchell et al., 2001). Alternatively, conformational changes 
or clustering of receptors at the cell surface – as observed for integrins - can also 
contribute to strong ligand binding. 
The P-selectin homodimer has unique functional characteristics compared with its 
monomeric form, and dimerization occurs in the endoplasmic reticulum and Golgi 
compartments of endothelial cells (Barkalow et al., 2000). 
Also the CRD of DC-SIGN, when clustered in the tetrameric extracellular domain 
(Mitchell et al., 2001), provides a means of amplifying specificity for multiple 
repetitive units on host molecules targeted by DC-SIGN (Frison et al., 2003) and may 
also explain the interaction of these receptors with the gp120 envelope protein of 
human immunodeficiency virus-1, which contributes to virus infection.  
 
 
 
Plasma membrane organization 
 
The plasma membrane plays a crucial role in the life of cells: it defines boundaries 
and maintains different environments between cytosol and extracellular environment. 
Inside eukaryotic cells, the organellar membranes maintain the essential difference 
between contents of each organelle and the cytosol. In the model proposed by 
Singer and Nicolson about 30 years ago (Singer and Nicolson, 1972), the plasma 
membrane was described as a neutral lipid bilayer forming a two-dimensional 
solution where proteins were homogeneously distributed and free to move laterally 
as well as rotationally.  
However, in the last decade experimental results have been obtained that challenged 
the Singer-Nicolson view, providing increasing evidence that the plasma membrane 
of eukaryotic cell is far from being homogeneous, but is rather a mosaic of differently 
originated microdomains. 
The heterogeneity of the plasma membrane is indicated by the spatial and temporal 
confinement of proteins and lipids in defined nanometric-scale areas of the 
membrane (Jacobson et al., 1995; Maxfield, 2002) (Fig.8). Dynamic events like 
change in mobility or in association between lipids and proteins within these 
microdomains can have a direct impact on the biological functions of these molecules 
and subsequently on cellular processes such as cell activation, ligand-receptor 
recognition, Ag presentation, and cell-cell interactions. 
The nanometric size of these plasma membrane heterogeneities, estimated ranging 
from 700 to 50 nm, has made difficult if not impossible any investigation by 
conventional microscopy. However, in the last two decades, several novel microscopy 
techniques were developed to overcome this problem, and some of them will be 
presented in the next section. 
Hereafter, four different types of membrane microdomains will be discussed in detail.  
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Figure 8. Schematic representation of the various types of microdomains present 
on the cell membrane.. 
 
 
Lipid rafts 
The plasma membrane has a lipid composition that is very distinct from the other 
membranes in the cell. In general, all membranes contain glycerophospholipids, but 
unlike the organellar membranes, the plasma membrane has higher levels of sterols 
and sphingolipids (Fig.9). 
 
 
 
Figure 9. Structure of the major lipidic components of the cell membrane. PE, 
phosphatidylethanolamine; PC, phosphatidylcholine; PS, phosphatidylserine; PtdIns, 
phosphatidylinositol phosphates. SM, sphingomielin; GlcCer, glucosylceramide; GalCer, 
galactosylceramide; LacCer, lactosylceramide. 
 
 
Glycerophospholipids consist of glycerol, two fatty acid chains, one of which is 
usually unsaturated, and phosphatidic acid carrying the head group. Sphingolipids 
contain a C18-C20 sphingoid base, sphingosine, and a fatty acid that is amide-linked 
to the nitrogen (ceramide). They have either a phosphocholine head group 
(sphingomyelin) or a carbohydrate structure (glycosphingolipids). Sphingolipids differ 
from glycerophospholipids in that both fatty acid chains are often saturated. 
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Sterols, with cholesterol being the principal form found in vertebrates, are based on 
a rigid four-rings structure and are present at 30-40 mol % of plasma membrane 
lipids (Lange et al., 1989; van Meer, 1989). 
A second well-known property of the plasma membrane is the different composition 
of the two leaflets of the bilayer. Sphingolipids are almost exclusively present in the 
outer leaflet, while glycerophospholipids such as phosphatidylinositol, 
phosphatidylethanolamine, and phosphatidylserine, are restricted to the inner leaflet 
(Bretscher, 1973). This bilayer asimmetry of the plasma membrane as well as the 
different lipid composition of the organellar membranes are maintained by active 
transport (Sprong et al., 2001). 
Since cholesterol is known to preferentially interact with sphingolipids (Ramstedt and 
Slotte, 2002) and is most abudantly present in the plasma membrane,  it is important 
to discuss its effect on the physical properties of the lipid bilayer (Fig.10). 
 
 
 
Figure 10. Cholesterol content determines the physical properties of the lipid 
bilayer. 
 
 
Pure phospholipid bilayers below their melting temperature Tm exist in a solid or 
“gel” phase that melts above the Tm to a fluid or “liquid” phase (liquid disordered). 
The gel phase is probably not of physiological relevance, but the liquidity/fluidity 
state of the bilayer is significantly altered by the presence of different amount of 
cholesterol. In fact, cholesterol orders the acyl chains of the disordered phase and 
hence reduces permeability (Ohvo-Rekila et al., 2002), favoring the formation of a 
liquid ordered phase (Ipsen et al., 1987). 
The formation of this ordered phase is especially promoted by those lipids that 
contain linear saturated acyl chains, which can pack more easily around cholesterol. 
Sphingolipids are prevalently saturated and in fact they have been shown to favor 
liquid ordered phases, also thanks to their ability to form intermolecular hydrogen 
bonds (Li et al., 2001; Ramstedt and Slotte, 2002). 
Experiments using unilamellar vesicles and artificial membranes have shown that 
liquid disordered and liquid ordered phases can coexist within the same lipid bilayer 
(Mesquita et al., 2000; Wang and Silvius, 2000). The possibility that coexistance of 
two different lipid phases may occurr also in the plasma membrane has provided the 
basis for the development of the “rafts hypothesis” (Simons and Ikonen, 1997). Lipid 
rafts have been defined as membrane microdomains enriched in glycosphingolipids 
and cholesterol that act as platforms where specific membrane proteins can 
segregate. These lipid platforms are lipid-ordered entities that float in a sea of 
disordered phospholipids. Based on this, lipid rafts have been shown to be involved 
in signal transduction (Simons and Toomre, 2000), endo- (Manes et al., 2003; Parton 
and Richards, 2003) or exo- cytosis (Salaun et al., 2004), and membrane trafficking 
(Helms and Zurzolo, 2004). 
The most controversial issues related to lipid rafts are the absolute size, the 
organization, and the lifetime of the raft. 
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Size has been shown to vary from 30 nm to several µm, depending on the system 
studied as well as on the detection method used. In fact, for lipid monolayers studied 
by Atomic Force Microscopy (AFM; see Chapter 2) values ranging from 15 to 200 nm 
were reported (Yuan and Johnston, 2000), and the principle of detection relies on 
the thickness difference between different phases of lipids. In fact, membranes with 
lipids in the ordered phase, therefore also lipid rafts, are supposed to be thicker than 
disordered lipid phase (van Meer, 2002). Comparable values were found by Single-
Particle Tracking experiments, based on difference in lateral mobility (Pralle et al., 
2000), as well as by Transmission Electron Microscopy (TEM; see Chapter 2) studies 
(Prior et al., 2003). However, it should be considered that lipid composition as well 
as dynamic interactions may affect the size of a raft. 
Despite the difficulties in “seeing” lipid rafts and therefore estimating the exact size 
of a raft entity, there is general consensus that these microdomains do exist in the 
cell membrane, although no agreement has been reached regarding the organization 
of lipid rafts. In fact, three models have been proposed to depict lipid rafts. 
The most commonly cited is the hypothesis proposed by Simons & Ikonen (1997), 
where lipid rafts are described as 50 nm structures originating from lipids of specific 
chemistry that spontaneously associate with each other forming distinct lipid 
platforms where certain proteins can be segregated. Alternative view is suggested by 
Anderson & Jacobson (Anderson and Jacobson, 2002) who picture rafts as “lipid 
shells”: proteins that preferentially associate with certain types of lipids would 
recruite these lipid shells into functional structures (the raft) as a dynamic and 
regulated process. The third model assumes that a large fraction of the cell 
membrane is raft-like and exists as a mosaic of domains, the amount of which is 
regulated by a cholesterol-based mechanism (Maxfield, 2002). 
At the moment, one the most challenging question concerning lipid rafts is to 
understand the dynamic of raft formation and therefore the lifetime of these 
microdomains. 
One of the key feature of lipid rafts is their resistance to solubilization by detergents, 
like Triton X-100, at 4°C. Accordingly, association to Triton X-100 detergent-resistant 
membranes (DRMs) has been the first operational criterion to define raft-associated 
proteins (Brown and London, 1997; Schroeder et al., 1998; Simons and Ikonen, 
1997). DRMs can be separated from the rest of the cell lysate by ultracentrifugation 
on a sucrose gradient. However, recent biochemical studies have shown that DRMs 
extracted by using different detergents can vary in their specificity for raft markers 
(Schuck et al., 2003). Therefore, besides detergent extraction, the association of a 
protein with lipid rafts requires also confirmation by additional methods. 
One of these is based on the enriched presence of cholesterol in lipid rafts. It relays 
on the use of specific molecules that are able to disrupt lipid rafts integrity either by 
forming complex with cholesterol within the plasma membrane or by extracting 
cholesterol from the membrane, such as nystatin and methyl-β-cyclodextrin, 
respectively. Therefore, treatment of cells with these compounds specifically 
interferes with the activity of raft-associated proteins. However, it should be noted 
that these agents can have pleiotropic effects that may affect more cell functions 
than just lipid rafts disruption (Brown and London, 1997; Edidin, 2001). 
A third well-established procedure to assess the localization of a given protein with 
lipid rafts is the Ab-induced lateral co-patching of the protein with the raft-associated 
glycosphingolipid GM1 (Simons and Toomre, 2000). The patches of these molecules 
can be subsequently labeled and analyzed by fluorescence microscopy. 
Considering the elusiveness of lipid rafts, all these methods should be used 
simultaneously before establishing the localization of a membrane protein with lipid 
rafts. 
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A further level of complexity in the plasma membrane is represented by the different 
lipid composition of the outer and the inner leaflet. Lipid rafts found in the outer 
leaflet are enriched in sphinoglipids and cholesterol, whereas very little is know about 
the lipid rafts in the inner leaflet, except that they require cholesterol for their 
integrity and that they do not contain sphingolipids. Nevertheless, the outer and 
inner leaflet rafts, where binding receptors and kinases are localized respectively, 
must be coupled somehow to each other to initiate signaling cascade (fig. 11). 
What determines the segregation of proteins into lipid microdomains? 
A very elegant study using Fluorescence Resonance Energy Transfer (FRET) on post-
translationally lipid-modified monomeric GFPs has shown that the nature of the lipid 
anchor was sufficient to determine the localization of the modified protein in specific 
submicroscopic domains in the plasma membrane (Zacharias et al., 2002). 
The plasma membrane compartmentalization, especially in the form of lipid rafts, has 
been shown to be particularly important in cells of the immune system.  
In fact, the involvement of lipid rafts in multichain immunoreceptors such as T-cell 
Ag receptor or B-cell Ag receptor has been extensively studied (Dykstra et al., 2003; 
Horejsi, 2003). 
 
 
 
 
Figure 11. The lipid composition of inner and outer membrane leaflets is different. 
GPI-anchor is known to target proteins to the outer leaflet lipid rafts, while prenylation or 
acylation favors insertion of proteins in the inner leaflet lipid rafts. No clear motives are 
determined for localization of transmembrane proteins in lipid rafts. Moreover, it is not known 
yet how outer and inner leaflet lipid rafts are connected to each other. 
 
 
Clustered rafts provide stable and efficient signaling platforms for ligand-engaged 
immune receptors. Also, lipid rafts have been shown to play a very important role in 
the spatial organization of peptide-MHC class II complexes on APC surfaces 
(Karacsonyi et al., 2004; Poloso and Roche, 2004). Finally, recent studies have 
documented the key role played by lipid rafts in the life cycle of a variety of 
pathogenic viruses, bacteria, and parasites (van der Goot and Harder, 2001). The 
emerging general picture is that lipid rafts facilitate the access of pathogens by 
concentrating cellular receptors for the pathogen, regulate pathogen intra-cellular 
trafficking towards specific replication subcellular sites, and finally mediate the 
assembly and the subsequent budding of enveloped viruses (Manes et al., 2003). 
Clearly, a future challenge will be to unravel the molecular mechanism underlying the 
ability of rafts to recruite and concentrate signaling receptors and their accessory 
proteins in the plasma membrane plane. The detection of protein-rafts interaction 
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and the identification of lipid contents of rafts in living cells will require new 
technology that combines spatial and temporal high-resolution. 
 
 
Caveolae 
Classically, caveolae are defined as specific flask-shaped invaginations of 50-100 nm 
diameter, enriched in cholesterol, glycosphingolipids, and GPI-linked proteins, 
characterized by the presence of the protein caveolin (Fig.8). 
Three members of the caveolin gene family have been cloned to date: caveolin-1, 
which is in two isoforms, α and β (Glenney and Soppet, 1992), caveolin-2 (Scherer et 
al., 1996), and the largely muscle-specific caveolin-3 (Tang et al., 1996). These 
molecules are similar in structure and function but differ in their cellular distribution 
and specific properties. All caveolins have a central 33-amino acid long hydrophobic 
domain that adopts a hairpin conformation into the membrane, leaving both N- and 
C-terminus facing the cytoplasm. Caveolin-1 as well as caveolin-2 can form homo- or 
heter-oligomers that are believed to form the ridges of the caveolar coat. Caveolin-1 
and –3, but not caveolin-2, are plamitoylated in three cysteines at the C-terminal 
region, which is supposed to strengthen the association with the membaren that is 
already mediated by the hydrophobic domain. 
Caveolae are particularly abundant on endothelial cells, adipocytes, fibroblasts and 
lung epithelial cells (Smart et al., 1999), and have been implicated in the transcytosis 
of macromolecules (Predescu et al., 1997; Predescu et al., 2001), in cholesterol 
transport (Gargalovic and Dory, 2003), and in signal transduction (Shaul and 
Anderson, 1998). Also, caveolae have been shown to play an important role in 
endocytosis of macromolecules as well as in the internalization of several 
microorganisms. 
An endocytic process peculiar to caveolae is potocytosis, a poorly-understood 
mechanism for pumping ions and small molecules into the cytoplasm of a cell, during 
which caveolae are transiently closed but do not leave the plasma membrane, and no 
endosome is formed (Anderson et al., 1992). 
Many pathogens have been found to require caveolae-mediated endocytosis to gain 
entry into the host cell. Viruses such as Simian virus 40 (SV40) or Respiratory 
Syncytial virus (RSV) have been shown to associate with flask-shaped caveolae. In 
fact, SV40 binds to MHCI, caveolin-1 is recruited around the virus, and the SV40-
containing caveolae pinch off the plasma membrane, targeting their load to the ER 
via a specific organelle called caveosome (Pelkmans et al., 2001; Stang et al., 1997). 
RSV interacts with the DCs membrane at sites rich in GM1, and after internalization 
the virus can be found in caveolin-poisitive vacuoles (Werling et al., 1999). 
One of the best characterized interactions between bacteria and caveolae is the entry 
of the type 1 fimbriated Escherichia coli into murine bone marrow derived mast cells 
(Shin et al., 2000). The type 1 fimbrial adhesin, FimH, of E.coli binds to its receptor 
CD48, a GPI-anchored protein on mast cell plasma membrane, thereby mediating the 
uptake of E.coli into mast cells in a compartment particularly rich in cholesterol, GM1, 
and the protein caveolin-1. Since caveolae or lipid rafts are believed to naturally 
avoid fusion with lysosomes, bacteria that gain entry through caveolae have found a 
way to survive intracellularly. 
The bacteria Chlamydia trachomatis is also able to exploit caveolae to invade 
phagocytic and non-phagocytic cells (Norkin et al., 2001). In fact, the entry is 
inhibited by rafts- or caveolae-disrupting agents (methyl-β-cyclodextrin or filipin) and 
the cellular compartments containing the bacteria are positive for caveolin-1. 
Considering what is known about lipid rafts and caveolae, it seems reasonable to 
postulate that caveolae can be considered as a specialized form of lipid rafts. In fact, 
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although lipid rafts exist in all cells while caveolae occur only in some specific cell 
type, both types of microdomains have similar lipid composition and seem to be able 
coexist in the same cell type. 
 
 
Tetraspanins 
The tetraspanins are a large superfamily of proteins with four transmembrane 
regions that are found in all cells but erythrocytes (Boucheix and Rubinstein, 2001). 
Although several classes of proteins can span the plasma membrane four times, 
tetraspanins are characterized by distinct structural features: a small outer loop 
(EC1), a larger outer loop (EC2), a small inner loop (IL) and two short cytoplasmic 
tails (Fig.12). Moreover, they have 4-6 conserved extracellular cysteine residues in 
EC2 and polar amino acids within the transmembrane domains (Stipp et al., 2003).  
 
 
Figure 12. Representation of the general structure of a tetraspanin. The length of 
different parts of the molecules can vary among different tetraspanins. The amino and 
carboxy termini are located in the cytoplasm. 
 
 
The major role of tetraspanins is to organize cell surface receptors into active 
complexes that can mediate important cellular processes such as adhesion, 
migration, co-stimulation, and signal transduction (Berditchevski, 2001; Hemler, 
2001; Yanez-Mo et al., 2001). Fundamental to all these processes is the ability of 
tetraspanins to interact with each other, thereby forming multimolecular membrane 
microdomains also known as ‘tetraspanin web’ (Charrin et al., 2003a; Rubinstein et 
al., 1996). These interactions occur between their transmembrane domains leading 
first to the formation of the so-called tetraspanin core. Clusters of tetraspanin cores 
would eventually lead to the formation of larger tetraspanin microdomains. Proteins 
that specifically interact with the EC2 domain of a tetraspanin would also be recruited 
in these microdomains (Yunta and Lazo, 2003). Therefore, the participation of the 
tetraspanins in the core as well as the nature of the individually associated proteins 
provides great variability and further complexity to these domains (Fig. 13). 
Although tetraspanins (except for CD37 and CD53 that are specific for the immune 
system) are ubiquitously expressed, recent studies have shown an increasing interest 
on the function of these proteins in the immune system. In fact, leukocytes express 
20 of the 28 known tetraspanin proteins on their plasma membrane, and association 
of these tetraspanins with other proteins such as signaling molecules, 
immunoreceptors, and integrins is widely documented (Tarrant et al., 2003). The 
importance of tetraspannins in the immune system has been underlined by 
tetraspanin-deficient mice, which have a phenotype in various arms of the immune 
system.  
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Figure 13. Hypothetical formation of a tetraspanin microdomain. The tetraspanin 
binds to a protein, which may be specific for each tetraspanin, on the plasma membrane. This 
heterodimer can be incorporated into a larger complex, where the tetraspanin proteins form 
the core. Furthermore, this complex can interact with similar compexes, giving origin to a real 
tetraspanin web. The involved tetraspanins are determined by their pattern and level of 
expression, as well as by the presence of specific partners, which may also be different from 
cell to cell. These variations confer a great number of possible combinations that can be 
reflected in functional differences. TS: any of the tetraspanin proteins. P: receptor or 
membrane protein. 
 
 
One of the mechanisms by which tetraspanins regulate leukocyte signal transduction 
could be to serve as a bridge between signaling molecules and the cytoplasmic 
domains of cell surface receptors. For example, the tetraspanin CD63 has been found 
to associate with tyrosine kinase activity and CD11/CD18 integrin transmitting an 
activation signal in neutrophils (Skubitz et al., 1996). Conversely, other studies have 
suggested a role for tetraspanins as barrier to segregate signaling molecules and 
surface receptors in order to avoid inappropriate signaling. In fact, on T cells, CD81 
and CD82 have been shown to sequester CD4 within tetraspanin domains where 
tyrosine kinase Lck is absent, thereby preventing CD4-mediated signaling (Imai et 
al., 1995). Also, engagement of CD37 has been shown to significantly reduce T cell 
proliferation, and similarly mice CD37-/- T cells have been found to enter first division 
earlier than wild-type T cells and to have an enhanced early IL-2 production (van 
Spriel et al., 2004). 
The most extensively investigated tetraspanin molecular interactions are those 
involving integrins (Berditchevski, 2001). Especially interactions between β1 integrins 
and tetraspanins are widely documented. CD81 has been reported to strengthen 
rapid adhesion of α4β1 to VCAM-1 in monocytes and primary murine B cells under 
shear flow (Feigelson et al., 2003). A similar effect was shown for the tetraspanin 
CD151 and α6β1 integrin (Lammerding et al., 2003). Similarly, anti-CD81 antibody 
were shown to induce T cell-B cell collaboration by activating the β2 integrin LFA-1 
on T cells (VanCompernolle et al., 2001). Also, a functional association between 
CD82 and LFA-1 has been reported to enhance T cell activation (Shibagaki et al., 
1999). 
Recent studies demonstrated that palmitoylation (i.e. the post-translational addition 
of palmitate, a 16-carbon saturated fatty acid, usually to membrane proximal 
cysteine residues) is essential for stabilization of tetraspanin-tetraspanin interactions 
(Charrin et al., 2002; Yang et al., 2002). Since palmitoylation allows targeting of 
certain cytoplasmic proteins to the plasma membrane as well as recruitment of 
proteins into lipid rafts, the evaluation of tetraspanin complexes in relation to other 
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plasma membrane microdomains, such as lipid rafts, is a current area of interest 
(Claas et al., 2001). Although a physical and functional link has been demonstrated 
between cholesterol and tetraspanins (Charrin et al., 2003b), the common view is 
that tetraspanin complexes are autonomous domains that can exist inside or outside 
lipid rafts (Claas et al., 2001; Kropshofer et al., 2002). In fact, it has been recently 
proposed that the surface of APC could be populated by MHC class II molecules 
organized in at least two distinct membrane microdomains: one set of MHC II 
molecules irrespective of their antigen cargo residing in lipid rafts, and a tetraspan-
associated MHC II molecules population carrying a selected set of antigenic peptides, 
which may be important for antigen presentation and T cell stimulation (Kropshofer 
et al., 2002). 
In summary, tetraspanins should be considered molecular facilitators as well as 
transmembrane linkers that constitute a novel type of protein/lipid microdomain the 
functional potential of which remains to be elucidated. 
 
 
Transient confinement zone   
Artificial membranes have been succesfully used to investigate several membrane 
dynamic processes. However, the observation that phospholipids in the plasma 
membrane have a long-range diffusion rate 5 to 100 fold slower than in artificial 
membranes (Sonnleitner et al., 1999; Swaisgood and Schindler, 1989) has puzzled 
biologists for many years. Recently, a study, in which single-particle tracking with 
temporal resolution of 25 µs together with single-molecule fluorescence microscopy, 
demonstrated that the lateral diffusion of phospholipids in cell membranes is 
confined in 230-nm compartments (Fujiwara et al., 2002). Within these 
compartments, the typical nonraft lipid molecule DOPE (1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine) has been shown to laterally diffuse as fast as in artificial 
membranes. This demonstrated that the lateral diffusion on the cell membrane is not 
per se slow, but it is limited by the existance of membrane compartments. DOPE has 
been also shown to reside within a compartment for 11 ms on average before 
hopping to the adjacent compartment. In this study, it was also demonstrated that 
the membrane-associated actin meshwork is responsible for the formation of these 
transient confinement zones (TCZs) (Kusumi and Sako, 1996). In fact, various 
transmembrane proteins that are anchored to the actin mesh underneath the cell 
membrane act as “rows of pickets” that define the compartments, thereby 
temporarily confining phospholipids (Fig. 8). 
These TCZs were found in several cell types, suggesting that the formation of 
ultrafine membrane compartments for molecular diffusion might be a universal 
concept for all eukaryotic cells (Murase et al., 2004). Moreover, Nakada et al. 
(Nakada et al., 2003) demonstrated that accumulation of actin-anchored proteins 
formed membrane diffusion barriers during neuronal polarization and development. 
Dietrich et al. (Dietrich et al., 2002) investigated physical and chemical 
characteristics of the TCZs in relation to lipid rafts, demonstrating that trapping of a 
certain lipid or protein in a TCZ is not simply due to particles encountering a much 
more viscous region (represented by the different lipid composition of the raft). In 
fact, they found that the same TCZ can be revisited by the same particle, implying a 
stable location for the TCZ, most probably originating from membrane-cytoskeleton 
interactions. Moreover, unlike lipid rafts, the TCZ abudance is temperature 
independent. Therefore, they postulated that rafts could be considerably smaller than 
the measured TCZ diameter and that the entire raft unit might diffuse within the 
TCZ. This would explain why cholesterol depletion seems to prevent extensive 
transient confinement. 
Chapter 1 
 38 
In summary, this membrane-skeleton-fence model (Kusumi and Sako, 1996) 
suggests that the lateral compartments or TCZs might be necessary to preserve 
spatial information of signal transduction in the membrane. 
 
 
 
AIM OF THIS THESIS 
 
DCs are the sentinels of the immune system and act at the interface between innate 
and aquired immunity. During their life-time, DCs establish several dynamic 
interactions: they recognize invading microorganisms or nascent tumor cells, migrate 
on extracellular matrix, roll on and adhere to endothelial cells, and instruct 
lymphocytes to eliminate dangerous antigens. 
All these interactions are mediated by specific membrane receptors, among which 
the β2 integrin LFA-1 and the C-type lectin DC-SIGN. Interestingly, these receptors 
have two common ligands, ICAM-2 and ICAM-3. While LFA-1 is present on 
monocytes as well as on monocyte-derived DCs, DC-SIGN expression is quickly 
upregulated during differentiation of monocytes into DCs. However, LFA-1-mediated 
adhesion rapidly decreases during DC development, and while on DCs binding to 
ICAM-1 is completely lost, interaction with ICAM-2 and ICAM-3 become exclusively 
DC-SIGN dependent.    
The aim of this thesis was to investigate the relation between organization at the cell 
surface and functional activity of LFA-1 and DC-SIGN. Particularly, Transmission 
Electron Microscopy (TEM) and Near-field Scanning Optical Microscopy (NSOM) have 
been employed to study the cell surface distribution pattern of these receptors at 
high resolution. Moreover, the interactions of LFA-1 and DC-SIGN with other 
components of the cell membrane, such as lipid rafts, have been determined. 
A description of the high-resolution microscopy techniques available for studying cell 
surface receptors is given in Chapter 2. During my PhD, I developed a TEM on 
whole-mount approach to investigate cell surface distribution of membrane receptors 
at high resolution. This approach is widely described in Chapter 3 and 4. In Chapter 
3, we show that LFA-1 activation state changes during development of monocyte-
derived DCs along with major modification of its organization within the cell 
membrane. In chapter 4, by using EM, we describe the distribution of DC-SIGN in 
well-defined microdomains at the cell surface of immature DCs that serve as portals 
for virus entry. As a result of a challenging multidisciplinary project involving 
biologists and physicists, the distribution of DC-SIGN in microdomains on DCs was 
also studied by NSOM imaging for the first time sub-micron sized microdomains on 
whole cells under liquid conditions (Chapter 5). Finally, in Chapter 6 I demonstrated 
that DC-SIGN, besides being a very efficient virus receptor, is also able to recognize 
fungi such as C.albicans, and in Chapter 7 I investigated the carbohydrate specificity 
of DC-SIGN in fungal recognition. 
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High-resolution microscopy to study cell 
membrane receptors. 
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High-resolution microscopy 
 
The term “resolution” indicates the ability to distinguish two separate items from one 
another. Resolution can be quantified as the smallest distance between two objects 
in which the objects still appear to be separate. The resolution limit that can be 
achieved in light microscopy is directly related to the wavelength of the light. This 
phenomenon is known as <diffraction limit> and originates from the fact that it is 
impossible to focus light to a spot smaller than half its wavelength. Therefore, the 
maximal resolution in light microscopy is equal to ½ wavelength. Since the 
wavelength of blue light is 400 nm, the theoretical resolution of an optical 
microscope is about 200 nm (Fig. 1). That means that it is never possible to resolve 
two objects in the light microscope that are separated by less than 250 nm. Since 
increasing evidence indicates that dynamic cell-signaling events start by interaction 
of individual proteins at the molecular scale, imaging techniques with a higher 
resolution are necessary. 
 
 
Figure 1. Sizes of of cells and their components on a logarithmic scale, indicating the range 
of resolvable objects in light and electron microscopy. 
 
 
Electron Microscopy 
The development of the electron microscope (EM) started in early 1930’s encouraged 
by the spatial resolution barrier of light microscopes (Spence, 2003). The first type of 
electrone microscope to be developed was the Transmission Electron Microscope 
(TEM). TEM exactly mirrors its optical counterpart except that it uses a focused beam 
of electrons instead of light to examine objects on a very fine scale. A TEM can be 
compared to a slide projector that shines a beam of light through the slide; this light 
will be affected by the structures and objects on the slide. Therefore, certain parts of 
the light beam will be transmitted through certain parts of the slide. The transmitted 
beam is projected onto a screen, producing an enlarged image of the slide. A TEM is 
schematically represented in Fig. 2. 
The basic steps involved in TEM are: 
a) an electron source (called electron gun) that forms a stream of highly 
energetic electrons, which are accelerated toward the specimen by a positive 
electrical potential; 
b) the electron stream is confined into a thin, focused, monochromatic beam by 
using metal apertures and magnetic lenses; 
c) a magnetic lens focuses the electron beam onto the sample; 
d) the electron beam strikes the specimen and parts of it are transmitted. 
The image is the result of beam electrons that are scattered by the specimen versus 
those that are not.  
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Figure 2. Principal features of a light microcope and a transmission electron 
microscope. The similarities of the overall design are shown. The TEM requires that the 
specimen is placed in a high-vacuum environment.  
 
 
The principle of the high resolution capacity of EM derives from the fact that 
electrons, when excited, travel in a wave-like fashion identical to that of light, but 
with the advantage that their wavelength is as small as 0.004 n. This would provide 
a theoretical resolution of 0.02 Å, however, because the aberrations of the electron 
lens are hard to correct, the practical resolving power of most modern TEMs is, at 
best, 0.1 nm (1 Å). 
Since electrons are strongly scattered by collision with air molecules, the EM must be 
run under high-vacuum conditions. Therefore, there is no posibility of viewing 
biological specimens in the living, wet state. In fact, tissues or cells must be 
chemically fixed and subsequently dehydrated before being analyzed by EM. 
Moreover, since the electron beam has a very limited penetrating power, specimen 
usually must be cut into thin sections (typically 30-100 nm thick) before TEM 
analysis. 
In the TEM, contrast is achieved by staining the specimen with an electron-dense 
material (e.g. uranyl acetate): some of the electrons passing through the specimen 
will be scattered by electron-dense structures while other electrons will simply pass 
through unstained parts of the cell. In this way, the scattered electrons are lost from 
the beam, and the stained structures will appear dark (Fig. 3). 
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Figure 3. Section of immature DC adherent to a fibronectin-coated coverslips. 
 
 
In order to visualize specific proteins in a biological sample, immunogold EM is 
performed. This coinsists of labeling the desired protein with specific primary 
antibody, followed by a secondary antibody to which colloidal gold has been 
attached. Gold is electron-dense and will appear as black dots on the image. 
Immunogold EM can be performed on thin sections as well as on entire cells, the 
latter technique also known as whole-mount. In this approach, cells are not 
sectioned, instead they adhere to a substrate (formvar) and the whole cell surface is 
available for gold labeling and subsequent TEM analysis. This method has been 
successfully applied to detect spatial distribution of several membrane proteins such 
as the potassium channels Kv1.3 (Panyi et al., 2003) and the IL-2 receptor α-subunit 
(Vereb et al., 2000). 
An electron microscopic image is essentially a two-dimensional projection of a certain 
object, in which features coming from different levels (height) cannot be separated 
but instead overlap. A possible remedy is the “optical sectioning” approach that 
allows the reconstruction of 3D information starting from 2D imaging. Electron 
tomography (ET) acquires projections of the specimen from different directions; 
subsequently, these projections are computationally merged in order to reconstruct 
the volume of the imaged object (Koster et al., 1997). ET can be used for 3D 
imaging of macromolecular and cellular structures (Baumeister, 2002). The 
projection images are acquired by tilting the specimen incrementally around an axis 
that is perpendicular to the electron beam. Although a major limitation is represented 
by the specimen thickness, which should be lower than 500 nm, ET has been 
succesfully used to image isolated organelles (Murk et al., 2003) as well as 
supramolecular assemblies (Frangakis et al., 2002). 
 
 
Atomic Force Microscopy 
The invention of the scanning tunneling microscope (STM) (Binnig, 1983) has 
stimulated detailed analyses of surfaces both in material sciences and, more recently, 
in biology and biochemistry. It enabled the visualization of the atomic and molecular 
structure of surfaces. This instrument was the first in a row of newly developed 
scanning probe microscopes that all have in common a sharp probe that is scanned 
over a surface. While scanning, an interaction between probe and sample is 
measured in these instruments, from which an image is reconstructed. In a second 
type of scanning probe microscope, the atomic force microscope (AFM) (Binnig, 
1986), the interaction force between probe and sample is exploited to maintain a 
constant distance between the two objects (Fig.4). 
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Figure 4. Schematic view of an Atomic Force Microscope (AFM) setup.  
 
 
The most important characteristic of the AFM is its ability to image objects in liquids 
(Marti, 1987), which is of special importance for biological studies because it allows 
visualization of biological structures in their native environment (Henderson et al., 
1992). Development of imaging routines and modes of operation adapted for the 
measurement of the soft biological objects (Hansma, 1994; Putman et al., 1994) has 
significantly contributed to the reduction of damage done to these objects by the 
scanning tip (Fig. 5). 
 
 
 
Figure 5. Imaging in 
tapping mode by AFM in 
liquid. A) Height plot of 
purified ALCAM molecules 
spread on a mica surface; B) 
3D-reconstrution of the height 
image. C) Living mouse 
fibroblast adherent to a glass 
coverslip.  
 
 
 
 
 
 
 
 
 
 
Therefore, AFM has become one of the most popular tools to image biological 
objects with subwavelength resolution. Besides imaging surfaces, the AFM can also 
be exploited to obtain additional information from a sample. The interaction force 
between tip and sample can be measured by moving the AFM tip perpendicular to 
the surface while measuring the force on the tip. With these so-called forcedistance 
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curves it appeared possible to detect surface interaction forces, either continuously 
(Burnham, 1989) or discretely (Hoh, 1992; O'Shea, 1992). Moreover, the position 
accuracy and force sensitivity of an AFM probe even allowed detection of single 
molecular bonds (Florin et al., 1994). This method of detecting individual bonds is 
straightforward: the force probe, functionalized with a biomolecule, is brought into 
contact with a surface that is covered with the counter-molecule (Fig. 6) and a 
molecular bond is formed. Upon retraction of the tip from the surface, the bond is 
broken and the adhesion force measured at that point represents the rupture force 
of the molecular pair. 
 
 
Figure 6. Schematic representation of the tip-substrate configuration used in the 
initial studies on measurement of rupture forces of individual molecules. The force 
probe of the AFM was functionalized with a monolayer of the molecules of interest. The 
substrate was also densely packed with the counter-molecule. 
 
 
Grubmuller and co-workers (Grubmuller et al., 1996) as well as Florin and co-workers 
(Florin et al., 1994) demonstrated the capability of AFM to measure discrete and 
biologically specific rupture forces of molecular complexes. They chose to investigate 
the biotin-streptavidin system because it is one of the strongest noncovalent 
interactions in nature. These two initial publications have substantially contributed to 
the development of a new field of experimentation using AFM: measurement of inter 
and intramolecular interactions in situ. Several investigators reproduced and 
extended the (strept)avidin-biotin findings by determining the bond strength with 
discrete methods (Allen et al., 1996; Chilkoti et al., 1995; Moy et al., 1994; Wong et 
al., 1998) or with statistical analysis (Lo, 1999). This was followed by the 
measurement of intra or intermolecular rupture forces of other biomolecules with 
lower affinities, including antibody-antigen (Hinterdorfer et al., 1996; Willemsen et 
al., 1998), membrane receptor-ligand pairs (Baumgartner et al., 2000; Lehenkari and 
Horton, 1999), and flexible molecules such as titin (Carrion-Vazquez et al., 1999) and 
tenascin (Oberhauser et al., 1998). 
Clearly, AFM has become a versatile instrument to stretch and disrupt individual 
molecules and molecular complexes. However, thus far, the AFM force 
measurements on individual molecules have only been reported on rather isolated 
systems that hardly resemble the ones in the physiological situation. If the 
instrument is to be exploited to solve, for instance, immunological questions that 
require a cascade of molecular reactions and interactions, it should be adapted for 
the detection of biomolecular interactions in systems containing multiple molecular 
components. Here it is essential that the resolution of the AFM is high enough to 
resolve individual molecules, so that cooperative processes between homogeneous 
and heterogeneous sets of molecules can be discerned. 
Another disadvantage of the force measurements with an AFM is that force is 
generated in only one direction. Especially in the case of rupture force 
measurements, this might not be the energetically mostly preferred way to separate 
complexes. Although the use of flexible cross-linkers also allows rotational degrees of 
freedom that might be favorable in the disruption process, it would be extremely 
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interesting to be able to generate and measure the lateral and torsional forces in a 
directed way to see the effect on the rupture forces. 
Compared to other nanoscopic force measurement devices, such as optical and 
magnetic trapping and micropipettes, the AFM has the disadvantage that it is a 
surface technique, implying that the hydrodynamic damping is higher than in bulk 
liquid, and thus the force sensitivity is intrinsically lower than those other techniques 
(Gittes, 1998). However, most rupture force experiments are performed on molecular 
complexes that are formed in or on top of a biological surface, e.g., the cell 
membrane. Here, surface effects, like discrete layering of fluid, electrostatic, and van 
der Waals attraction, might influence the functioning of the biological system, and 
the AFM might be the most suitable technique to study these effects after all. 
 
 
Near-field Scanning Optical Microscopy  
Fluorescence microscopy has gained a firm position among the most important 
research tools in modern cell biology. It offers high chemically specific contrast, and 
is non-invasive, and sample handling is non-destructive and therefore allows the 
study of living cells. Moreover, optical detection is very fast, providing picosecond 
time resolution, and the very nature of light offers additional contrast mechanisms 
(e.g. based on polarization or phase discrimination) that yield additional information. 
Furthermore, imaging can be performed in three dimensions by multi-photon 
excitation, confocal detection or deconvolution techniques. Finally, a wide range of 
ultra-sensitive detectors, e.g. cooled CCD (charge-coupled device) cameras, photon-
counting devices and other equipment are available that make optical detection 
extremely sensitive, even down to the single-molecule level. The ability to tailor 
fluorescent fusion proteins, exploiting the strong auto-fluorescence of the green 
fluorescent protein (GFP) family (Patterson et al., 2001), has fueled interest in 
fluorescence microscopy even further. The most successful applications of these 
fluorescent proteins are in gene expression, protein targeting and trafficking, and 
protein-protein interaction studies (Lippincott-Schwartz et al., 2001; Tsien, 1998). 
Employing various forms of these fluorescent proteins, in most cases using 
fluorescence resonance energy transfer (FRET) as a read-out (Wouters et al., 2001), 
highly potent cellular indicators for calcium (Miyawaki et al., 1999; Miyawaki et al., 
1997), pH (Llopis et al., 1998), cyclic AMP (Zaccolo et al., 2000), cyclic GMP (Honda 
et al., 2001), caspases (Harpur et al., 2001), and small G protein activity (Mochizuki 
et al., 2001), among others, have been developed.  
The limit to the resolution that can be reached in optical imaging techniques is 
directly related to the wavelength of the light. This diffraction limit originates from 
the fact that it is impossible to focus light to a spot smaller than half its wavelength. 
In practice this means that the maximal resolution in optical microscopy is ~250-300 
nm. Since a large body of evidence indicates that dynamic cell-signaling events start 
by oligomerization and interaction of individual proteins (i.e. at the molecular scale), 
the need for imaging techniques that have a higher resolution is growing. 
Traditionally, high-resolution cell biology (Table 1) is the arena of electron 
microscopy, which offers superb resolution but lacks the above-mentioned 
advantages of fluorescence microscopy.  
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Table 1. High-resolution imaging in cell biology 
Type Subtype Remarks Application References 
 
 
 
Light 
Microscopy 
 
Wide field, phase-contrast, 
differential interference 
contrast (DIC), etc. 
 
Confocal Laser Scanning 
Microscopy (CLSM) 
 
Total Internal Reflection 
Fluorescence microscopy 
(TIRF) (Evanescent wave 
microscopy) 
 
Reflection contrast microscopy: 
interference reflection 
microscopy (IRM)  
 
 
• max. resolution 250 
nm 
• spectral, 
polarization and 
phase contrast 
• relatively easy to 
do 
• widely accessible 
• non invasive 
• possible on living 
cells 
• dynamics; protein 
diffusion, targeting 
and trafficking 
 
• TIRF: cell-substrate 
contact zone, tunable 
penetration depth 
• DIC: Cell-substrate 
contacts, focal 
adhesion  
• Intermolecular and 
intramolecular 
dynamics by FRET 
• CLSM, FRAP 
 
• Various microscopy 
imaging 
• Single Molecule 
Imaging (Table 2) 
 
(Smilenov et al., 
1999) (IRM) 
 
(Lippincott-
Schwartz et al., 
2001) (FRAP) 
 
(Toomre and 
Manstein, 2001) 
(TIRF) 
 
(Johns et al., 2001) 
(TIRF) 
(Richter et al., 
2000) (IRM) 
 
 
 
Electron 
Microscopy 
 
Scanning EM 
 
Transmission EM 
 
Scanning Transmission EM 
 
• max. resolution 0.1 
nm 
• contrast based on 
density 
• requires expert 
knowledge 
• invasive 
• not possible on 
living cells 
 
 
• cell surface 
• cell sections 
• immunogold labeling 
• mass determination 
• imaging of sub-
molecular structure 
 
(Bagley et al., 
2000) 
 
(Muller and Engel, 
2001) 
 
 
 
 
 
 
 
 
 
 
 
Scanning 
Probe 
Microscopy 
 
Subtype        Contrast               
 
SICM            Ionic current 
 
 
SCM/ScaM   Dielectric  
                     properties 
 
SCPM           Chemical  
                     potential 
 
SThM           Thermocouple 
                     junction scanned 
                     across sample 
 
AFM             Short-range 
                     interaction 
                     forces between   
                     tip and sample      
 
• surface techniques 
• simultaneous 
topography 
imaging  
 
• resolution 
dependent on 
probe radius (tens 
of nm) and sample 
physical properties 
• requires expert 
knowledge 
• apart from AFM 
techniques still in 
experimental phase 
• non invasive 
• possible on living 
cells 
 
 
• cell volume changes 
• localization of single 
ion-channel on cell 
surface 
 
• polymer 
science/tissue 
engineering 
• single-molecule 
imaging  
• molecular interactions 
in cells (AFM force 
imaging) 
• sub-molecular 
resolution of proteins 
by carbon nanotubes 
(AFM) 
 
(Korchev et al., 
2000a; Korchev et 
al., 2000b) (SICM, 
cell volume) 
 
(Willemsen et al., 
2000)(AFM, Forces) 
 
(Engel and Muller, 
2000) (AFM, sub-
molecular 
resolution) 
 
(Lehenkari et al., 
2000) (AFM in cell 
biology) 
 
(Woolley et al., 
2000) (AFM, 
nanotubes) 
  
NSOM/        Optical, sub- 
PSTM          wavelength  
                  optical fiber probe  
 
                    
 
• NSOM: optical 
contrast combined 
with topography 
• optical resolution 
depending on 
probe aperture 
diameter (20-120 
nm) and probe-
sample distance 
(less than 5-10 nm) 
• possible on living 
cells (see text) 
 
 
See Table 2 and 3 
 
See Table 2 and 3 
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The advent of scanning probe microscopy (Table 1), and especially atomic force 
microscopy (AFM), in which an atomically sharp probe attached to a cantilever is 
scanned over the surface of interest, has made nanometer resolution attainable also 
on living cells (Hansma, 1994; Putman, 1994). However, although AFM produces a 
high-resolution topographical picture of the sample, it lacks chemical specificity. 
Hence, although individual molecules can be seen, their identities cannot be defined. 
This seriously limits the usefulness of AFM for high-resolution imaging on cells. 
Initially, this contrast problem has been tackled by the use of immunogold-labeling 
approaches (Damjanovich et al., 1995; Neagu et al., 1994). A promising new way 
around the problem comes from work on the specific labeling of the AFM probe with 
bio-molecules (e.g. with antibodies or ligands). This introduces a contrast mechanism 
based on specific interactions between the probe and certain types of molecule in the 
specimen (Willemsen et al., 2000). Other attempts to enhance AFM contrast involve 
the modification of the probe using fluorescent molecules, which introduces an 
optical contrast mechanism (Vickery and Dunn, 2001).  
Currently, however, the combination of high-resolution scanning probe and 
fluorescence microscopy is the realm of another scanning probe technique: near-field 
scanning optical microscopy (NSOM). 
In NSOM, as in the case of the AFM, a sharp probe physically scans the sample 
surface (Fig.7). 
 
 
 
Figure 7. The principle of scanning probe microscopy. In AFM and NSOM, a sharp 
probe is used to map the topographic features on the sample surface accurately. This is done 
by physically scanning the probe over the surface while maintaining a constant probe-sample 
distance by force feedback. 
 
 
Besides topography, NSOM also generates optical images. A typical NSOM 
configuration is shown in Fig. 8. The practical feasibility of this kind of NSOM was 
first demonstrated by Pohl et al. (Pohl DW, 1984), immediately following the advent 
of scanning probe microscopy and in fact before the introduction of the AFM.  
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Figure 8. Typical NSOM configuration. The optical detection sensitivity of NSOM depends 
largely on the extremely small excitation/detection volume set by the aperture dimensions as 
well as the depth of penetration of the near-field into the specimen. Together, these 
properties effectively reduce background fluorescence and thereby enhance detection 
sensitivity. The NSOM probe is a tapered optical fiber (Fig. 22). Laser light is coupled into the 
fiber and is used to excite fluorophores as the probe scans the sample surface. The probe-
sample distance is maintained constant at <10 nm during scanning by shear-force-based 
distance detection in combination with an electronic feedback system controlling the 
piezoelectric scan stage. Fluorescence is collected by a conventional inverted microscope. 
Dual-channel optical detection allows wavelength and/or polarization discrimination. 
 
 
The most generally applied near-field optical probe consists of a small aperture, 
typically 20--120 nm in diameter (i.e. much smaller than the wavelength of the 
excitation light), at the end of a metal-coated tapered optical fiber1 (Fig. 9).  
This probe is the most critical element of the technique and is difficult to produce 
reliably and in large quantities (Van Hulst NF, 2000). In fluorescence mode2, it serves 
as a constriction that funnels an incident light wave to dimensions that are 
substantially below the diffraction limit.This results in a light-source that has the size 
of the aperture. However, in contrast to common light sources such as light bulbs 
and lasers, the light emitted by the probe is predominantly composed of evanescent 
waves, rather than propagating waves. The intensity of the evanescent light decays 
exponentially and to insignificant levels ~100 nm from the aperture. Effectively, the 
probe can excite fluorophores only within a layer of <100 nm from the probe – that 
is, in the “near-field” regime (Fig. 9 B). Sample fluorescence can subsequently be 
collected by conventional optics (Fig. 8), and transformed into an optical image of 
the sample surface in which the resolution is now primarily dictated by the aperture 
dimensions rather than by the wavelength of the light.  
                                                 
1 Other types of probe exist; for example aperture-less and non-metal-coated aperture type probes have 
been described. Applications of the former in biology have, to our knowledge, not yet been described; 
examples of the latter are reviewed below.  
2 In this paper we focus on fluorescence-mode NSOM. Applications of transmission-type NSOM to 
biological systems have also been described; however, for these the reader is referred to Van Hulst and 
Moers, 1996, Biological applications of Near-field Scanning Optical Micrsocopy. IEEE Engineering in 
Medicine and Biology Jan/Feb, 51-58. 
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Figure 9. The near-field optical probe. A. An optical fiber is pulled to a final diameter of 
20-120 nm and subsequently coated with aluminum. This coating serves to confine the light 
to the tip region. A subsequent etching step results in a flat and circular endpoint and 
aperture. The aperture functions as a miniature light source, and its diameter primarily 
determines the optical resolution of the microscope. B. The principle of surface-specific 
excitation. The optical near-field generated at the aperture has significant intensity only in a 
layer of <100 nm from the aperture; lower lying fluorophores are therefore not excited. 
Hence, background fluorescence is effectively suppressed. This forms the basis for the high 
optical detection sensitivity of this technique. 
 
 
Since the near-field intensity decays so rapidly with distance from the probe, for 
efficient excitation it is essential to have accurate control of the probe-sample 
distance during scanning. As in AFM, this can be accomplished by using a (force) 
feedback loop. However, in contrast to regular AFM, which exploits the bending of a 
cantilever attached to the probe as a direct measure of the probe-sample interaction 
force, in NSOM an indirect method, based on shear-force damping, is commonly 
used. For this, the NSOM probe, or a piezo-electric tuning fork attached to it, is 
oscillated at its resonance frequency in a lateral vibrational mode (with a <1 nm 
amplitude); when in proximity to the sample, shear-forces damp this motion and 
induce measurable changes in the oscillation amplitude, and phase. An electronic 
feedback system, controlling the probe-sample distance directly via the piezo-electric 
scan stage, is subsequently used to maintain a constant oscillation amplitude/phase 
during scanning. In this way, a constant probe-sample distance of <10 nm is realized 
(Fig. 8). The feedback signal itself, as in AFM, is used to generate a topographic map 
of the sample surface (Fig.7). Of course, unique for NSOM is that a corresponding 
fluorescence map is simultaneously generated.  
The optical detection sensitivity of NSOM depends largely on the extremely small 
excitation/detection volume set by the aperture dimensions as well as the depth of 
penetration of the near-field into the specimen. Together, these properties effectively 
reduce background fluorescence and thereby enhance detection sensitivity. 
Developments in instrumentation that greatly improved signal-to-background ratios 
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allowed single-molecule fluorescence studies to come within reach of far-field 
methods such as total internal reflection, confocal and bright-field microscopy (see 
Table 2).  
 
 
Table 2. Single-molecule fluorescence microscopy 
 
 
Technique 
Application Living 
cells?  
Resolution Localization 
accuracy 
dyes/µm2 
(max) 
References 
 
Wide-field 
single molecule 
diffusion in cell and 
artificial membranes 
Yes <250 nm <<40 nm < 10 (Schmidt et al., 1996) 
 
(Schutz et al., 2000) 
 
(Harms et al., 2001) 
 
 
Confocal 
• enzyme/DNA 
conformational 
dynamics studied 
by single pair 
FRET 
• single dye 
photophysics 
Yes  ~250 nm ~40 nm 10 (Weiss, 1999) 
 
(Ha et al., 1996) 
 
(Ha et al., 1999) 
 
(Moerner et al., 1999) 
 
(van Oijen et al., 
1999) 
 
(Deniz et al., 1999) 
 
(Talaga et al., 2000) 
 
 
TIRF 
• cell-substrate 
contact zone 
• inter- and 
intramolecular 
interactions and 
dynamics; FRET 
• Single molecule 
diffusion 
Yes ~250 nm ~40 nm 10 (Ishijima et al., 1998) 
 
(Kitamura et al., 
1999) 
 
(Ishii, 2000) 
 
(Sako et al., 2000) 
 
 
 
NSOM 
• single GFP/dye 
photophysics 
• DNA 
conformation 
studied by single 
pair FRET 
• single molecule 
spectroscopy 
• lifetimes of 
single dyes 
Not yet >50 nm 
possible 
>6 nm 100 (Ambrose et al., 
1994)  
 
(Ha et al., 1996) 
 
(Ruiter AG, 1997) 
 
(Garcia-Parajo et al., 
2000; Garcia-Parajo 
et al., 1999) 
 
(Van Hulst NF, 2000) 
 
 
The advantage of single-molecule studies is that they provide a way to monitor time-
dependent processes and reaction pathways in non-equilibrated systems, which 
reveals the distribution of a given molecular property instead of a statistical average. 
This has already led to a whole new frontier in science, its applications ranging from 
basic photo-physics and material research to biology (Ishii, 2000; Sako et al., 2000; 
Xie and Lu, 1999). Nowadays almost all experiments in this field use far-field 
methods, mainly because they are relatively easy to use. However, the obvious 
disadvantage is that, because of the diffraction-limited system response, only 
scarcely labeled samples can be studied, but, in biology, molecules are usually 
present in close proximity. The combination of topographical information, optical 
super-resolution and single-molecule detection sensitivity therefore makes NSOM a 
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unique tool for biological applications. 
A large body of evidence indicates that (induced) lateral organization in the plasma 
membrane is crucial to trigger cell signaling. One example is the early events in 
signal transduction by the epidermal growth factor receptor (EGFR), dimerization and 
phosphorylation following EGF binding (Yarden and Schlessinger, 1987a; Yarden and 
Schlessinger, 1987b). Another is the formation of focal adhesions, large signaling 
complexes involved in cell-adhesion and migration, and their equivalent on 
leukocytes, “adhesisomes”. An important first step in the assembly of such 
complexes appears to be clustering of integrin receptors (Balaban et al., 2001; van 
Kooyk and Figdor, 2000). Understanding of the signaling capacities of these adhesion 
sites requires insight into their assembly and spatial organization on the molecular 
level. The concept of “lipid rafts” provides yet another level of organization in the 
plasma membrane at the sub-microscopic level (Simons and Toomre, 2000). So far, 
these phenomena have been studied by use of far-field optical techniques, such as 
TIRF, IRM and confocal microscopy (Table 1). Clearly, higher-resolution/sensitivity 
would produce a major step forward in our understanding of the underlying 
mechanisms. 
So far, most applications of NSOM in biology involve systems that are more or less 
isolated (Table 3) – for example, studies on fluorescently labeled chromosomes 
(Moers M.H. Kalle W.H., 1996), DNA (Garcia-Parajo et al., 1998; Ha et al., 1996), 
and purified fluorescent proteins (Garcia-Parajo et al., 2000; Garcia-Parajo et al., 
1999).  
 
 
Table 3. Biological applications of NSOM 
 
 
System 
 
Mode 
 
Type of analysis 
 
Air 
 
Liquid 
 
References 
 
Fibroblasts 
 
Shared Aperture 
(collection mode), non-
coated probe 
 
Study on the localized interactions 
between labeled con A molecules on the 
surface of 3T3 fibroblasts (FRET) 
 
+ 
  
(Kirsch et al., 1999) 
 
DNA 
 
Aperture type, metal-
coated fiber 
 
DNA conformation probed using dual-
labeled oligomers (FRET) 
 
+ 
  
(Ha et al., 1996) 
 
Human 
erythrocytes 
 
Aperture type, metal-
coated fiber 
 
Imaging of molecular colocalization of 
malarial and host skeletal protein on the 
cell membrane 
 
+ 
  
(Enderle et al., 1997) 
 
Human skin 
fibroblast 
 
Aperture type, metal-
coated fiber 
 
Investigation of cell membrane domains 
 
+ 
 
+ 
 
(Hwang et al., 1998) 
 
Human breast 
tumor cell 
 
Shared Aperture 
(collection mode), non-
coated probe 
 
Detection and characterization of ErbB2 
clustering on the surface of quiescent 
and activated cells 
 
+ 
  
(Nagy et al., 1999) 
 
Chromosome 
 
Aperture type, metal-
coated fiber 
 
High-resolution fluorescence in situ 
hybridization 
 
+ 
  
(Hausmann M, 2001) 
 
 
 
Cell biological studies include fluorescence of colocalization of malarial and host 
skeletal proteins on malaria-infected erythrocytes (Enderle et al., 1997). 
Furthermore, sub-wavelength-sized membrane patches in human skin fibroblasts 
(Hwang et al., 1998) and activation-dependent receptor clustering on a human 
breast carcinoma cell line have also been studied (Nagy et al., 1999). Although these 
studies show a resolution well beyond that of a confocal microscope, to the best of 
our knowledge no study showing single-molecule detection sensitivity in a cell 
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membrane by NSOM has been reported. 
To demonstrate the potential of near-field optical microscopy to study the 
distribution and orientation of cell surface molecules, we investigated the distribution 
of LFA-1 (αL/β2 integrin) molecules in murine fibroblasts. Figure 10 A shows a 
bright-field image as well as a near-field “zoom-in” on the surface of a fixed and 
critical-point-dried L-cell (mouse fibroblast cell line) expressing human GFP-tagged 
LFA-1.  
 
 
 
Figure 10. A. Single molecule detection on cells by NSOM. This figure shows a 40 nm 
optical resolution near-field “zoom-in” on the indicated area (3.2 × 3.2 µm2) in the bright-field 
image of a fibroblast expressing LFA-1-GFP. GFP excitation is accomplished using 488 nm 
light (Ar-Kr laser line), linearly polarized along 90°. Fluorescence is collected using a 1.3 
numerical aperture oil-immersion objective in combination with standard optical filters. A 
polarizing beam-splitter cube (Newport, Fountain Valley, CA) is used to split the fluorescence 
signal into two perpendicular polarized components (c.f. Fig.21). Both signals are then 
detected using photon-counting avalanche photodiode detectors (APD, SPCM-100, EG&G 
Electro optics, Quebec). The red/green color-coding of the signals reflects the orientation of 
the GFP molecules in the plane of the sample. Examples of clustered molecules (arrows) as 
well as examples showing clear single-molecule detection sensitivity are indicated (circles, 
squares). The squares show the fast-blinking behavior typical of single GFP fluorescence. The 
circles present demonstrations of discrete photo dissociation phenomena. B. Estimation of 
the resolution in the near-field image. This figure shows a line trace through the feature 
marked with the hexagon in the near-field image. The full width at half maximum (FWHM; 
arrows) of such traces can be used to obtain an estimate for the maximal resolution (half the 
FWHM) in the near-field image. On this basis, we estimate the resolution in the near-field 
image to be ~40 nm. 
 
 
The near-field image shows a number of interesting findings. First individual 
fluorescent LFA-1 molecules (circles, squares and hexagon) as well as clusters of 
molecules can be recognized (arrows). Secondly, one can observe different 
orientations of the GFP linked to the LFA-1 βchain, as determined by the polarization 
of the emitted light. The latter is of great value to discriminate LFA-1 molecules that 
are closer than half the tip aperture diameter. Although these molecules cannot be 
discriminated by their fluorescence intensity signal, the difference in polarization 
contrast reveals them as separate entities (see e.g. (Van Hulst NF, 2000)). Finally, 
the figure shows examples of photo dissociation (circles) and the characteristic 
blinking behavior (squares and inset) of single GFP fluorescence (Garcia-Parajo et al., 
2000). Figure 10 B depicts a line trace through the feature marked with a hexagon, 
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showing a signal-to-background ratio of 7 and a 90 nm full width at half maximum 
(FWHM; arrows). From the latter, one can calculate that the lateral resolution in this 
image is ~40 nm (Van Hulst NF, 2000). Taken together, the discrete photo-behavior, 
defined polarization characteristics and the number of counts per spot provide 
compelling evidence that individual molecules can be recognized on the cell surface 
by NSOM. 
A direct comparison between the localization accuracy of cell membrane receptor 
molecules of NSOM and far-field imaging techniques is instructive (Table 2). In 
confocal fluorescence studies, using a 1.3 numerical aperture objective, two groups 
have reported a lateral positioning accuracy of 30-40 nm (Schmidt et al., 1996; Van 
Oijen AM, 1998). For 104 collected photons and a 70 nm aperture probe, NSOM can 
be calculated to attain a localization accuracy of 6 nm - a level comparable to the 
FRET interaction-distance regime (0-10 nm). Given a resolution of ~50 nm, NSOM 
therefore should allow independent observation of several hundreds of 
molecules/µm2, which is an order of magnitude more than that achievable by far-
field methods. We expect the achievable level of sensitivity of near-field methodology 
to be sufficient to tackle questions related to the distribution of molecules that are 
packed at physiologically relevant densities on the cell surface. We therefore 
anticipate that NSOM will yield results comparable to those obtained by 
(immunogold) transmission electron microscopy but under physiological conditions. 
These intrinsic advantages of NSOM might revolutionize the life sciences. But why is 
NSOM hardly used in cell biology, despite its development almost two decades ago?  
First, as an imaging tool, NSOM is a complex technique that requires well-trained 
operators. Second, as we point out above, the resolution and sensitivity of a near-
field microscope depend strongly on the quality of the probe aperture and the 
accuracy of the feedback system, necessitating full control of the technology. 
Moreover, the top-grade near-field microscopes are still under development in 
experimental physics laboratories and are therefore not widely accessible. 
NSOM combines the high resolution of scanning probe microscopy with the contrast 
of optical microscopy. It can achieve single-molecule detection sensitivity on the cell-
surface and NSOM allows independent observation of molecules at physiologically 
relevant packing densities. The level of detail and sensitivity offered by this technique 
will be of particular value in exploring the spatial organization of the plasma 
membrane. Co-localization studies, a common application of far-field fluorescence 
imaging in cell biology, when performed with an NSOM will provide unprecedented 
detail and accuracy, which are impossible to obtain by diffraction-limited imaging 
techniques. Potentially of great importance will be the application of NSOM in single-
pair FRET studies combined with high-resolution imaging in order to study inter-
molecular interactions or intramolecular dynamics at the single-molecule level on 
cells. The first such examples have already been reported (Kirsch et al., 1999); 
however, although clearly showing resolution below the diffraction limit, single-
molecule detection sensitivity has not yet been reached. Importantly, NSOM bridges 
the gap between the diffraction-limited response of normal light microscopy and the 
5-10 nm distance sensitivity inherent in FRET and, as such, already provides 
important additional but otherwise inaccessible information.  
In the past decade, especially the past two years, several other approaches to break 
the diffraction limit have been developed. These include interferometric microscopy 
methods such as 4Pi confocal microscopy (Hell SW, 1992), I5M (Gustafsson et al., 
1999), standing-wave-total-internal-reflection fluorescence microscopy (Cragg, 2000) 
and harmonic excitation light microscopy (Frohn et al., 2000). These methods, 
however, do not have single-molecule detection sensitivity, and all require extended 
electronic post-processing of the images. Recently, a novel technique involving “point 
spread function (PSF) engineering” that exploits stimulated emission depletion 
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(STED) has been described (Klar et al., 2000). This method involves the induced 
quenching of fluorescence by stimulated emission at the rim of the diffraction-limited 
focal spot, thereby squeezing it to an almost spherical shape of ~100 nm in 
diameter. Thus far, this is the only technique that seriously rivals the small 
excitation/detection volume and therefore sensitivity of NSOM. The maximal 
resolution obtained with aperture type NSOM relates to the limited energy 
throughput of the near-field probe. This limits the minimum size of the aperture to 
be used and hence the resolution of the microscope to ~20 nm. A possible way 
around this involves exploiting single-molecule emitters, attached to a scanning 
probe, acting as light source to excite molecules in the sample (Michaelis et al., 
2000). 
The most important technical challenge that remains is the construction of an NSOM 
instrument that operates under physiologically relevant conditions and allows the 
study of soft, rough and motile surfaces, such as the plasma membrane of living 
cells. When combined with single-molecule detection sensitivity and an optical 
resolution that is comparable to transmission electron microscopy, this will prove to 
be an invaluable tool in cell biology. These are truly exciting times. 
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SUMMARY  
 
Human monocytes express high levels of the ICAMs-binding β2-integrin LFA-1 and 
exploit it to bind to endothelial cells and to extravasate into the underlying tissue 
upon inflammation. As precursors of dendritic cells, microenvironmental factors can 
induce monocytes to differentiate into monocyte-derived immature dendritic cells 
(DCs). Interestingly, these DCs do express significant levels of LFA-1 but, unlike 
monocytes, we observed that binding to ICAM-1, ICAM-2 and ICAM-3 through LFA-1 
is completely lost. Assuming that organization of adhesion receptors on monocyte 
and DCs plasma membrane can change dynamically during cell differentiation, this 
prompted us to investigate and compare the relationship between cell membrane 
organization and function of LFA-1 on monocytes and DCs. In this work, we 
demonstrate that loss of ligand binding by LFA-1 during DC development directly 
correlates with a gradual exclusion of LFA-1 molecules from cholesterol rich micro-
domains. High-resolution transmission electron microscopy on whole-mount samples 
of monocytes and DCs mapping the cell surface distribution of LFA-1 at sub-micron 
level, shows that while on DCs LFA-1 is randomly distributed, on the precursor 
monocytes LFA-1 is organized in well-defined 100-150 nm sized  microdomains. We 
found that these microdomains on monocytes were heterogeneous regarding their 
activation state, as demonstrated by expression of the activation reporter epitope 
recognized by NKI-L16 mAb. Live imaging of monocyte and T cells interactions shows 
that only active NKI-L16 positive LFA-1 microdomains are dynamically recruited at 
the cellular interface to form large micron-sized macroclusters. These findings show 
that in addition to affinity regulation, LFA-1 function is tightly controlled at the cell 
surface by surface distribution at least three levels: random distribution of inactive 
molecules, pro-active ligand-independent nanometric microdomains, and  ligand-
triggered micron-sized macroclusters.  
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INTRODUCTION 
Integrins are transmembrane α/β heterodimers that regulate cell-cell and cell-
extracellular matrix interaction. Within the immune system, lymphocyte function-
associated antigen-1 (LFA-1; αLβ2; CD11a/CD18) is a leukocyte specific integrin that 
mediates leukocyte migration across the endothelium both during normal lymphocyte 
recirculation and in response to inflammatory signals, migration within tissues, and 
formation of immunological synapse (Carman et al., 2003; Dustin and Springer, 
1989; Grakoui et al., 1999; Lub et al., 1995; van Kooyk et al., 1989). LFA-1 binds to 
its major counter receptor, ICAM-1 (Marlin and Springer, 1987), and at lower affinity 
also to ICAM-2 (Staunton et al., 1989), and ICAM–3 (de Fougerolles and Springer, 
1992; de Fougerolles et al., 1991).  
Two not-mutually-exclusive mechanisms have been proposed for the regulation of 
integrin activation. LFA-1 can undergo conformational changes responsible for an 
increased affinity for the ligands (Shimaoka et al., 2003). Mutagenesis studies (Lu et 
al., 2001a; Lu et al., 2001b) as well as the use of specific “activation reporter” mAbs 
(Beals et al., 2001; Dransfield and Hogg, 1989) have suggested the existence of 
different affinity states for LFA-1 molecules. NMR and negative stain electron 
microscopic structures have revealed conformational rearrangement and movement 
such as separation of the two cytoplasmic tails and extension of the extracellular 
domains that lead to a general mechanism of integrin activation (Takagi et al., 2002; 
Vinogradova et al., 2002). Early studies also showed that the Ca2+-dependent mAb 
NKI-L16 (Keizer et al., 1988; van Kooyk et al., 1991) specifically recognizes a Ca2+-
bound extended conformation of the αL subunit (Xie et al., 2004). A second 
mechanism that regulates integrin activation is a dynamic reorganization of LFA-1 
receptors into clusters at the cell membrane that locally increases the binding 
valency and strengthens the interaction with the ligand (a phenomenon known as 
avidity regulation) (Katagiri et al., 2003; van Kooyk et al., 1999). However, 
experimental evidence for the formation of LFA-1 clusters on activated cells has been 
rather qualitative and based on micron-sized patches of molecules on the plasma 
membrane of polarized cells (van Kooyk et al., 1994). Moreover, it is still 
controversial whether the formation of integrin clusters precedes or follows ligand 
binding (Bazzoni and Hemler, 1998; Carman and Springer, 2003). Recent findings 
show that on T lymphocytes recruitment of LFA-1 within specialized membrane lipid 
microdomains, enhances LFA-1 clustering (Krauss and Altevogt, 1999; Marwali et al., 
2003) and have direct implications for LFA-1 as a signaling molecule (Leitinger and 
Hogg, 2002).  
Human monocytes express high levels of LFA-1 and use it to mediate antibody-
dependent cytotoxicity, to adhere to endothelial cells and to extravasate into the 
underlying tissue (Martz, 1987; Springer, 1990). Recently, endothelial cells have 
been shown to form upright microvilli-like projections that are enriched in ICAM-1 
molecules (Carman et al., 2003). Transmigrating monocytes present regions of 
increased density of LFA-1 molecules that form linear clusters and colocalize with the 
ICAM-1-enriched projections (Carman et al., 2003). As precursors of antigen-
presenting dendritic cells (DCs), monocytes have been shown to differentiate in DCs 
(Banchereau and Steinman, 1998) upon reverse transmigration over endothelial 
monolayers (Randolph et al., 1998) or when cultured in vitro in presence of GM-CSF 
and IL-4 (Romani et al., 1996). The monocyte-derived immature DCs do express 
LFA-1 but, unlike monocytes, adhesion to ICAM-2 and ICAM-3 is completely 
mediated by the C-type lectin DC-SIGN (CD209) (Geijtenbeek et al., 2000a; 
Geijtenbeek et al., 2000c). 
These observations suggest that the plasma membrane organization of adhesion 
receptors on monocyte and immature DCs must change dynamically, along with the 
specific alterations occurring in the development from precursors towards DCs, and 
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prompted us to investigate and compare the relationship between cell membrane 
organization and adhesiveness of LFA-1 on monocytes and immature DCs. In this 
paper, we demonstrate that, besides binding to ICAM-2 and -3, LFA-1 mediated 
binding to ICAM-1 is completely lost during development of monocyte-derived 
immature DCs. This coincides with a parallel gradual exclusion of LFA-1 molecules 
from micro-domains. We use high-resolution transmission EM (TEM) on whole-mount 
samples of monocytes and monocyte-derived immature DCs to map the cell surface 
distribution of LFA-1 at sub-micron level. Our findings demonstrate three levels of 
LFA-1 surface distribution pattern at the cell membrane. 
 
 
MATERIALS AND METHODS 
 
Monoclonal antibodies and chemicals 
Identification of LFA-1 was carried out using the following mouse monoclonal 
antibodies: blocking mAb NKI-L15 (IgG2a), and activation reporter mAb NKI-L16 
(IgG2a), reactive with the α chain of human LFA-1 (CD11a) and raised as described 
previously (Keizer et al., 1985; Keizer et al., 1988); the non-blocking mAb TS2/4 
(IgG1) reactive with the α chain of human LFA-1, kindly provided by Dr. E. Martz 
(Sanchez-Madrid et al., 1982); the anti-β2 activating mAb KIM185 (IgG1), kindly 
provided by Martyn Robinson, Celltech; the anti-β2 blocking mAb NKI-L19 (IgG1) 
used to block all β2 integrins activity. ICAM-1 molecules were stained using mAb 
REK-1 (IgG1). For detection of CD46 and CD55 the Abs E4.3 (PharMingen) and 143-
30  (CLB, Amsterdam) were used, respectively. Isotype specific Alexa-conjugated 
secondary Ab and Alexa-488-conjugated Cholera Toxin B subunit (Alexa-488-CTxB 
were from Molecular Probes. TS2/4 and NKI-L15 were directly labeled with the Alexa 
Fluor 647 labeling kit (Molecular Probes). Methyl-β-cyclodextrin (MCD) was from 
Sigma (St. Louis, MO). The Rhodamine-conjugated goat anti-mouse IgG H&L Fab 
fragment was from Abcam Ltd. (Cambridge, UK). Goat anti-CTxB antibody was from 
Calbiochem. Goat-anti-mouse-conjugated 10 nm gold were from Aurion.  
 
Cells 
Monocytes were obtained from buffy coats of healthy individuals and were purified 
using Ficoll density centrifugation. Immature DC were obtained as already reported 
elsewhere (Geijtenbeek et al., 2000c). Briefly, they were cultured from monocytes in 
presence of IL-4 and GM-CSF (500 and 800 U/ml, respectively) for seven days. At 
day 7 their phenotype was confirmed by flow cytometry analysis: low levels of CD14, 
moderate levels of CD86, and. high levels of MHC class I and II. The Jurkat T cell 
line was kept in culture in Iscove’s medium supplemented with 5% Fetal calf serum.  
 
Fluorescent beads adhesion assay 
Carboxylate-modified TransFluorSpheres (488/645 nm, 1 µm Ø; Molecular Probes) 
were coated with ICAM-1-Fc, and the fluorescent beads adhesion assay was 
performed as described previously (Geijtenbeek et al., 1999). When the lipid raft-
disrupting agent MCD was used, the cells were resuspended in serum free medium 
containing the appropriate concentration of MCD and pre-incubated for 30 min at 
37°C. When necessary, fifty thousand cells were then incubated with blocking mAb 
(NKI-L15 or NKI-L19, 20µg/ml) for 10 min at room temperature. The ligand-coated 
fluorescent beads (20 beads/cell) were added and the suspension was incubated for 
30 min at 37°C. Adhesion was determined by measuring the percentage of cells, 
which have bound fluorescent beads, by flow cytometry using the FAC-Scalibur 
(Becton Dickinson, Oxnard, CA). 
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Flow cytometry 
For flow cytometry analysis, cells were incubated (30 min, 4°C) in PBA (PBS, 
containing 0.5% BSA and 0.01% sodium azide), with different mAb (5 µg/ml), 
followed by incubation with FITC-labeled goat anti-mouse IgG antibody (GAM-FITC; 
Zymed, San Francisco, CA; 1:50 dilution in PBA) for 30 min at 4°C. The relative 
fluorescence intensity was measured on a FACSCalibur. Isotype specific controls were 
included. 
 
Confocal microscopy 
For studies of colocalization with lipid rafts, cells were stained on ice in CLSM buffer 
(PBS/ 3%BSA/ 0.15% Glycine / 1% human serum) with anti-LFA-1 mAb (NKI-L15 or 
NKI-L16 or TS2/4), anti-CD55 mAb, anti CD46 mAb, and CTxB-Alexa488 (10µg/ml). 
Isotype specific controls were always included. Secondary Abs used were Alexa568-
conjugated goat anti mouse IgG for LFA-1, CD55, and CD46, and goat anti-CTxB for 
CTxB-Alexa488. Patching was induced by incubation at 12°C for 1 hour, followed by 
fixation with 2% paraformaldehyde. Cells were then mounted onto poly-L-lysine 
coated glass coverslips, fixed a second time and sealed in Mowiol. Analysis was done 
with a biorad MRC1024 Confocal Laser Scanning Microscope. Signals were collected 
sequentially to avoid bleed through. For double or triple labeling experiments where 
NKI-L16 mAb was used, cells could not be fixed before adding the primary Abs, since 
NKI-L16 binding is lost after fixation. Therefore, cells were allowed to adhere on 
fibronectin-coated coverslips and stained with anti-LFA-1 (NKI-L16 or NKI-L15 or 
TS2/4) and anti-ICAM-1 (10µg/ml) at 40C, after prolonged incubation in CLSM buffer 
to minimize aspecific binding. Isotype specific controls were always included. After 
removing unbound Abs by extensive washing in cold PBS, cells were quickly fixed in 
1% paraformaldehyde and, after blocking step in CLSM buffer, secondary staining for 
LFA-1 and ICAM-1 was performed using isotype-specific Alexa-conjugated goat anti 
mouse antibodies.  
 
Electron microscopy labeling procedure.  
For transmission electron microscopy (TEM), monocytes and DCs were allowed to 
spread on glass coverslips covered by a thin layer of poly-L-lysine-coated Formvar for 
1 hour at 37°C, washed to remove unbound cells, and immediately fixed with 1% 
paraformaldehyde (PFA) for 15 min. After two washing steps with PBS and a 
subsequent incubation (60 min at RT) with I-buffer (PBS, 0.1% glycine, 1% BSA, 
0.25% gelatin) to reduce aspecific background, the specimens were incubated for 30 
min with the primary antibodies (TS2/4 or NKI-L15) in I-buffer on ice, rinsed in PBS, 
and further fixed in 1% PFA, 0.1% glutaraldehyde (GTA) for 15 min to prevent 
further unwanted capping induced by the secondary Abs. After two washing steps 
with PBS and a block in I-buffer, the samples were incubated with 10 nm diameter 
gold-labeled goat anti-mouse for 60 min at room temperature. After extensive 
washing to remove unbound gold particles, a final fixation in 1% GTA in Phosphate 
Buffer for 20 min at room temperature was performed. Isotype specific controls were 
always included. When labeling was performed using NKI-L16 as primary Ab, no 
prefixation with 1% PFA was performed to prevent loss of Ab binding. Therefore, 
after adhesion on the substrate, cells were washed in ice-cold buffer and incubated 
on ice with cold NKI-L16.  
 
 
Analysis of gold particles distribution pattern 
After gold labeling and fixation, the specimens were dehydrated by sequential 
passages through 30, 50, 70, 90% and absolute ethanol. Then the ethanol was 
substituted by liquid CO2, and the samples were critical point dried. The formvar 
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films were then transferred from the glass onto copper grids, and the specimens 
were observed in a JEOL 1010 transmission electron microscope, operating at 60-80 
kV. Gold particles were detected on the periphery and thinner parts of cells, where a 
good contrast could be achieved. Since monocytes and immature DC widely spread, 
the membrane area available for analysis represented up to 60-70% of the whole 
labeled plasma membrane. For each cell at least four-six areas were analyzed at 
random. The digital images of electron micrographs were processed by custom-
written software based on Labview (National Instruments, TX). The distribution 
pattern of LFA-1 (i.e.: the degree of clustering) was analyzed by counting the 
number of gold particles found on the plasma membrane in a semi-automatic 
fashion. Subsequently, coordinates were assigned to the observed beads and inter-
particles distance statistics were obtained using a nearest neighbor distance 
algorithm. Clusters were then defined when gold particles were less than a set 
distance apart from a neighboring particle. 
 
Live imaging  
Monocytes were allowed to adhere onto a FN coated glass Petridish for 30 min at 
37ºC. After several washing steps in cold PBS, monocytes were labeled with NKI-L16 
mAb (10µg/ml) for 15 min at 4ºC. After removing excess of Ab, the secondary 
Rhodamine-conjugated goat anti-mouse IgG H&L Fab fragment were added for 15 
min at 4ºC. The unbound secondary Ab was thoroughly washed away and the Alexa 
-647-conjugated TS2/4 (or NKI-L15) was added for 15 min at RT. After washing in 
Imaging medium (RPMI 1640, without L-glutamine and phenol red), labeled 
monocytes were put in microscope setup at 37ºC and 5% CO2 and allowed to 
recover for 15 min before imaging was started. After 20 min, unlabeled Jurkat T cells 
were added and the interactions were analyzed with a Zeiss LSM 510 microscope, 
equipped with a type S heated stage CO2 controller and PlanApochromatic 63x 1.4 oil 
immersion DIC lens (Carl Zeiss GmbH, Jena, Germany). Cells were imaged using 
Zeiss LSM Image Browser version 3.2 (Carl Zeiss) and processed with Image J 
version 1.32j software (National Institutes of Health, http://rsb.info.nih.gov/ij). 
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RESULTS 
 
 
LFA-1-mediated binding is lost during development of monocyte-derived 
immature DC. 
In previous reports, it was shown that monocyte-derived immature DCs express high 
amounts of DC-SIGN and moderate amounts of LFA-1. Also, while on monocytes 
LFA-1 mediates adhesion to all ICAMs, on immature DCs adhesion to ICAM-2 and 
ICAM-3 is completely mediated by DC-SIGN (Cambi et al., 2004; Geijtenbeek et al., 
2000a; Geijtenbeek et al., 2000c). These observations suggested a change in LFA-1 
binding capacity from monocytes to DCs. Therefore, we measured LFA-1-mediated 
binding to its major ligand ICAM-1 during DC development. As shown in Figure 1A, 
monocytes and immature DCs profoundly differ in their capacity to bind ICAM-1 
coated fluorescent beads. On monocytes, more than 60% of the cells spontaneously 
bound ICAM-1 beads, and this interaction was almost completely β2-integrin 
mediated, as shown by the severe block in presence of anti-β2 blocking mAb NKI-
L19. The use of specific anti-αL blocking mAb (NKI-L15) indicated that on monocytes 
binding to ICAM-1 was mostly mediated by LFA-1 (40%), while the other two β2-
integrins MAC-1 and p150,95 mediated the residual binding. Upon differentiation of 
monocytes into immature DCs, spontaneous binding to ICAM-1 gradually decreased.  
 
 
 
Figure 1. Integrin-mediated binding to ICAM-1 and the expression of the LFA-1 
activation reporter epitope NKI-L16 decrease during development of monocyte-
derived DCs. A) Integrin-dependent ICAM-1 binding was monitored during development of 
monocyte-derived DCs, which is indicated in the upper drawing. The adhesion to ICAM-1 was 
determined using 1 µm ligand-coated fluorescent beads. Specificity was determined by 
measuring binding in presence of anti-LFA-1 blocking NKI-L15 mAb and anti-β2 blocking NKI-
L19 mAb. To enhance binding, the anti-β2 activating mAb KIM185 was used. Neither blocking 
nor activation was observed in presence of isotype controls (not depicted). One 
representative experiments out of three is shown. B) The expression levels of LFA-1 on 
monocytes and immature DCs were assessed by FACS analysis. The empty histogram 
represents the isotype control, and the gray histogram indicates the specific staining with 
anti-LFA-1 mAb (NKI-L15 and NKI-L16). Mean fluorescence intensity is indicated. One 
representative donor is shown. 
 
 
In fact, on immature DCs, binding to ICAM-1 beads was barely detectable and only 
slightly inducible by the anti-β2 activating mAb KIM185. 
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No significant enhancement of binding was observed upon addition of Mn2+ (data not 
shown). Moreover, on immature DCs, none of the other known stimuli of LFA-1 
activation, such as cytochalasin D, thapsigargin, or PMA, were able to enhance LFA-1 
binding capacity (data not shown)To exclude that the decreased binding to ICAM-1 
observed on DCs was due to decreased levels of LFA-1, we compared the expression 
of LFA-1 on monocytes and on DCs. Figure 1B shows that the expression levels of 
LFA-1, detected with the anti-αL mAb NKI-L15 (upper panel), remained unaltered 
during DC development. Therefore LFA-1, although almost equally detectable on 
monocytes and immature DC, could exist in two different activation states on the 
plasma membrane of these two cell types. The transition of LFA-1 from inactive into 
active state depends on the presence of extra-cellular Ca2+ ions, and that Ca2+ 
occupancy of LFA-1 molecule could be reported by the α chain specific mAb NKI-L16 
(Keizer et al., 1988; van Kooyk et al., 1994; van Kooyk et al., 1991). Recent studies 
more specifically showed that NKI-L16 recognizes a Ca2+-bound extended 
conformation of the α subunit (Xie et al., 2004). Therefore, we asked whether this 
NKI-L16 epitope was differently expressed by monocytes and DCs. As shown in Fig. 
1B (lower panel), the NKI-L16 epitope was highly expressed on monocytes but was 
barely detectable on DCs. 
Altogether, these observations clearly indicate that major changes in the activation 
state of LFA-1 occur during development of monocyte-derived DC. Moreover, since 
NKI-L16 has been shown to be a reporter of clustered (increased avidity) LFA-1 
(Binnerts and van Kooyk, 1999), these data also suggested a different organization 
of LFA-1 on the plasma membrane of monocytes and immature DCs. 
 
 
Involvement of lipid rafts on LFA-1 activity on monocytes and immature 
DCs. 
The recruitment of active LFA-1 into specific cholesterol- and glycosphingolipids-
enriched microdomains, known as lipid rafts, was proposed as additional mechanism 
to regulate the integrin activity (Leitinger and Hogg, 2002). Therefore, we 
investigated whether lipid rafts also played a role in the different regulation of 
binding capacity of LFA-1 on monocytes and immature DCs. 
On monocytes, the effect of methyl-β-cyclodextrin (MCD), a lipid rafts disrupting 
agent that extracts membrane cholesterol, was tested on ICAM-1 binding by the 
fluorescent beads adhesion assay. As shown in Fig. 2 A, MCD treatment inhibits 
binding to ICAM-1-coated beads of about 40%, indicating that lipid rafts disruption 
upon cholesterol extraction affected LFA-1 ligand binding capacity.  
To provide further evidence that on monocytes LFA-1 co-localizes with lipid rafts, we 
examined the co-distribution of LFA-1 and the lipid raft marker GM1, a 
glycosphingolipid, on monocytes compared with immature DCs, by antibody patching 
and confocal microscopy. As shown in Fig. 2 B, when co-capping was induced on 
monocytes, LFA-1 completely co-localizes with GM1 to the same extent as for the 
lipid raft associated GPI-anchored protein CD55. As expected, no co-localization of 
the lipid raft non-associated marker CD46 with GM1 was detected. On the contrary, 
on immature DCs, LFA-1 is completely excluded from the lipid rafts fraction similarly 
to CD46. 
The gradual exclusion of LFA-1 from these membrane microdomains parallels loss of 
the activation reporter epitope NKI-L16 as well as binding capacity. In fact, already 
after three days of monocyte differentiation into DC, LFA-1 is not co-localizing with 
GM1 on the majority of the cells (data not shown). 
On monocytes, no difference in colocalization with lipid rafts was observed between 
NKI-L16 positive and NKI-L16 negative LFA-1 molecules (data not shown), 
suggesting that on monocytes LFA-1 resides in lipid rafts even if the molecule is not 
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in the Ca2+-bound extended active conformation recognized by the NKI-L16 mAb.  
 
 
 
 
 
Figure 2. LFA-1 resides with lipid rafts on monocytes. A) LFA-1 mediated adhesion to 
ligand-coated fluorescent beads was measured on monocytes after cholesterol depletion by 
20mM MCD. The assay was performed as described in Fig. 1. Data shown are means ± SD of 
one representative experiment (out of three) performed in triplicate. B) Confocal microscopy 
analysis of copatching of LFA-1 and GM1 on monocytes and immature DCs. Receptor co-
patching and staining were performed as described in Material and methods and cells were 
analyzed by confocal microscopy. CD55 and CD46 were used as positive and negative lipid 
rafts markers, respectively. Results are representatives of multiple cells in three independent 
experiments. Bar, 5µm.  
  
  
LFA-1 forms well-defined submicron-sized microdomains on monocytes. 
The organization of the cell membrane as mosaic of many distinct lipid and protein 
microdomains ranging from 20 to 500 nm (Mayor and Rao, 2004) and our findings 
that LFA-1 differentially associates with lipid rafts on monocytes and immature DCs 
(Fig. 2) prompted us to investigate the cell surface organization of LFA-1 at high 
resolution.  
We used TEM on whole-mount samples of monocytes and immature DCs, after 
specific labeling of LFA-1 with gold particles. Recently, we and others demonstrated 
the applicability of this method to map distribution pattern of cell membrane 
receptors (Cambi et al., 2004; Panyi et al., 2003; Vereb et al., 2000). 
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Monocytes and immature DCs were allowed to adhere to formvar, then specifically 
labeled with mAb against LFA-1 and finally with gold particles. It should be noted 
that the specimens were not sectioned, thus making the whole cell surface available 
for gold labeling and subsequent TEM analysis. To exclude the possible influence of 
the substrate on LFA-1 distribution, TEM analysis was also performed on cells that 
were gold-labeled in suspension and then mounted onto poly-L-lysine. No differences 
were seen between cells stretched on the support or cells adhering to poly-L-lysine 
(unpublished data). 
Interestingly, we found that the distribution of LFA-1 changed dramatically during DC 
development (Fig. 3). Whereas on monocytes LFA-1 is organized in well-defined 
clusters (upper panels), on immature DC the gold particles are evenly distributed 
over the cell surface (lower panels).  
To quantitatively describe LFA-1 distribution pattern, the nearest neighbor distance 
values among the gold particles were calculated applying a spatial-point-pattern 
analysis (Cambi et al., 2004). As shown in Fig. 4 A, on monocytes, almost 80% of 
the gold particles reside within 50 nm distance from its nearest neighbor. In contrast, 
on immature DC, the nearest neighbor distance values are almost equally distributed 
in all distance categories, indicating no preferential organization of gold particles. 
The relative partitioning of gold particles in clusters of various sizes (i.e.: number of 
particles/cluster) was also quantified. As shown in Fig. 4 B, while on monocytes only 
20% of gold particles were detected as single features, on immature DCs up to 70% 
of gold particles were found as isolated single features on the cell membrane. 
The microdomains of LFA-1 on monocytes have an average diameter of 150 nm and 
are randomly localized on the cell. Similarly to NKI-L15 and TS2/4 mAbs, NKI-L16 
also showed clustered distribution of gold-labeled LFA-1 on the cell membrane of 
monocytes (Fig. 5 A). However, when LFA-1 was labeled by NKI-L16, the number of 
gold particles per µm2 was about four folds lower than what observed when NKI-L15 
was used (Fig. 5 B). Labeling with TS2/4 mAb gave results similar to NKI-L15 (data 
not shown). 
To exclude that this difference in amount of gold particles per µm2 was due to a 
different labeling efficiency, i.e. binding affinity of NKI-L16 for αL chain lower thank 
NKI-L15, we also calculated the density of LFA-1 clusters on the cell surface. As 
shown in Fig. 5 C, we found that NKI-L16 labeled only one third of all LFA-1 clusters 
detectable on monocyte cell membrane. TS2/4 labeling gave similar results as NKI-
L15 (data not shown). In addition, all three mAbs showed similar distribution of 
nearest neighbor distance values among gold particles (Fig. 5 D) as well as 
comparable cluster sizes (Fig. 5 E), indicating that the microdomains of LFA-1 labeled 
by NKI-L16 mAb are similar to the NKI-L16 negative clusters in terms of density and 
size, but represent a minor fraction of LFA-1 that strongly bind Ca2+ and is in an 
extended active conformation. 
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Figure 3. LFA-1 cell surface distribution is clustered on monocytes and random on 
immature DCs. Monocytes and immature DCs were specifically labeled with 10 nm gold 
particles, as described in Materials and methods. Cells were allowed to adhere onto poly-L-
lysine-coated formvar film and photographed in an electron microscope. Results are 
representatives of multiple cells in several independent experiments. The upper pictures 
represent whole cells imaged by TEM. Middle and lower pictures are higher magnifications 
were 10 nm gold particles are visible. Bar is 200nm, unless otherwise indicated.  
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Figure 4. Quantitative analysis of the distribution of gold particles labeling LFA-1. 
The digital images of electron micrographs were processed by a custom-written software 
based on Labview. Gold labels were counted, and coordinates were assigned to each feature. 
Subsequently, inter-particles distances were calculated using a nearest neighbor distance 
algorithm. A) Nearest neighbor distance values were calculated for each image, and the data 
of several independent experiments were pooled. Subsequently, the nearest neighbor 
distances were divided into three classes 0-50 nm, 50-100 nm, and >100 nm, and the 
percentage of nearest neighbor distance values falling into each class was plotted. B) The 
partitioning of gold labels in clusters of various size (i.e.: number of particles/cluster) was 
also quantified. Clusters were defined when gold particles were less than 50 nm apart from a 
neighboring particle. The percentage of gold particles involved in the formation of a certain 
cluster size was calculated for monocyte and immature DC. The insets are two representative 
processed digital images, where each type of cluster is shown in a different color. One 
representative experiment out of three is shown. 
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Figure 5. The activation reporter epitope NKI-L16 is expressed by a sub-
population of LFA-1 clusters on monocytes. A) Monocytes were labeled as described in 
Fig.4, and the distribution patterns obtained with the three different anti-αL mAbs were 
compared. B) Quantitative analysis of the distribution of gold particles labeling LFA-1 was 
performed as described in Fig. 4 B. The percentage of nearest neighbor distance values 
falling into each class was plotted. Data are the mean of three independent experiments ± 
SD. C) The partitioning of gold labels in clusters of various size (i.e.: number of 
particles/cluster) was also quantified and compared for the three mAbs. Clusters were defined 
as described in Fig. 4 B. One representative experiment out of three is shown. D) Gold labels 
detected per µm2 were counted as well as the number of clusters per µm2 E). One 
representative experiment out of three is shown. Scale bar represents 200 nm. 
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Monocytes express LFA-1 as well as the LFA-1 ligand ICAM-1, allowing the formation 
of aggregates of homotypically adherent cells. The interaction with the counter-
receptor has been suggested to  trigger the formation of LFA-1 microclusters (Kim et 
al., 2004). However, in our studies, cells were seeded at low density to avoid 
stimulation by homotypic aggregation and were extensively washed allowing LFA-1 
distribution to equilibrate. 
Therefore, our results show that on monocytes LFA-1 microdomains are formed in a 
ligand-independent manner and are in a heterogeneous activation state (NKI-L16 
epitope expressing and non-expressing microdomains) and that differentiation of 
monocytes into DCs leads to a random distribution pattern of inactive LFA-1 
molecules. 
 
 
NKI-L16 positive microdomains of LFA-1 readily bind the ligand ICAM-1. 
To further investigate the difference between NKI-L16 positive and NKI-L16 negative 
LFA-1 microdomains on monocytes, we performed a double labeling of LFA-1 using 
anti-αL mAbs NKI-L16 and TS2/4. As shown in Fig. 6 A, all LFA-1 microdomains are 
detectable by TS2/4, but only a subpopulation of them shows also the expression of 
NKI-L16 epitope (indicated in yellow). Interestingly, when monocytes were seeded at 
high density, NKI-L16 positive LFA-1 represented a minor fraction of the total LFA-1 
present at the cell surface and was specifically detected at the contact zone between 
adjacent cells (Fig. 6 B).   
 
 
 
 
 
Figure 6. The NKI-L16 positive LFA-1 molecules colocalize with ICAM-1 at the cell-
cell contacts. A) Monocytes were allowed to adhere onto poly-L-lysine-coated glass 
coverslipis for 30 min at 37°C. After extensive washing with cold PBS, cells were incubated 
with TS2/4 (red) and NKI-L16 (green) on ice for 30 min to label total LFA-1 and active LFA-1 
microdomains, respectively. Unbound Abs were removed, and cells were fixed with 2% PFA. 
Subsequently, isotype specific Alexa-conjugated goat anti-mouse Abs. Colocalization is 
indicated in yellow. B) Monocytes were seeded at high density on poly-L-lys-coated glass 
coverslips and labeled as described for panel A. Total LFA-1 is shown in green and NKI-L16 
fraction in red. Colocalization is indicated in yellow in the merged picture. C) Triple labeling 
for total LFA-1 (green), active LFA-1 (blue) and the ligand ICAM-1 (red) was performed on 
high-density seeded monocytes. Colocalization is shown in the merged picture. Bar is 5µm, 
unless otherwise indicated. 
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Figure 7. The NKI-L16 positive activated LFA-1 microdomains are rapidly recruited 
at the monocyte-T cell contact. A) Monocytes were allowed to adhere at low density onto 
a glass coverslip for 30 min at 37ºC. After washing with PBS, monocytes were double labeled 
with anti-aL mAbs NKI-L16 and TS2/4, as described in Materials and methods. After removal 
of unbound Abs, Jurkat T cells were added in a ratio of X:Y with monocytes. The formation of 
spontaneous conjugates between monocytes and T cells was followed at 37 ºC with a Zeiss 
LSM 510 microscope. B) No enrichment of NKI-L16 positive LFA-1 molecules at the cell-cell 
contact site was observed in presence of the blocking anti-aL mAb NKI-L15. 
 
 
Since monocytes express both LFA-1 and its counter-receptor ICAM-1 (data not 
shown), we wanted to investigate whether the NKI-L16 positive LFA-1 fraction 
enriched at the contact site between adjacent cells was specifically involved in the 
binding to ICAM-1 on the opposing cell. Therefore, we allowed the formation of 
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conjugates among monocytes, and after fixating the cells, we performed a triple 
labeling using TS2/4 and NKI-L16 to detect all or the activated LFA-1 molecules, 
respectively, as well as anti-ICAM-1 mAb. As shown in Fig. 6 C, the NKI-L16 
expressing LFA-1 fraction clearly colocalized with the ligand at the contact sites, 
forming macroclusters of LFA-1 molecules that were  up to several micron large.To 
understand whether this ligand-binding L16 positive LFA-1 macroclusters observed at 
the contact site derived from the recruitment of pre-existing activated microdomains, 
we followed dynamically the contact formation between monocytes and Jurkat T 
cells. Freshly isolated monocytes were allowed to adhere onto glass coverslips and 
double labeled with the Alexa-647-conjugated neutral mAb TS2/4 and the activation 
reporter mAb L16, which was detected by a Rhodamine-conjugated secondary Fab 
fragment (Fig. 7 A). The upper row consists of consecutive snapshots of the 
conjugate formation between monocytes and T cells observed by bright field 
microscopy. The middle and bottom rows indicate the fluorescence signal of the 
activated LFA-1 fraction (labeled by NKI-L16 and TRITC-conjugated goat-anti-mouse 
Fab fragment) and the total LFA-1 (labeled by Alexa-647-conjugated TS2/4), 
respectively. Clearly, a specific enrichment of LFA-1 molecules at the contact site 
between monocyte and T cell is visible from 270 sec to 810 sec after the beginning 
of the movie (Fig. 7 A). When the interaction between monocytes and T cells 
occurred in presence of the Alexa-647-conjugated anti-αL blocking mAb NKI-L15, no 
recruitment of NKI-L16 positive LFA-1 fraction was observed (Fig. 7 B). These 
observations clearly indicate that pre-formed activated microdomains of LFA-1, 
detected by the activation reporter NKI-L16, are quickly recruited at the cell-cell 
contact and form larger macroclusters. We quantified the recruitment of NKI-L16 
positive LFA-1 with respect to the total LFA-1 labeled by TS2/4 or NKI-L15 by 
calculating the recruitment index (Fig. 8). 
 
 
 
Figure 8. Quantification of the recruitment of the activated LFA-1 fraction at the 
monocyte-T cell contact site. The recruitment index of each Ab was defined as the 
fluorescence intensity at the contact site divided by the fluorescence intensity of the whole 
cell. Data are referred to the images shown in Fig. 7.  
 
 
DISCUSSION 
LFA-1 is the most prominent β2 integrin expressed by leukocytes that regulates 
leukocyte adhesion and migration and is involved in the formation of the 
immunological synapse (Dustin and Springer, 1989; Grakoui et al., 1999; Lub et al., 
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1995; van Kooyk et al., 1989). Here we investigated the functional properties as well 
as the cell surface distribution of LFA-1 on monocytes and monocyte-derived DCs. 
For the first time, using high-resolution TEM and spatial-point pattern analysis, we 
clearly demonstrated a correlation between adhesiveness and sub-micron-sized 
avidity changes of LFA-1 when monocytes differentiate into DCs.  
We showed that on monocytes LFA-1 strongly bind to ICAM-1, highly express the 
activation reporter epitope NKI-L16, is organized in well-defined ligand-independent 
nanometric microdomains, and fully resides in lipid rafts. In contrast, on DCs LFA-1 is 
not able to bind to ICAMs, lacks the activation reporter epitope NKI-L16, is randomly 
distributed at the cell surface, and is completely excluded from lipid rafts. 
Interestingly, on monocytes, LFA-1 microdomains are heterogeneous in terms of 
activation state, as indicated by the expression of the NKI-L16 epitope by about one 
third of the total microdomain population. Moreover, this NKI-L16 positive fraction of 
LFA-1 colocalizes with the ligand ICAM-1 expressed on adjacent cells. Finally, by 
dynamic imaging of monocyte-T cell interactions, we demonstrated that this NKI-L16 
positive fraction of LFA-1 microdomains is actively recruited at the cell-cell contact 
forming ligand-driven macroclusters. 
Monocytes can readily differentiate into antigen-presenting DCs upon reverse 
transmigration of endothelial monolayers (Randolph et al., 1998) or when cultured in 
vitro in presence of GM-CSF and IL-4 (Romani et al., 1996). Therefore, using 
monocytes and in vitro monocytes-derived DCs instead of LFA-1 transfectants allows 
us to follow changes in the behavior of endogenous adhesion receptors in a semi-
physiological system. Moreover, monocyte-derived DCs are currently manipulated ex 
vivo for the development of anti-tumor and anti-virus therapies (Figdor et al., 2004). 
At this purpose, a detailed characterization of the migratory and adhesive properties 
of monocyte-derived DCs is essential.  
Monocytes and DCs express equivalent level of LFA-1 at the cell surface, but greatly 
differ in terms of LFA-1-mediated binding to ICAM molecules (Fig. 1 A), indicating a 
marked difference in activation state of LFA-1 molecules on the two cell types. 
Recent crystal, NMR, and negative stain EM showed snapshots of different 
conformational states of integrin fragments, indicating clear structural 
rearrangements of both β and α subunits upon integrin activation (Beglova et al., 
2002; Takagi et al., 2002; Xiao et al., 2004). In the low affinity conformation, the 
headpiece of the integrin folds over its legs facing down towards the cell membrane; 
in the high affinity conformation, the headpiece extends upwards upon activation. 
This molecular switch occurs at the ‘genu’ of the integrin subunits (Takagi and 
Springer, 2002). In particular, upon activation, the α subunit leg has been shown to 
extend at a Ca2+-dependent epitope in the thigh/genu interface (Xie et al., 2004). 
This epitope appears only in the α chain extended conformation and in the case of 
αL is specifically recognized by the mAb NKI-L16 (Xie et al., 2004). We have shown 
that LFA-1 binding capacity is directly correlated to the expression of this epitope 
(Fig. 1 B). Since in the αL subunit inactive conformation, the NKI-L16 epitope has 
been shown to shielded from Ab recognition, the complete lack of NKI-L16 epitope 
observed on DCs would suggest that all LFA-1 molecules assume the ‘off’ bent 
conformation. On the contrary, on monocytes binding of the NKI-L16 mAb is 
detected, indicating the presence of LFA-1 molecules in an extended active 
conformation.             
The thorough investigation of LFA-1 cell surface distribution pattern by TEM and 
spatial point pattern analysis has shown that on DCs LFA-1 molecules, which do not 
express the NKI-L16 epitope, are randomly distributed on the cell membrane as 
single features. Analogously, on K562 cells transfected with wild-type LFA-1 (K-LFA-
1), no spontaneous binding to ICAM-1 occurs, no NKI-L16 epitope is detected, and 
the cell surface distribution of LFA-1 is random as defined by the spatial point pattern 
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analysis (data not shown). These data are in agreement with the observations 
reported by Kim et al. (Kim et al., 2004) on the absence of FRET-detectable 
microclustering and binding activity on K-LFA-1 cells. Conversely, on monocytes LFA-
1 is organized in well-defined microdomains that can be divided into two 
subpopulations: microdomains that express NKI-L16 epitope and are therefore in an 
extended active state and microdomains that are NKI-L16 negative and therefore are 
constituted by LFA-1 molecules in the inactive bent conformation. Since no 
differences in terms of gold particles proximity and cluster size were observed 
between clusters labeled with NKI-L16 and those labeled with other anti-αL 
antibodies (Fig. 5), we hypothesize that the LFA-1 molecules that form a 
microdomain may all assume either the inactive or the active conformation within 
that microdomains. Similar results were obtained when endogenous LFA-1 was 
investigated on the human monocytic cell line THP-1: high ICAM-1 binding capacity 
correlates with clear NKI-L16 expression and distribution in microdomains. LFA-1 
microdomains detected on monocytes are not induced by ligand binding. Monocytes 
were allowed to adhere at low density to prevent that cell contact with ICAM-1 
molecules from adjacent cells could induce aggregation of LFA-1 molecules, as 
suggested by Kim et al. (Kim et al., 2004). They reported that only binding of 
multimeric ligand (i.e. ICAM-1Fc/Anti-IgA complexes) to LFA-1 induced FRET-
detectable microclustering on K-LFA-1 cells. This is in apparent contrast with our 
findings. However, we do not exclude that upon binding of multimeric ligand a 
further increase in receptor proximity might occur within the LFA-1 microdomains 
that would induce FRET-detectable changes in intra-domain receptor density. Crystal 
and FRET analysis of the integrin molecules within these ordered assemblies would 
provide better details on the molecular and spatial organization of LFA-1 
microdomains. 
The organization of LFA-1 in microdomains may also explain why HIV-1 particles 
bearing host-derived ICAM-1 are efficiently spread by monocytes but not by 
monocyte-derived DCs (Bounou et al., 2004). Recently, similar observations for the 
C-type lectin DC-SIGN, a DCs specific receptor that binds to HIV-1 enevlope protein 
gp120 (Geijtenbeek et al., 2000b) showed that DC-SIGN is able to bind and 
internalize HIV-1 particles only when it is organized in sub-micron-sized 
microdomains, not when randomly distributed (Cambi et al., 2004). Therefore, LFA-1 
microdomains on monocytes may be exploited by host-derived ICAM-1-bearing HIV-1 
through a similar mechanism using LFA-1 microdomains as docking platforms, 
thereby facilitating HIV-1 dissemination to target cells.   
It has long been debated whether clustering of integrins triggers ligand binding or is 
rather a result of ligand binding. Here, we present snapshots of monocyte cell 
membrane, in the absence of ligand binding, where LFA-1 shows a sub-micron 
clustered distribution pattern. Since the activity of integrins on circulating leukocytes 
must be upregulated within seconds, the organization of LFA-1 in small pre-defined 
clustered units could facilitate the establishment of these fast interactions. Carman et 
al. showed that on monocytes linear clusters of LFA-1 colocalize with ICAM-1-
containing microvilli on the endothelium prior monocyte extravasation (Carman and 
Springer, 2004). Our observations suggest that the existence of preformed LFA-1 
microdomains on monocyte cell surface may facilitate or accelerate the interaction of 
monocytes with these endothelial ICAM-1-enriched projections.  
In this regard, we investigated the interaction between monocytes double labeled for 
LFA-1 (NKI-L16 and TS2/4 Abs) and unlabeled ICAM-1 bearing Jurkat T cells by live 
imaging and quantified the accumulation of LFA-1 at the cell-cell contact (Fig. 7 and 
8). The recruitment index of NKI-L16 positive LFA-1 molecules at the contact site 
between monocyte and T cell is clearly higher than the recruitment index of the total 
LFA-1 labeled by TS2/4. This indicates that the pre-formed NKI-L16 positive 
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microdomains may act as ‘primed’ scaffolds of LFA-1 molecules that readily bind the 
ligand. These scaffolds are recruited at the contact site where larger LFA-1 
macroclusters are subsequently formed (Fig. 9).  
Strengthening of these contacts can be further achieved by the interaction of LFA-1 
cytoplasmatic tails with known cytoplasmatic regulatory proteins, such as β2-
interacting talin, cytohesin, and myosin, and a chain-interacting molecules like RapL 
or caveolin-1 (Calderwood, 2004). 
 
 
 
 
Figure 9. Major changes in LFA-1 organization at the cell surface as well as 
adhesive properties occur during development of monocyte-derived DCs. 
 
 
The organization of membrane receptors in microdomains has been often associated 
with the colocalization of these receptors with cholesterol and glycosphingolipid 
enriched lipid microdomains, also known as lipid rafts. On T cells, activated but not 
inactive LFA-1 was found to reside in chlesterol  rich lipid rafts (Leitinger and Hogg, 
2002). Interestingly, our studies on monocytes show that both active (NKI-L16 
positive) and inactive (NKI-L16 negative) LFA-1 microdomains colocalize with GM1-
enriched lipid rafts. However, on DCs random inactive LFA-1 is completely excluded 
by the lipid raft environment  (Fig. 2). 
Information is lacking about how the recruitment of integrins in lipid rafts is 
regulated. Unlike for other lipid raft-associated transmembrane proteins, no lipid 
modification (such as myristoylation or palmitoylation) has been reported for integrin 
molecules. Therefore it is likely that the association of LFA-1 with lipid rafts might 
regulated by complex formation between the integrin and other membrane proteins. 
Conceivable candidates are members of the tetraspannin family, such as CD81 and 
CD82, for which an interaction with LFA-1 has been documented (Shibagaki et al., 
1999; VanCompernolle et al., 2001). The contribution of these transmembrane 
proteins to LFA-1 association with lipid rafts is currently under investigation.    
Interestingly, the other β2 integrins (MAC-1 and p150,95), which are also expressed 
on both monocytes and DCs, do lose their ICAM-1 binding capacity during DC 
development similarly to LFA-1 (Fig. 1 A), but they maintain a clustered organization 
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from monocytes to DCs (data not shown). This suggests that other mechanisms 
might be regulating the cell surface organization of MAC-1 and p150,95. 
Accumulating evidence suggests that many integrin-mediated functions occur 
through physical interaction of integrins with other associated proteins (Cambi, 
2005). Interactions with different partners at the cell surface may explain the 
different behaviour of the three β2 integrins.  
In summary, we demonstrated that phenotypical changes occurring during 
development of precursor cells such as monocytes into antigen-presenting dendritic 
cells involve also rearrangement of receptor organization at the cell surface. 
Moreover, our findings reveal the existence of a hierarchical organization of LFA-1 
that goes from random inactive molecules, to pro-active ligand-independent 
nanometric microdomains, to ligand-triggered micron-sized macroclusters. The 
present challenge is to better understand what regulates these sub-micron-sized 
avidity changes of LFA-1. 
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SUMMARY  
The C-type lectin DC-SIGN (CD209) facilitates binding and internalization of several 
viruses, including HIV-1, on dendritic cells, but the underlying mechanism for being 
such an efficient phagocytic pathogen-recognition receptor is poorly understood. By 
high-resolution electron microscopy, we demonstrate a direct relation between DC-
SIGN function as viral receptor and its microlocalization on the plasma membrane. 
During development of human monocyte-derived dendritic cells, DC-SIGN becomes 
organized in well-defined microdomains, with an average diameter of 200 nm. 
Biochemical studies and confocal microscopy indicate that DC-SIGN microdomains 
reside within lipid rafts. Finally, we show that the organization of DC-SIGN in 
microdomains on the plasma membrane is important for binding and internalization 
of virus particles, suggesting that these multi-molecular assemblies of DC-SIGN act 
as a docking site for pathogens like HIV-1 to invade the host. 
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INTRODUCTION 
In the past two years, several new genes have been identified encoding leukocyte 
specific carbohydrate binding proteins that belong to the lectin-like receptors (Figdor 
et al., 2002; Kogelberg and Feizi, 2001). Many of these lectins are members of the 
calcium dependent C-type lectin family and recognize their ligands through the 
structurally related Ca2+-dependent carbohydrate-recognition domains (C-type CRDs) 
(Drickamer, 1999). Many C-type lectins act as cell adhesion receptors (Vestweber 
and Blanks, 1999), while others are specialized in antigen recognition (Mahnke et al., 
2000; Stahl and Ezekowitz, 1998). 
Dendritic cells (DCs) constitute a specific group of professional antigen presenting 
leukocytes, constantly patrolling the body for foreign intruders (Banchereau and 
Steinman, 1998; Steinman, 1991). DCs are equipped with a variety of dynamically 
regulated pathogen-recognition receptors. While some of them are members of the 
toll-like receptor (TLRs) family, signaling molecules specialized in sensing pathogens 
(Akira, 2003), others belong to the C-type lectin family and mediate pathogen 
binding and uptake (Mahnke et al., 2000; Stahl and Ezekowitz, 1998).   
DC-SIGN (CD209) is a C-type lectin specifically expressed by DCs and has a dual 
function. As an adhesion receptor, DC-SIGN supports initial DC-T cell interaction by 
binding to ICAM-3 (Geijtenbeek et al., 2000c), and mediates tethering and rolling of 
DC on the endothelium by interacting with ICAM-2 (Geijtenbeek et al., 2000a). As a 
pathogen-recognition receptor, DC-SIGN binds HIV gp120 thus facilitating the 
transport of HIV from mucosal sites to draining lymph nodes where infection of T 
lymphocytes occurs (Geijtenbeek et al., 2000b). Recently, DC-SIGN was also shown 
to bind other viruses like CMV (Halary et al., 2002), Ebola (Alvarez et al., 2002), 
Dengue (Tassaneetrithep et al., 2003) and hepatitis C (Lozach et al., 2003; 
Pohlmann et al., 2003), as well as microorganisms such as Leishmania (Colmenares 
et al., 2002), Candida albicans (Cambi et al., 2003), Mycobacterium (Geijtenbeek et 
al., 2003; Maeda et al., 2003; Tailleux et al., 2003), and Schistosoma  (van Die et al., 
2003).  
Recent studies have demonstrated that some microbial pathogens exploit cholesterol 
enriched lipid microdomains as essential docking sites to enter host cells (Gatfield 
and Pieters, 2000; Lafont et al., 2002; Rosenberger et al., 2000). These 
microdomains, also known as lipid rafts, are localized regions with elevated 
cholesterol and glycosphingolipid content that can be found on the plasma- and 
endosomal-membrane of eukaryotic cells (London and Brown, 2000; Simons and 
Ehehalt, 2002; Simons and Toomre, 2000). Some viruses, such as HIV-1 appear to 
target lipid raft microdomains during viral entry into cells, as well as during viral 
assembly before budding from cells (Dimitrov, 1997; Manes et al., 2000). Other 
studies suggest that cholesterol-dependent membrane properties, rather than lipid 
rafts per se, are responsible to promote efficient HIV-1 infection in T cells 
(Percherancier et al., 2003). 
DC-SIGN, like other C-type lectins, recognizes pathogens by binding to carbohydrate 
moieties in a Ca2+-dependent manner, through a conserved carbohydrate recognition 
domain (CRD) (Drickamer, 1999).  This CRD has a high specificity for complex 
mannose residues and is located at the distal end of the extracellular domain, which 
consists of several amino acid repeats (Soilleux et al., 2000). Recently, purified 
truncated forms of DC-SIGN containing either the complete extracellular domain 
(ECD) or only the CRD were used to analyze the quaternary structure as well as the 
affinity of DC-SIGN for its ligands. Biochemical studies indicated that in vitro ECDs 
aggregate to form tetramers, thus enhancing DC-SIGN capacity to bind multivalent 
ligands, such as pathogen sugar arrays (Mitchell et al., 2001). Surface plasmon 
resonance studies showed that while the ECD readily binds hepatitis C virus 
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glycoprotein E2, distant monomeric CRDs do not unless closely seeded (Lozach et al., 
2003).  
These findings suggest that the organization of DC-SIGN molecules on the plasma 
membrane may be critical for pathogen binding. This prompted us to investigate the 
cell surface distribution pattern of DC-SIGN and its possible association with lipid 
rafts. Using transmission electron microscopy on whole-mount samples of 
transfected cells and monocyte-derived DCs, we have mapped the micro-localization 
of DC-SIGN at high resolution. Subsequently, spatial-point-pattern-analysis showed 
that DC-SIGN is organized in well-defined microdomains. Moreover, biochemical 
studies and confocal microscopy analysis demonstrated that DC-SIGN co-localizes 
with lipid rafts. Finally, we show that these microdomains of DC-SIGN act as a 
docking site for HIV-1 particles, facilitating entry of the virus into DCs. 
  
 
MATERIALS AND METHODS 
 
Antibodies and reagents 
For labeling as well as blocking of DC-SIGN, the mAb AZN-D1 was used (Geijtenbeek 
et al., 2000c). For detection of CD46 and CD55 the Abs E4.3 (PharMingen) and 143-
30  (CLB, Amsterdam) were used, respectively. Alexa-647-conjugated goat anti 
mouse IgG was from Molecular Probes. FITC-conjugated Cholera Toxin B subunit 
(FITC-CTxB), Triton-X 100, and methyl-β-cyclodextrin (MCD) were from Sigma (St. 
Louis, MO). Goat anti-CTxB antibody was from Calbiochem. 
 
Cells 
Monocytes were obtained from buffy coats of healthy individuals and were purified 
using Ficoll density centrifugation. Immature DCs were obtained as reported 
elsewhere (Geijtenbeek et al., 2000c). Briefly, DCs were cultured from monocytes in 
presence of IL-4 and GM-CSF (500 and 800 U/ml, respectively) for three days to 
obtain intermediate DCs and for six days to obtain immature DCs. Stable K562 
transfectants expressing DC-SIGN (K-DC-SIGN) were generated as already published 
(Geijtenbeek et al., 2000c). 
 
Adhesion assays 
Carboxylate-modified TransFluorSpheres (488/645 nm, 1 µm Ø; Molecular Probes) 
were coated with ICAM-3-Fc or GP120, and the fluorescent beads adhesion assay 
was performed as described previously (Geijtenbeek et al., 1999). When the lipid 
raft-disrupting agent MCD was used, the cells were resuspended in serum free 
medium containing the appropriate concentration of MCD and pre-incubated for 30 
min at 37°C. When necessary, fifty thousand cells were then incubated with blocking 
mAb (20 µg/ml) for 10 min at room temperature. The ligand-coated fluorescent 
beads (20 beads/cell) were added and the suspension was incubated for 30 min at 
37°C. Adhesion was determined by measuring the percentage of cells, which have 
bound fluorescent beads, by flow cytometry using the FAC-Scalibur (Becton 
Dickinson, Oxnard, CA). Streptavidin-modified TransFluorSpheres (505/515 nm, 40 
nm Ø; Molecular Probes) were coated with ICAM-3-Fc or GP120 as already described 
for 1 µm beads and were added to DCs in a ratio of approximately 20 beads/cell. 
Bound beads were detected by confocal microscopy analysis of the cells. 
When binding to soluble GP120 was performed, biotinylated GP120 (50mM) was 
added to the cells (10e5) for 30 min on ice, in presence or absence of anti-DC-SIGN 
blocking Ab (AZN-D1 20 µg/ml). After the incubation, cells were extensively washed 
and incubated with Alexa-488-conjugated streptavidin for 30 min on ice. 
Subsequently, bound GP120 molecules were detected by flowcytometry. 
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Labeling procedures 
For flow cytometry analysis, cells were incubated (30 min, 4°C) in PBA (PBS, 
containing 0.5% BSA and 0.01% sodium azide), with different mAb (5 µg/ml), 
followed by incubation with FITC-labeled goat anti-mouse IgG antibody (GAM-FITC; 
Zymed, San Francisco, CA; 1:50 dilution in PBA) for 30 min at 4°C. The relative 
fluorescence intensity was measured on a FACSCalibur. Isotype specific controls 
were included. For transmission electron microscopy (TEM), K-DC-SIGN were fixed 
onto poly-L-lysine-coated formvar, while DCs were allowed to spread on glass 
coverslips covered by a thin layer of fibronectin-coated Formvar for 1 hour at 37°C 
and immediately fixed with 1% paraformaldehyde (PFA) for 15 min. After two 
washing steps with PBS and a subsequent incubation (60 min at RT) with I-buffer 
(PBS, 0.1% glycine, 1% BSA, 0.25% gelatin) to reduce aspecific background, the 
specimens were incubated for 30 min with the primary antibodies in I-buffer on ice, 
rinsed in PBS, and further fixed in 1% PFA, 0.1% glutaraldehyde (GTA) for 15 min. 
After two washing steps with PBS and a block in I-buffer, the samples were 
incubated with rabbit anti-mouse IgG (to detect mAb) for 30 min on ice. A final 
incubation with 10 nm diameter gold-labeled Protein A (to detect polyclonal 
antibodies) was performed, followed by final fixation in 1% GTA in Phosphate Buffer 
for 20 min at room temperature. When double labeling was performed, the cells 
were treated as described above, except that anti-DC-SIGN (AZN-D1) and 
biotinylated-CTxB were added simultaneously, and finally, goat-anti-mouse-
conjugated 5 nm gold and streptavidin-conjugated 10 nm gold were used to label 
DC-SIGN and GM1, respectively. Isotype specific controls were always included. 
 
Electron microscopy and analysis of the distribution patterns of gold 
particles 
After gold labeling and fixation, the specimens were dehydrated by sequential 
passages through 30, 50, 70, 90% and absolute ethanol. Then the ethanol was 
substituted by liquid CO2, and the samples were critical point dried. The formvar 
films were then transferred from the glass onto copper grids, and the specimens 
were observed in a JEOL 1010 transmission electron microscope, operating at 60-80 
kV. Gold particles were detected on the periphery and thinner parts of cells, where a 
good contrast could be achieved. In case of DC, which widely spread (see 
supplemental figure 1), the membrane area available for analysis represented up to 
60-70% of the whole labeled plasma membrane. For each cell at least four-six areas 
were analyzed at random. 
The digital images of electron micrographs were processed by custom-written 
software based on Labview (National Instruments, TX). The distribution pattern of 
DC-SIGN (i.e.: the degree of clustering) was analyzed by counting the number of 
gold particles found on the plasma membrane in a semi-automatic fashion. 
Subsequently, coordinates were assigned to the observed beads and inter-particles 
distance statistics were obtained using a nearest neighbor distance algorithm. 
Clusters were then defined when gold particles were less than a set distance apart 
from a neighboring particle. 
 
Confocal microscopy 
Cells were stained at 4°C with anti-DC-SIGN antibody (AZN-D1 10 µg/ml), anti-CD55 
antibody, anti CD46 antibody, and FITC-CTxB (10 µg/ml). Isotype specific controls 
were always included. Secondary staining for DC-SIGN, CD55, and CD46 was with 
Alexa-647-conjugated goat anti mouse IgG, and for FITC-CTxB with goat anti-CTxB. 
Patching was induced by incubation at 12°C for 1 hour, followed by fixation with 1% 
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paraformaldehyde. Cells were mounted onto poly-L-lysine coated glass coverslips. 
Signals were collected sequentially to avoid bleed through. 
 
Detergent extraction and flotation assay 
For detergent resistant membrane isolation, K-DC-SIGN cells (10x106) were lysed on 
ice in 0.5 ml of lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, and 1% 
Triton X-100, plus a cocktail of protease inhibitors: 1 mM PMSF, 10 µg/ml Aprotinin, 
and 10 µg/ml Leupeptin). After 30 minutes of incubation, the lysate was made 40% 
with respect to sucrose. Then, the lysate-sucrose mixture was overlaid with 2 ml of 
30% sucrose in lysis buffer and finally with 1 ml of 4% sucrose in lysis buffer. The 
mixture was centrifuged at 200000xg for 14-16 hours in an SW60Ti rotor (Beckman 
Coulter, CA). The gradient was fractionated in 0.5 ml fractions from the bottom of 
the tube. 
 
Immunoblot analysis 
Proteins from the sucrose fractions were separated by SDS-PAGE and then 
transferred to PROTRAN nitrocellulose transfer membranes (Schleicher & Schuell, 
NH). Membranes were blocked for 1 hour at room temperature using 2% non-fat 
dried milk (Campina, NL) and 1% BSA (Calbiochem, CA) in 0.1% PBS/Tween-20. 
Blots were subsequently incubated with specific antibodies [polyclonal anti-CD55, 
CD46 from Santa Cruz Biotechnology (CA) and a polyclonal anti-DC-SIGN antibody 
(CSRD) that was raised in our laboratory], followed by the appropriate horseradish-
peroxidase (HRP)-conjugated secondary antibodies (Dako A/S, DK). Finally, proteins 
were detected using enhanced chemiluminescence (Amersham Biosciences, UK). 
 
HIV-1 infection of dendritic cells 
Infection of intermediate and immature DC with the M-tropic strain HIV-1Ba-L  was 
performed as already described (Geijtenbeek et al., 2000b). Briefly, intermediate and 
immature DC (1.5 x 106) were incubated with mAb against DC-SIGN (AZN-D1 (20 
µg/ml) and AZN-D2 (20 µg/ml)) for 20 min at room temperature. Subsequently, cells 
were incubated with the M-tropic strain HIV-1Ba-L for 2h with a multiplicity of infection 
of 0.004. After incubation, cells were washed and cocultured with activated PBMC in 
the presence of 5 U/ml human recombinant IL-2 (Roche Diagnostics GmbH, 
Mannheim, Germany). PBMC were activated by culturing them prior to infection for 
three days in the presence of 2 µg/ml of phytohemaglutinin (PHA, Sigma, St. Louis, 
USA). After seven days, culture supernatants were collected, and p24 antigen levels 
were determined by a p24 antigen ELISA (AMPAKTM, DAKO, Cambridgeshire, UK). 
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RESULTS 
 
DC-SIGN is organized in microdomains on the cell surface. 
To study the correlation between functional state and cell surface organization of 
DC-SIGN, we used K562 transfectants stably expressing DC-SIGN. K-DC-SIGN 
expressed high levels of DC-SIGN (Fig. 1a) and bound strongly to 1 µm fluorescent 
beads coated with ICAM-3 or GP120 (Fig. 1b). The binding of K-DC-SIGN to these 
ligands was specific, as shown by the inhibition exerted by anti-DC-SIGN mAbs. 
Moreover, the lack of adhesion in presence of EGTA confirmed that DC-SIGN bound 
to these ligands in a Ca2+ dependent manner, typical of C-type lectin like receptors. 
In order to determine the organization of DC-SIGN on the cell membrane at high 
resolution, transmission electron microscopy (TEM) was used on whole-mount 
samples of K-DC-SIGN, after specific labeling with anti-DC-SIGN mAb and 10 nm 
gold particles. It should be noted that the specimens were not sectioned thus making 
the whole cell surface available for gold labeling and subsequent TEM analysis. This 
method has been successfully applied to detect spatial distribution of other 
membrane proteins such as the potassium channels Kv1.3 (Panyi et al., 2003) and 
the IL-2 receptor α-subunit (Vereb et al., 2000). As shown in Figure 1c, DC-SIGN 
showed a clear distribution in well-defined microdomains on K-DC-SIGN plasma 
membrane.  
 
 
 
Figure 1. DC-SIGN is organized in microdomains on the cell surface of K-DC-SIGN. 
(a) The expression levels of DC-SIGN on untransfected K562 and on K-DC-SIGN were 
assessed by FACS analysis. The open histogram represents the isotype control, and filled 
histogram indicates the specific staining with anti-DC-SIGN (AZN-D1). (b) DC-SIGN 
expressed by K562 transfectants strongly binds to ICAM-3 and gp120. The adhesion was 
determined using 1 µm ligand-coated fluorescent beads. Specificity was determined by 
measuring binding in presence of AZN-D1. No blocking was observed in presence of isotype 
control (not shown). Blocking exerted by EGTA indicates that DC-SIGN binds to the ligands in 
a Ca2+ dependent manner. The average of five independent experiments is shown (P<0.001). 
(c) K-DC-SIGN cells were specifically labeled with 10 nm gold particles, as described in 
Materials and Methods. Cells were allowed to adhere onto poly-L-Lysine-coated formvar film 
and photographed in an electron microscope. Gold particles were detected on the periphery 
on the thinner less electron dense parts of cells, where good contrast could be achieved. One 
representative picture is shown. (Scale bar = 200 nm). 
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These microdomains had an average diameter of 200 nm and appeared to be 
randomly localized on the cell surface. To exclude that the gold labeling pattern 
observed could be due to internalized DC-SIGN molecules, also sections of these cell 
samples were analyzed by TEM. The results demonstrated that the gold particles 
were exclusively detected on the outside of the cell membrane (unpublished data), 
confirming the presence of DC-SIGN in microdomains on the cell surface. To show 
that the clustering of DC-SIGN is not an artifact due to the procedure, we also 
analyzed by TEM other trans-membrane receptors transfected into K562, among 
which the β2-integrin LFA-1. Unlike DC-SIGN, LFA-1 molecules showed a random 
distribution pattern (unpublished data). It should be noted that the number of gold 
particles observed per µm2 was generally comparable with that observed for K-DC-
SIGN, which should exclude difference in distribution due to major difference in the 
expression levels of the two receptors.  
 
 
DC-SIGN predominantly resides in lipid rafts. 
To determine whether lipid rafts are important for DC-SIGN function, K-DC-SIGN 
cells were treated with methyl-β-cyclodextrin (MCD) to extract membrane 
cholesterol, and its effect on DC-SIGN-mediated ligand binding was tested by the 
fluorescent beads adhesion assay.  As shown in Fig. 2a, MCD treatment partially 
inhibits binding to gp120-coated beads, indicating that cholesterol extraction partially 
affected DC-SIGN ligand binding capacity.  
 
 
 
 
Figure 2. DC-SIGN colocalizes with lipid rafts on K-DC-SIGN. (a) To investigate the 
effect of cholesterol depletion on DC-SIGN mediated adhesion, K-DC-SIGN cells were 
incubated in serum free medium with or without 20mM MCD for 30 min at 37ºC. 
Subsequently, gp120-coated fluorescent beads (1 µm Ø) were added and the mixture was 
incubated for an additional 30 min at 37ºC. Binding was measured by flow cytometry. After 
MCD treatment, cell viability was assessed by trypan blue staining. The results represent the 
average of three independent experiments (P<0.001). (b) K-DC-SIGN were solubilized with 
1% Triton X-100, subjected to sucrose gradient centrifugation and analyzed by western 
blotting for the indicated molecules. The numbers indicate the gradient fractions. Fractions 9 
and 10 are low-density fractions containing DRMs and are referred to as raft fractions. (c) 
Confocal microscopy analysis of co-patching of DC-SIGN and GM1. K-DC-SIGN cells were 
stained at 4ºC with 10µg/ml anti-DC-SIGN (or anti-CD55 or anti-CD46) and FITC-CTxB 
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(10µg/ml). Co-patching was induced by adding secondary Ab (see Materials and Methods), 
and, after fixation in PFA, cells were analyzed by confocal microscopy. Merged images are 
shown in the right panel. Results are representatives of multiple cells in three independent 
experiments. (Scale bar = 5 µm). 
 
 
To further demonstrate the association of DC-SIGN with lipid rafts, K-DC-SIGN cells 
were solubilized in Triton-X 100 on ice and fractionated by centrifugation on a 
sucrose gradient at 4°C. With this procedure, lipid rafts, which can be isolated as 
detergent-resistant membranes (DRMs), were recovered in low-density fractions, 
whereas any other detergent soluble material was concentrated in the high-density 
fraction (Fig. 2b). The GPI anchored protein CD55 was used as raft marker and was 
found in raft fractions, whereas the negative control (non-raft associated protein), 
CD46, was almost completely detectable in the non-raft fractions. Similarly to CD55, 
a significant portion of DC-SIGN was recovered in the low-density fraction, indicating 
that DC-SIGN is localized in DRMs on the plasma membrane of K-DC-SIGN cells. 
To provide further evidence that DC-SIGN co-localizes with lipid rafts, we examined 
the co-distribution of DC-SIGN and the lipid raft marker GM1, on K-DC-SIGN by 
antibody patching and confocal microscopy. As shown in Fig. 2c, when capping was 
induced on K-DC-SIGN cells, GM1 clearly co-localizes with DC-SIGN and to the same 
extent as for CD55. However, some smaller patches of DC-SIGN were also detectable 
outside the lipid raft area, indicating that DC-SIGN might not permanently reside in 
lipid rafts, as also observed in figure 2b. As expected, no co-localization of CD46 with 
GM1 was detected.  
Based on these observations, we conclude that DC-SIGN resides within a lipid raft 
environment on the plasma membrane of K-DC-SIGN cells. 
 
 
DC-SIGN distribution changes during DC development.  
During the differentiation of DC from monocyte precursors, the expression of DC-
SIGN on the cell surface gradually increases (Geijtenbeek et al., 2000c). However, as 
shown by flow cytometry, (Fig. 3a), no significant increases in DC-SIGN expression 
levels are seen between cells harvested after three days of culture (designated 
intermediate DC) and immature DC. Maximum DC-SIGN-mediated adhesion to ICAM-
3 as well as GP120 was observed on immature DC, although already on intermediate 
DC DC-SIGN was capable of completely mediating the binding to ICAM-3 (Fig. 3b left 
panel), which on monocytes is LFA-1 dependent (unpublished data). Comparably, 
while on monocytes, binding to gp120 is mediated by CD4 (Kedzierska and Crowe, 
2002; Kohler et al., 2003) and unpublished data), on intermediate DC as well as on 
immature DC DC-SIGN is almost entirely responsible for binding to gp120 (Fig. 3b 
right panel). To examine DC-SIGN cell surface distribution, both intermediate and 
immature DC were allowed to adhere to fibronectin, and DC-SIGN molecules were 
labeled with gold particles. Subsequently, the distribution on the plasma membrane 
was analyzed by TEM (Fig. 3c).  
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(b) The adhesion to ICAM-3 and gp120 was determined using 1µm ligand-coated fluorescent 
beads. Specificity was determined by measuring binding in presence of AZN-D1. No blocking 
was observed in presence of isotype control (not shown). One representative experiments out 
of three is shown. (c) Intermediate DC and immature DC were let adhere onto fibronectin-
coated formvar film, specifically labeled for DC-SIGN with 10 nm gold particles (see Materials 
and Methods), and analyzed by transmission electron microscopy. Results are representatives 
of multiple cells in several independent experiments. (Scale bar = 200 nm). 
 
Given the high capacity of DC to widely spread on the used substrates, very large 
membrane areas (often up to 60-70% of the whole visible plasma membrane) were 
Figure 3. DC-SIGN cell 
surface distribution during 
monocyte-derived DC 
development. DC-SIGN binding 
activity was monitored during 
development of monocyte-
derived DCs. As shown in the 
box, intermediate DCs indicate 
cells harvested after three days 
of monocytes differentiation. (a) 
The expression levels of DC-
SIGN on monocytes, 
intermediate DC and immature 
DC were assessed by FACS 
analysis. The dotted line 
histogram represents the isotype 
control, and the thick line 
histogram indicates the specific 
staining with anti-DC-SIGN (AZN-
D1). Mean fluorescence intensity 
is indicated. One representative 
donor is shown. 
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available for gold particles analysis, ensuring that the areas used for quantitation 
were truly representative (data not shown). Surprisingly, we found that the 
distribution of DC-SIGN changes dramatically during DC development. Whereas on 
intermediate DC, the gold particles are evenly distributed over the cell surface, on 
immature DC, there is a clear organization of DC-SIGN in spatially well-defined 
microdomains. 
To exclude the possible influence of the fibronectin substrate on DC-SIGN 
distribution, TEM analysis was also performed on DC that were gold-labeled in 
suspension and then mounted onto poly-L-lysine. No differences were seen between 
cells stretched on fibronectin or cells adhering to poly-L-lysine (unpublished data). 
Moreover, thin sections of resin-embedded immature DC were gold labeled and 
analyzed by TEM. Clusters of DC-SIGN molecules could be observed exclusively at 
the plasma membrane (data not shown). We also analyzed by TEM the cell surface 
distribution of other trans-membrane receptors expressed on DC, among which LFA-
1. Unlike DC-SIGN, LFA-1 did not show any changes in cell surface distribution 
pattern on intermediate and immature DC (see Chapter 3). 
To quantitatively describe DC-SIGN distribution pattern, the nearest neighbor 
distance values among the gold particles were calculated applying a spatial-point-
pattern analysis. A quantitative comparison of DC-SIGN clustering among 
intermediate DC, immature DC and K-DC-SIGN is shown in Fig. 4a. On immature DC 
as well as on K-DC-SIGN, almost 70 and 80 % of the gold particles reside within 50 
nm distance from its nearest neighbor, respectively. In contrast, on intermediate DC, 
only 30% of the nearest neighbor distance values are found in the same category, 
and the majority of inter-particle distances rather fall within the 50-150 nm range. It 
has to be noted that the intermediate and the immature DC compared by spatial-
point-pattern analysis had a similar amount of gold particles per mm2, confirming the 
comparable expression levels of DC-SIGN on the two cell types. 
Similarly to what was observed for K-DC-SIGN, on immature DCs, these 
microdomains were also found to have an average diameter of about 200 nm and 
were separated from each other by an average distance of 400 nm. Spatial analysis 
of the microdomains distribution over the cell surface did not reveal any preferential 
localization in specific surface areas of the observed cells. These data were also 
confirmed by using high-resolution near-field fluorescence imaging (BdB manuscript 
in preparation). 
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Figure 4. Quantitative analysis of the distribution of gold particles labeling DC-
SIGN. The digital images of electron micrographs were processed by a custom-written 
software based on Labview. Gold labels were counted, and coordinates were assigned to 
each feature. Subsequently, inter-particles distances were calculated using a nearest neighbor 
distance algorithm. Nearest neighbor distance values were calculated for each image, and the 
data of several independent experiments were pooled. Subsequently, the nearest neighbor 
distances were divided into three classes 0-50 nm (grey bar), 50-150 nm (black bar), and 
>150 nm (white bar), and the percentage of nearest neighbor distance values falling into 
each class was plotted (a). The partitioning of gold labels in clusters of various size (i.e.: 
number of particles/cluster) was also quantified. Clusters were defined when gold particles 
were less than 50 nm apart from a neighboring particle. The percentage of gold particles 
involved in the formation of a certain cluster size was calculated for K-DC-SIGN (b), 
immature DC (c), and intermediate DC (d). The insets are three representative processed 
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digital images, where each type of cluster is shown in a different color. For K-DC-SIGN, one 
representative experiment out of two is shown; for immature DC, one representative 
experiment out of six is shown; for intermediate DC, one representative experiment out of 
three is shown. 
 
 
The relative partitioning of gold particles in clusters of various sizes (i.e.: number of 
particles/cluster) was also quantified. A value of 50 nm was set to define the 
involvement of a gold particle in a cluster. Fig. 4d shows that on intermediate DC up 
to 80% of gold particles occur as single features. In contrast, on immature DC (Fig. 
4c) as well as on K-DC-SIGN (Fig. 4b), DC -SIGN shows a much broader distribution 
of cluster sizes, with an average of 10-20 gold particles per cluster on immature DCs. 
 
 
DC-SIGN resides in lipid rafts on DC. 
Since, on K-DC-SIGN, we found a clear association of DC-SIGN with lipid rafts, we 
investigated whether DC-SIGN also co-localized with lipid rafts on immature DCs. 
Extraction of cholesterol by MCD resulted in a significant block in binding of both 
ICAM-3- and gp120-coated beads (Fig. 5a). In contrast, DC-SIGN mediated binding 
on intermediate DCs was not affected by cholesterol depletion (unpublished data). 
To further demonstrate an interaction of DC-SIGN with lipid rafts on immature DCs, 
we investigated the codistribution of DC-SIGN and GM1 by confocal microscopy. Fig. 
5b shows that, when capping was induced, DC-SIGN clearly colocalized with GM1, 
almost to the same extent as the raft marker CD55. However, similarly to what was 
observed on K-DC-SIGN, small patches of DC-SIGN were also found not colocalizing 
with GM1.  
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(b) Confocal microscopy analysis of co-patching of DC-SIGN and GM1 on immature DC. 
Staining was performed as described in Fig. 2c. Cells were analyzed by confocal microscopy. 
Merged images are shown in the right panel. Results are representative of multiple cells in 
two independent experiments. (Scale bar = 5 µm). (c) Whole-mount samples of immature 
DC were double labeled for DC-SIGN (5 nm gold) and the raft marker GM1 (10 nm gold) and 
analyzed by TEM. Thin white arrows indicate GM1 co-localizing in DC-SIGN microdomains. 
Thick white arrows indicate DC-SIGN microdomains with no GM1. Black arrows indicate GM1 
alone. Results are representatives of multiple cells in two independent experiments. (Scale 
bar = 50 nm). 
 
 
To further prove the colocalization of GM1 with DC-SIGN, we performed double gold 
labeling for DC-SIGN and GM1 on immature DC, and analyzed the samples by TEM. 
As shown in fig. 5c, GM1 (10 nm gold) was found within DC-SIGN microdomains (5 
nm gold). Consistent with observations by confocal microscopy, some microdomains 
of DC-SIGN that lacked GM1 were also detected. Together, these results 
demonstrate that on immature DCs DC-SIGN resides in microdomains that to a 
significant extent are associated with a lipid rafts environment.    
 
 
DC-SIGN in microdomains facilitates binding to virus-sized particles. 
We showed that fluorescent beads coated with DC-SIGN specific ligands were bound 
by immature as well as intermediate DC, apparently independently of DC-SIGN 
organization on the cell membrane (fig. 3ab). 
However, since DC-SIGN on immature DC is an exquisite virus receptor and the 
fluorescent beads are at least one order of magnitude larger than viral particles, we 
investigated whether clustering of DC-SIGN into higher order assemblies might be 
needed to stabilize interactions with virus-sized particles. To detect possible 
differences in “avidity” for multimeric ligands between scattered and clustered DC-
Figure 5. DC-SIGN resides in 
lipid rafts on immature DC. 
(a) DC-SIGN mediated adhesion 
to ligand-coated fluorescent 
beads (1 µm Ø) on immature DC 
was measured after cholesterol 
depletion by MCD (20 mM). The 
assay was performed as 
described in Fig. 2a. One 
representative experiment out of 
three is shown. 
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SIGN molecules, and to mimic virus binding to DC-SIGN, we used fluorescent virus-
sized microbeads of 40 nm diameter, coated with gp120, which are now referred to 
as virus-sized particles. The extremely broad fluorescence emission peak of these 
microbeads currently precludes accurate quantification by flow cytometry, therefore 
binding of DC to these virus-sized particles was visualized by confocal microscopy. 
When comparing the capacity of intermediate and immature DC to bind these virus-
sized particles (Fig. 6), a very high binding was observed on immature DC. Many 
virus-sized particles were bound to the plasma membrane and a significant amount 
was phagocytosed (Fig. 6d and e). In contrast, intermediate DCs (Fig. 6a and b) 
hardly bound any microbeads, comparable to background levels or when DC were 
pretreated with the carbohydrate mannan to block DC-SIGN- (Fig. 6c and 6f). Similar 
results were obtained when microbeads coated with ICAM-3 were used (unpublished 
data). 
 
 
 
 
 
 
 
Chapter 4 
 97
 
 
Figure 6. DC-SIGN microdomains on immature DCs bind virus-sized particles. 
Green fluorescent microbeads (40 nm Ø) were coated with gp120 and added to the cells in a 
ratio of 20 beads per cell. The cells were incubated for 30 min at 37ºC, then washed and 
fixed in PFA. DC-SIGN was stained with AZN-D1 and Alexa-647-conjugated goat anti-mouse 
Ab (in red). Subsequently, the cells were mounted onto poly-L-lysine coated glass coverslips 
and analyzed by confocal microscopy. The overview of binding to gp120 microbeads of 
intermediate DC (a) and immature DC (d) is shown. Two representative cells of intermediate 
(b) and immature DC (e) are shown. Specific block with 100 µg/ml mannan was also 
performed by pre-incubating the cells at room temperature for 10 min prior to adding the 
microbeads (c and f); scale bar is 5 µm. Similar results were obtained with ICAM-3-coated 
microbeads (data not shown). (g) Binding of K-DC-SIGN, intermediate DC, and immature DC 
to soluble gp120 was also performed: 50000 cells were incubated with 50mM biotinylated 
gp120 for 30 min on ice, in presence or absence of anti-DC-SIGN blocking mAb (AZN-D1, 20 
µg/ml). A subsequent incubation with Alexa-488-conjugated streptavidin for 30 min on ice 
followed, and gp120 molecules bound to the cells were detected by flowcytometry. 
 
 
 Moreover, DC-SIGN on intermediate as well as on immature DC was found to be 
equally capable of binding to soluble recombinant gp120 (Fig. 6g), suggesting that 
the intrinsic binding capacity of DC-SIGN molecule on the two different DC types is 
comparable. Similar results were obtained when soluble ICAM-3-Fc chimeras were 
used (unpublished data). 
All these observations support our hypothesis that DC-SIGN molecules acquire a 
higher “avidity” for multimeric ligands when organized in multimolecular assemblies. 
 
 
DC-SIGN microdomains enhances HIV-1 infection. 
Having established that DC-SIGN microdomains bind virus-sized particles more 
efficiently in comparison to randomly distributed receptor molecules, we investigated 
whether the uptake of real virus was also enhanced by a clustered distribution of DC-
SIGN, using p24 ELISA. Therefore, intermediate DC and immature DC were pulsed 
for 2 hr with HIV-1 (M-tropic HIV-1Ba-L strain), washed, and cultured in the 
presence of activated PBMC. As shown in Fig. 7, virus replication was significantly 
higher when PBMC were cocultured with either intermediate or immature DC with 
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respect to PBMC alone challenged with the same amount of infectious virus. 
However, infection of PBMC cultured with virus-pulsed immature DC was much 
higher than the infection exhibited by PBMC cultured with intermediate DC. In 
addition, the infection of PBMC with immature DC was significantly blocked by anti-
DC-SIGN mAbs that were added to DC prior to incubation with HIV-1. In contrast, 
DC-SIGN contribution to PBMC infection was clearly much lower when intermediate 
DC were used. 
 
 
activated PBMC (1.5 x 106) for 7 days. Coculture supernatants were collected, and p24 
antigen levels were measured by ELISA. Black histogram represents PBMC infected in the 
absence of DC. One representative experiment out of two is shown. 
 
 
The incomplete blocking observed in the presence of anti-DC-SIGN Abs suggests the 
involvement of other HIV receptors also expressed on DC (Turville et al., 2002). The 
comparable expression levels of DC-SIGN, as shown above, as well as several 
costimulatory molecules (such as CD40 and CD80) on intermediate and immature DC 
suggest that these two DC types have similar antigen presentation capacity 
(unpublished data). 
All together our data demonstrate that DC-SIGN organized in microdomains rather 
than randomly distributed is more efficient in mediating binding and uptake of virus-
sized microbeads as well as real HIV-1 particles. 
 
 
DISCUSSION 
DC-SIGN is a DC specific C-type lectin that acts both as adhesion molecule and as 
pathogen-recognition receptor. Here we demonstrate that DC-SIGN can form 
microdomains on the plasma membrane, and that there is a direct correlation 
between the distribution of DC-SIGN in microdomains and its capacity to bind and 
internalize virus-sized ligand-coated particles. Moreover, to the best of our 
knowledge, this is the first report describing a C-type lectin in a lipid raft 
environment on DCs that forms highly organized well-defined (200 nm) multi-protein 
assemblies on the surface of a cell. 
To establish the association of proteins with lipid rafts is complicated and often 
controversial, which underscores the complexity of cell membranes. These lipid 
domains differ in their composition, physical properties, and biological functions 
(Schuck et al., 2003). Moreover, lipid raft compositions differ between cell types. 
Finally, the dynamics of the chemical membrane composition adds a further level of 
complexity. Therefore, the association of proteins with lipid rafts can only be 
Figure 7. Clustered DC-SIGN molecules 
efficiently bind HIV-1 particles and 
infect PBMC. DC-SIGN on immature DC 
enhances HIV-1 infection as measured in a 
DC-PBMC coculture. Either intermediate or 
immature DC (1.5 x 106) were preincubated 
for 20 min at room temperature with or 
without blocking mAb against DC-SIGN 
(AZN-D1 and AZN-D2, 20µg/ml). 
Preincubated intermediate or immature DC 
were pulsed for 2 hr with HIV-1 (M-tropic 
HIV-1Ba-L strain), and unbound virus 
particles and mAb were washed away. 
Subsequently, DC were cocultured with 
ti
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analyzed using different techniques simultaneously. Our observation that DC-SIGN 
resides within lipid rafts is based on several well-established raft analysis techniques. 
First, we showed by biochemical studies the partitioning of DC-SIGN in DRMs. 
Secondly, co-patching of DC-SIGN with the lipid raft marker GM1 was observed by 
confocal microscopy. Third, this association between DC-SIGN and GM1 was 
confirmed by transmission electron microscopy. Fourth, cholesterol extraction by 
MCD inhibited DC-SIGN-mediated binding. Surprisingly, on immature DC, the same 
MCD treatment did not have any effect on the organization of DC-SIGN 
microdomains, as observed by TEM (unpublished data). This may be explained by 
the fact that the remaining cholesterol may be sufficient to keep such domains intact 
(Schuck et al., 2003). Moreover, besides cholesterol, also glycosphingolipids, another 
lipid raft component, which is not depleted by MCD treatment, may in part maintain 
the integrity of DC-SIGN microdomains. The fact that cholesterol extraction by MCD 
partially affects DC-SIGN-mediated binding could be explained by considering the 
pleiotropic effects that MCD can have on cell functions, besides disrupting lipid rafts 
integrity (Brown and London, 2000; Edidin, 2001; Schuck et al., 2003). Therefore, 
MCD treatment can only be a preliminary indicator for a possible association of a 
protein with a lipid rafts environment. Also, it should be added that, unlike for GPI-
anchored proteins, very little is known about how trans-membrane proteins are 
recruited into lipid rafts, how stable these interactions are and what exactly the role 
of cholesterol is. Further studies are needed to better identify the molecular 
determinants that control the association of trans-membrane proteins with lipid rafts. 
In vitro studies with isolated recombinant C-type lectins suggested that these can 
oligomerize providing multiple surfaces to bind (multivalent) ligands (Drickamer, 
1999). DC-SIGN has been shown to form tetramers stabilized by a α-helical stalk 
(Mitchell et al., 2001), and purified truncated forms of DC-SIGN containing the 
complete extra-cellular domain were also shown to be able to bind ligands by surface 
plasmon resonance (Lozach et al., 2003). In these studies, the affinity of isolated 
CRDs or complete extracellular domains of DC-SIGN for the ligand was measured 
and compared with the affinity of the membrane bound form. While no interactions 
with the ligand could be found employing isolated CRDs, significant binding was 
detected if single CRDs were closely seeded (Kd = 48 nM) or if CRDs were part of a 
complete oligomeric soluble extracellular domain of DC-SIGN (Kd = 30 nM). The 
highest affinity was seen with membrane bound DC-SIGN expressed on the surface 
of transfected cells (Kd = 3 nM), suggesting that the natural plasma membrane 
environment strongly influences the function of this receptor. To some extent, this 
mirrors our observations: DC-SIGN on the cell surface of intermediate DC is 
randomly distributed and hardly binds virus-sized particles, whereas on immature 
DCs, the protein is organized in well-defined microdomains, which allow binding of 
40 nm virus-sized particles (Fig. 6). In apparent contrast, we showed that on 
intermediate DCs, randomly distributed DC-SIGN was able to bind 1 µm beads, 
coated with ICAM-3 or gp120 (Fig. 3B). This apparent discrepancy between 40 nm 
virus-sized particles and 1 µm beads can be explained by the fact that beads of 1 µm 
diameter have about 600-fold larger interaction surface saturated with numerous 
ligand molecules that can engage simultaneous interactions with several individual 
DC-SIGN molecules. These multiple interactions may signal into the cell and lead to a 
rapid recruitment of new DC-SIGN molecules, thus strengthening the binding. In 
contrast, when virus-size particles are used, the contact surface and therefore the 
number of ligand molecules is much smaller. Consequently, only interactions with 
DC-SIGN molecules organized in highly organized multi-protein assemblies can result 
in stable binding of virus-size particles (see model in Fig. 8). 
 
Chapter 4 
 100
 
Figure 8. DC-SIGN microdomains enhances binding of virus-sized particles with 
respect to isolated DC-SIGN molecules. Beads of 1 µm diameter are saturated with 
numerous coated ligand molecules that can engage simultaneous interactions with several 
individual DC-SIGN molecules. These multiple interactions may strengthen the binding both 
with random and clustered DC-SIGN. In contrast, when virus-size particles are used, the 
contact surface and therefore the number of ligand molecules is much smaller. Consequently, 
only interactions with DC-SIGN molecules in highly organized multi-protein assemblies may 
result in stable binding of virus particles. 
 
 
When a computer-aided simulation was performed to predict the capacity of round 
objects of different sizes to establish interactions with either random or clustered DC-
SIGN molecules, we found that objects with a diameter in the range of virus sizes 
(40-200 nm diameter) preferentially bind to clusters of DC-SIGN having the same 
size (B.d.B., unpublished data). In agreement with this model, no significant 
differences were detected in binding of intermediate and immature DC to soluble 
gp120 or to ICAM-3-Fc chimeras, indicating that the capacity of each single DC-SIGN 
molecule to recognize and bind the ligand is comparable on both DC types (Fig. 6g). 
The biological relevance of this clustering phenomenon is shown by the fact that 
immature DC compared to intermediate DC showed an enhanced DC-SIGN mediated 
binding and internalization of virus particles, and subsequent infection of PBMC in 
trans (Fig. 7). Therefore, we propose that engagement of viruses with DC-SIGN 
occurs much more productively when this receptor is organized in microdomains and 
resides in a lipid raft or cholesterol enriched environment. 
It remains to be established what controls DC-SIGN random distribution on 
intermediate DCs and what mechanism is responsible for the change into a clustered 
organization on immature DCs. We cannot exclude that, on intermediate DCs, DC-
SIGN may interact with an unknown membrane associated protein that prevents the 
formation of such microdomains. Alternatively, cytoskeletal constraints may differ 
between these cells, and this issue is currently under investigation. Preliminary 
observations suggest that releasing DC-SIGN molecules from the cortical actin 
cytoskeleton by cytochalasin D treatment results in an enhanced ligand binding, 
particularly on intermediate DCs (unpublished data). Further studies are needed to 
obtain insight into the formation of DC-SIGN multi-protein assemblies on DCs. 
DC-SIGN belongs to the C-type lectin family that, together with the TLR family, forms 
the first barrier against invading pathogens. This occurs through recognition of 
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pathogen-associated molecular patterns (or PAMPs) displayed at the cell surface of 
microorganisms. While TLRs have been shown to induce differential gene expression 
upon recognition of distinct pathogen structural components (Akira, 2003), for the C-
type lectins, and particularly for DC-SIGN, no direct signaling pathways has been 
demonstrated so far. It will be therefore interesting to investigate the interactions 
that might occur between these two families of pathogen-recognition receptors. 
In conclusion, our findings emphasize the importance of relating the function with 
the cell surface organization of DC-SIGN. Clustered distribution is essential to 
enhance the interaction as well as the internalization efficiency of DC-SIGN/pathogen 
complexes. In addition, our data highlight the importance of the plasma membrane 
as a specialized microenvironment, where finely orchestrated interactions among 
proteins, carbohydrates and lipids take place. These complex interactions mediate 
many fundamental processes that occur at the contact site between cells (cell-cell or 
cell-pathogen), such as assembly of signaling platforms and formation of entry 
portals for invasive pathogens. 
Insight in the cell surface organization of pathogen scavenger receptors like DC-SIGN 
will contribute to the development of novel strategies that specifically inhibit 
interactions with life-threatening pathogens like HIV-1 or Mycobacterium. 
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SUMMARY 
 
Clustering of cell surface receptors into micro-domains in the plasma membrane is an 
important mechanism for regulating cellular functions. Unfortunately, these domains 
are often too small to be resolved with conventional optical microscopy. Near-field 
scanning optical microscopy (NSOM) is a relatively new technique that combines 
ultra high optical resolution, down to 70 nm, with single molecule detection 
sensitivity. As such, the technique holds great potential for direct visualisation of 
domains at the cell surface. Yet, NSOM operation under liquid conditions is far from 
trivial. In this contribution, we show that the performance of NSOM can be extended 
to measurements in liquid environments using a diving bell concept. For the first 
time, individual fluorescent molecules on the membrane of cells in solution are 
imaged with a spatial resolution of 90 nm. Furthermore, using this technique we 
have been able to directly visualise nanometric sized domains of the C-type lectin 
DC-SIGN on the membrane of dendritic cells, both in air and in liquid.  
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INTRODUCTION 
The organisation of proteins into micro-or nanodomains in the cell membrane plays 
an important role in cellular function (Vereb et al., 2003). Resolving the exact size, 
structure and composition of these domains is important in order to understand their 
specific function. The combination of a high spatial resolution technique to resolve 
individual domains, together with single molecule detection sensitivity to determine 
the composition of the domain, is therefore required. Immunogold labelling in 
combination with transmission electron microscopy has the potential to offer both 
high resolution and insight into domain composition (Cambi et al., 2004; Panyi et al., 
2003; Vereb et al., 2000), however only very thin parts of a dried sample can be 
imaged. Furthermore, dehydrating cells results in compaction of the cell membrane, 
increasing the possibility to artificially induce protein aggregation, a clearly unwanted 
artefact when studying membrane domain organisation.  
To date, fluorescence microscopy remains as the most widely used technique for live 
cell imaging. Membrane components can be directly visualised via specific antibodies 
or direct fusion with a green fluorescent protein (GFP) family member (Stephens and 
Allan, 2003). Single molecule detection on cell membranes has been demonstrated 
using confocal, widefield epifluorescence and total internal reflection microscopy 
(Sako and Yanagida, 2003). In particular, the last two techniques have allowed the 
monitoring of protein dynamics revealing diﬀerences in the lateral diffusion of 
membrane proteins and strongly supporting the hypothesis of compartmentalisation 
within the cell membrane (Schutz et al., 2000). Unfortunately, these techniques are 
diffraction limited, with a resolution >300 nm for the visible regime, excluding direct 
visualisation of domains smaller than this value. Furthermore, the concentration of 
fluorescent molecules has to be reduced artificially in order to observe individuals.  
There are two possible routes to break the diﬀraction limit. One way concerns the 
use of point spread function engineering (Hell, 2003), where stimulated emission 
depletion microscopy has already shown single molecule detection sensitivity 
(Westphal et al., 2003). Applicability of this technique at the single molecule level on 
cells and over the full visible spectrum is still awaiting. The second approach is near-
field scanning optical microscopy (NSOM), where a subwavelength aperture probe is 
scanned in close proximity to the sample. So far, this is the only technique that 
combines surface sensitivity, single molecule detection, and nanometric (<90 nm) 
optical resolution together with simultaneous topographic information (Betzig and 
Chichester, 1993). Therefore, NSOM is an ideal technique to study the organisation 
of the plasma membrane in detail (Laurence and Weiss, 2003), while taking full 
advantage of all available fluorescence labelling methods, including the use of GFPs.  
The most relevant cell membrane studies using NSOM include localisation of host 
and malarial proteins on fixed mouse fibroblasts (Enderle et al., 1997), the imaging 
of membrane lipids and proteins on fibroblast (Hwang et al., 1998), the distribution 
of major histocompatibility complexes I and II (Nagy et al., 2001) and visualisation 
of individual GFP fused to integrins on fibroblasts (de Lange et al., 2001). More 
recently, single molecule studies on complete cells using NSOM have been performed 
(B.I. de Bakker, in preparation). However, all of these studies were performed on 
fixed and critical point dried samples mainly because of the difficulties in reliably 
regulating the distance between tip and the soft cell surface while operating in 
physiological buffers. Although important biological information can be extracted 
from NSOM on dry biological samples, these results are always subject to potential 
drying artifacts (Ris, 1985).  
Recently, we have introduced a diving bell concept which enables easy and reliable 
regulation of the tip–sample distance in liquid environments. Interaction forces 
exerted on the sample are below 300 pN (Koopman et al., 2003). Here, we show for 
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the first time detection of individual fluorescent molecules on a cell membrane in 
solution and with nanometric spatial resolution. To demonstrate the potential of the 
technique for cell membrane studies, we have investigated the spatial organisation of 
the transmembrane protein DC-SIGN on immature dendritic cells (imDC) in solution. 
ImDCs are crucial for our immune system, since they bind efficiently to pathogens 
via surface receptors. The recently identified surface receptor DC-SIGN is a C-type 
lectin exclusively expressed on DCs and plays important and distinct roles during the 
immune response (Geijtenbeek et al., 2000b; Geijtenbeek et al., 2000c). Near-field 
fluorescence imaging in liquid shows distinct fluorescence spots of 100 nm in 
diameter and different brightness spread randomly on the surface of the immature 
DC. These results on immature DCs in solution confirm our previous notion that DC-
SIGN is clustered into nanometric sized domains on the membrane of critical point 
dried immature DC (Cambi et al., 2004). The sizes of the domains are 100 nm, well 
below the diffraction limit of light, and thus not resolvable even with the best 
confocal microscope. Liquid operation of NSOM opens the way to directly visualise 
and quantify the size and composition of membrane domains, like lipid rafts (Simons 
and Ikonen, 1997), in solution.  
 
 
MATERIALS AND METHODS 
 
Technique: NSOM in liquid  
The core of a NSOM is the fibre probe which is raster scanned over the sample 
surface. The obtainable lateral optical resolution is determined by the size of the 
aluminium coated aperture (typically 90 nm) used to excite the sample. To obtain 
this resolution, the probe is kept in close proximity (<10 nm) to the sample surface 
using a piezo-electric force sensing element (tuning fork), oscillated at 32 kHz (Karrai 
and Grober, 1995). Height feedback is performed by keeping the phase difference 
between the driving excitation and the tuning fork signal constant (Ruiter et al., 
1998; Ruiter et al., 1997). In this way, optical and topographic maps of the surface 
are created simultaneously. To operate the NSOM in liquid, we use a diving bell con-
cept (Koopman et al., 2003) which ensures that the tuning fork is vibrating in air, 
while the tip is immersed in liquid. This enables reliable operation in liquid, while the 
force exerted on the sample is below 300 pN. Our home built combined 
confocal/NSOM microscope equipped with the tuning fork diving bell is schematically 
shown in Fig. 1.  
The proteins of interest are fluorescently labelled with Alexa-647 and excited using 
the 647 nm line of an argon/krypton-ion laser (CW, Spectra-Physics). In confocal 
mode, circularly polarised excitation light is reflected by a dichroic mirror (650 DRLP 
Omega Optical) and focused onto the sample using an oil immersion objective (100·, 
1.3 NA). In NSOM mode, the sample is excited via the fibre probe (aperture 90 nm). 
The emitted fluorescence is collected and spectrally separated from the excitation 
light using a 665 nm long pass filter. A polarising beam splitter is used to split the 
signal into two perpendicular polarisation components. Both signals are sent to pho-
ton counting avalanche photodiodes (APDs). The fluorescence images generated in 
this way reflect the in-plane orientation of each single fluorescent molecule.  
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Sample preparation  
Immature DCs were cultured from healthy human blood monocytes in the presence 
of interleukin-4 and GM-CSF (500 and 800 units/ml, respectively) for six days to 
obtain immature DC (Geijtenbeek et al., 2000c). The DCs were stretched on a poly-
L-lysine coated coverslip for 1 hr at 37ºC, rinsed three times with phosphate buffered 
saline (PBS) and fixed with 1% paraformaldehyde in PBS for 15 min at room 
temperature. The specimens were washed three times in PBA (PBS, containing 0.5% 
bovine serum albumin and 0.01% sodium azide). The cells were then incubated with 
primary monoclonal antibodies against DC-SIGN in PBA (10 µg/ml) for 60 min at 
room temperature. After three washing steps with PBS, a second incubation was 
performed for 60 min at room temperature, with an Alexa647 labeled goat 
antimouse IgG antibody (GaM-Alexa647) in PBA (10 µg/ml), allowing fluorescent 
detection of the anti-DC-SIGN antibody. Labeled samples were washed three times in 
PBS and post fixed in 1% paraformaldehyde. The wet samples were stored in PBS 
containing 1% paraformaldehyde. As a reference, critical point dried samples were 
also prepared, as already described (Cambi et al., 2004).  
 
Figure 1. Schematic diagram of 
the combined confocal/NSOM 
setup. The ipable mirror enables 
easy switching between the NSOM 
and confocal mode of operation. 
With the diving bell (see inset) only 
the tip is immersed in liquid, while 
the tuning fork sensor is vibrating 
in air (Koopman et al., 2003). 
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RESULTS AND DISCUSSION 
 
NSOM versus confocal on dried immature DCs  
To demonstrate the advantage of NSOM over confocal microscopy, we first examined 
the distribution of DC-SIGN on the membrane of a critical point dried immature DC in 
air. Some typical images are shown in Fig. 2. We select individual cells using a CCD 
camera and bright field illumination (Fig. 2A). The selected immature DCs are 
imaged in confocal mode with a typical scan size of 20 X 20 µm. A region of interest 
showing fluorescence contrast is selected for further confocal (Fig. 2B) and near-field 
investigation (Fig. 2D).  
 
 
Figure 2. A selected area of 
the dendritic cell of interest 
(A) is imaged in confocal 
mode (B). The same area is 
imaged with NSOM resulting in 
a topographic image (C) with 
a corresponding high 
resolution optical image (D). 
In the high resolution image 
individual ‘‘spots’’ can be 
resolved in the highlighted 
areas, whereas the same areas 
appear fully packed upon 
confocal investigation.  
Simultaneous with the near-
field optical information, we 
obtain topographic information 
as shown in Fig. 2C.  
 
 
 
The fluorescence intensity in the confocal image is high, due to both high expression 
levels and close packing of DC-SIGN on the membrane. The resolvable fluorescent 
‘‘spots’’, all have a similar diffraction-limited size of 300 nm. Comparing the NSOM 
fluorescent image of the same area, it is clear that the high resolution enables the 
identification of individual ‘‘spots’’ in areas apparently fully packed upon confocal 
investigation. Furthermore, while the ‘‘spots’’ resolved in the confocal image vary 
only in intensity, the NSOM optical image reveals ‘‘spots’’ differing both in size and 
intensity. This observation is consistent with our previous studies (Cambi et al., 
2004) and a detailed study using NSOM in air (B.I. de Bakker, in preparation), both 
working with critical point dried immature DCs.  
 
 
NSOM on immature DCs in liquid  
To investigate the organisation of DC-SIGN on immature DCs in solution, we have 
used the NSOM equipped with the diving bell for liquid operation. Just before 
imaging microscope slides containing the cells were washed with PBS, mounted in a 
liquid cell and covered with 1 ml of PBS solution. In Fig. 3A, the resulting topography 
is shown. The line trace in Fig. 3B demonstrates that the feedback is reliable and 
stable, with the tip following the contours of the cell.  
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Figure 3. The topography image (A) of an immature dendritic cell in buffer solution obtained 
with tuning fork shear force feedback. The white line in (A) indicates the position of the line 
trace as shown in (B).  
 
 
Fine dendrites, with a height of 100 nm, are apparent in the topographic image at 
the cell edges, while the central part of the cell, where the nucleus resides, can 
reach several microns in height. This is consistent with measurements using tapping 
mode atomic force microscopy on living DCs (A. Cambi, unpublished observations). 
The appearance of the small dendrites in the topography also demonstrates the 
gentle imaging capabilities of the technique. 
After selecting a region of interest with confocal microscopy, a high resolution image 
of the same area is performed with NSOM. Figure 4 shows the fluorescence image in 
confocal (4A) and NSOM (4B) modes. The colour in the optical images reflect the in-
plane orientation of the emission dipole of the excited fluorophores. The colour scale 
ranges from red to green, reflecting a 90ºC change in in-plane orientation. A yellow 
colour corresponds to an equal amount of photons on both APDs reflecting either the 
presence of multiple emitters in the excited volume, or a single emitter with 45 ºC in-
plane or an out of plane orientation.  
Comparing the confocal image in Fig. 4A with the NSOM optical image in Fig. 4B, the 
difference in lateral resolution is striking. In the confocal image, the dendritic cell 
appears to be completely covered with proteins. Individual molecules are only visible 
outside the cell region, due to unspecific binding of labelled antibodies to the 
substrate. In contrast, using near-field excitation we can not only resolve individual 
‘‘spots’’ but also individual molecules on the cell surface. 
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Figure 4. Fluorescence image of a dendritic cell in buffer solution collected in 
confocal mode (A) and NSOM mode (B). The white circles indicate the position of the 
line traces through single molecules (recognised by their unique dipole emission, red or green 
colour) in (C) and (D). These line traces reflect the superior resolution of NSOM (100 nm) in 
(D) as compared to the diffraction limited confocal resolution (300 nm) in (C). The intensity 
scale is locally changed in the confocal image (indicated by the white box in (A)) in order to 
visualise the individual molecule.  
 
 
The presence of a well-defined polarised emission (colour of most spots is green or 
red) is indicative for unique dipole emission and thus single molecule detection. It is 
important to note that due to the smaller excitation volume of NSOM the contribution 
of the fluorescence background from the cytosol is approximately ten times lower as 
compared with confocal illumination.  
The line traces through individual molecules in Fig. 4C (on the glass substrate) and 
Fig. 4D (on the cell membrane) demonstrate the superior resolution of NSOM (100 
nm) with respect to the diffraction limited resolution of confocal microscopy. In both 
cases, the resolution is measured as the full width at half maximum of a Gaussian fit 
to the fluorescence profile. To our knowledge, these images show for the first time 
single molecule detection on a cell membrane in solution with nanometric resolution.  
 
 
Size and intensity of domains on cells in liquid  
Figure 5A shows again a NSOM image of an imDC containing labelled DC-SIGN 
proteins. To obtain this image, we use an excitation intensity of 400 W cm2
 
and an 
integration time per pixel of 10 ms, for the 256 x 256 pixel image. It is clear that the 
‘‘spots’’ differ in brightness and size. The number of molecules in each fluorescent 
‘‘spot’’ is related to its brightness. This brightness is determined by adding all photon 
counts within a contour of 15% of the peak intensity and subtracting the background 
in the immediate vicinity of each ‘‘spot’’. The resulting brightness distribution for 87 
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domains is shown in Fig. 5B. The photons detected per domain range from less than 
1 kCounts to almost 60 kCounts, while the photons being collected from a single 
molecule are approximately 0.5 kCounts. The broad and large deviation from the 
single molecule value indicates a wide spread in the number of Alexa647 molecules 
per spot, strongly supporting the notion that DCSIGN is clustered into domains on 
the membrane of immature DCs in solution. 
 
 
Figure 5. (A) Near-field image 
of an imDC in buffer solution, 
excited at 400 W cm2. The 
bright ‘‘spots’’ in (A) vary in 
size and intensity. This is 
reflected by the intensity 
distribution in (B) and the size 
distribution in (C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The size of every individual domain can be determined by fitting the measured 
intensity with a 2D Gaussian profile. The spot size is then defined as the full-width at 
half-maximum (FWHM) of the fit. The resulting size distribution for 87 ‘‘spots’’ is 
shown in Fig. 5C. The size distribution peaks at 105 nm indicate that measured 
average size of the domains is mainly determined by the size of the (90 nm) 
aperture and, therefore, well below the diffraction limit of light.  
The biological role of DC-SIGN clustering is extensively discussed in Chpater 4 
(Cambi et al., 2004). The organisation of DC-SIGN into domains resulted crucial for 
dendritic cells to regulate their virus binding capacities. We observed DCSIGN 
clustering by means of transmission electron microscopy (Cambi et al., 2004). Here, 
we confirm that DC-SIGN is organised in sub-diffraction limit sized domains on the 
membrane of hydrated DCs. The size of the domains on DCs in solution is somewhat 
smaller than the domain sizes found on dehydrated DCs as reported by Cambi et al. 
(Cambi et al., 2004) and work in preparation by B.I. de Bakker. This deviation is 
most probably due to the differences in sample preparation (see Materials and 
methods session).  
 
 
CONCLUSIONS  
In this work, we have demonstrated the detection of individual molecules on the 
membrane of cells in solution with nanometric optical resolution using NSOM. 
Furthermore, we have investigated the distribution of DC-SIGN in the membrane of 
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whole, hydrated immature DCs in liquid. We found that DC-SIGN is organised in 
clusters, with a size of 100 nm or smaller and with a wide spread in molecules per 
domain, upto a factor of 60. These results are consistent with the observation of 200 
nm sized domains using TEM (Cambi et al., 2004) and NSOM on dried DCs 
confirming that indeed DCSIGN is organised into sub-diffraction limit sized domains 
in the membrane of imDCs.  
The application of NSOM in solution will open the way to high resolution live cell 
imaging. As a scanning probe technique, NSOM is less suitable for monitoring fast 
lateral diffusion of membrane complexes, however its superb resolution in the z-
direction should allow monitoring of exo-and endocytosis processes with high speed 
and sensitivity.  
Currently, we are investigating the co-localisation between membrane proteins and 
lipids associated to lipid rafts (Simons and Ikonen, 1997). Until now, possible 
association between lipid rafts and membrane proteins could only be studied using 
biochemical methods such as detergent extraction in combination with flotation 
assays or confocal techniques based on co-patching (Fra et al., 1994). With the 
single molecule detection capabilities and high resolution of NSOM, we should be 
able to directly visualise lipid rafts and quantify their size and composition.  
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SUMMARY 
 
Dendritic Cells (DC) that express the type II C-type lectin DC-SIGN (CD209) are 
located in the submucosa of tissues, where they mediate HIV-1 entry. Interestingly, 
the pathogen Candida albicans, the major cause of hospital-acquired fungal 
infections, penetrates at similar submucosal sites. Here we demonstrate that DC-
SIGN is able to bind C. albicans both in DC-SIGN transfected cell lines and in human 
monocyte derived DC. The binding was shown to be time- as well as concentration-
dependent, and live as well as heat-inactivated C. albicans were bound to the same 
extent. Moreover, in immature DC, DC-SIGN was able to internalize C. albicans in 
specific DC-SIGN enriched vesicles, distinct from those containing the mannose 
receptor, the other known C. albicans receptor expressed by DC. Together, these 
results demonstrate that DC-SIGN is an exquisite pathogen uptake receptor that not 
only captures viruses but also fungi. 
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INTRODUCTION 
 
Epithelial surfaces form the first line of defense against microbes. A small proportion 
of incoming microbes that enter at sites of micro lesions is handled by antigen-
presenting cells (APC), in particular Dendritic Cells (DC) (Steinman, 1991). Candida 
albicans is among the most frequently isolated fungal pathogen in humans that 
invades the mucosal surface (Edwards, 1991). As the major cause of hospital-
acquired fungal infections (Sternberg, 1994), the recognition of C. albicans by cell 
surface receptors has major pathogenetic consequences. Nevertheless, only limited 
information is available on the molecular mechanisms involved in recognition of this 
fungus. C. albicans can switch from a unicellular yeast form into various filamentous 
forms, all of which can be found in infected tissues (Odds, 1987). The ability to 
reversibly switch between these forms is thought to be important for C. albicans 
virulence. Several studies now demonstrate that dendritic cells can bind and 
phagocytose fungi like C. albicans (d'Ostiani et al., 2000; Forsyth et al., 1998; Huang 
et al., 2001). Protection from mucocutaneous candidiasis clearly relies on cell-
mediated immunity induced after processing of C. albicans and presentation by DC to 
prime T cells (Newman and Holly, 2001). 
Recent studies in mice demonstrate that while the yeast form activates dendritic cells 
to produce IL-12 and primes T helper type 1 (Th1) cells, the hyphal form inhibits IL-
12 and Th1 priming and induces IL-4 production (d'Ostiani et al., 2000). These 
results indicate that dendritic cells fulfill the requirement of a cell uniquely capable of 
sensing the two forms of C. albicans (d'Ostiani et al., 2000). In addition, it was 
recently reported that human dendritic cells are also able to bind C. albicans, and 
that this interaction is mediated by the mannose receptor (MR, CD206), which is also 
observed on macrophages (Newman and Holly, 2001). 
However, the observation that C. albicans, both as a commensal as well as a true 
pathogen, is also found in areas (sub-mucosa) highly enriched in DC-SIGN positive 
dendritic cells prompted us to investigate whether C. albicans could be bound by this 
C-type lectin as well. 
Recently, we isolated from monocyte-derived DC a novel C-type lectin, designated 
DC-Specific ICAM-3 Grabbing Non-integrin (DC-SIGN; CD209). We discovered that 
DC-SIGN acts as a binding partner for ICAM-3, mediating the early contact between 
DC and T cell and therefore the initiation of primary immune responses (Geijtenbeek 
et al., 2000c). In addition, DC-SIGN also displays a high affinity for ICAM-2, 
supporting transendothelial migration of DC and DC trafficking (Geijtenbeek et al., 
2000a). Moreover, DC-SIGN binds and captures HIV-1 at mucosal sites of initial 
infection, and protects the virus from degradation for subsequent transport by DC to 
lymphoid organs (Geijtenbeek et al., 2000b). Here we demonstrate for the first time 
that next to viruses also fungi are recognized by DC-SIGN.  
 
 
MATERIALS AND METHODS 
 
Reagents and antibodies.  
Fluorescein isothiocyanate (FITC) was from Fluka. Mannan and D-mannose were 
from SIGMA Chemical Co., St. Louis, MO. IL-4 and granulocyte macrophage colony 
stimulating factor (GM-CSF) used for culturing monocyte-derived dendritic cells were 
from Schering-Plough (International, Kenilworth, USA). The following Abs were used: 
AZN-D1, AZN-D3 (mouse IgG1, anti-DC-SIGN (Geijtenbeek et al., 2000b)); AZN-L50 
(mouse IgG1, anti-ALCAM) (Nelissen et al., 2000); NKI-L19 (mouse IgG1 anti-β2 
integrins); mAb clone 19.2 against MR was from BD Biosciences PharmIngen; the 
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directly APC-conjugated mAb against CD45RO was from Becton Dickinson; Cy5-
conjugated goat-anti-mouse IgG was from Molecular Probes. 
 
C. albicans culture conditions. 
C. albicans, strain UC820, a clinical isolate that has been well described (Forsyth and 
Mathews, 1996), was maintained on agar slants at 4°C. Previous experiments 
showed that strain UC820 can develop hyphae and pseudohyphae in vitro and in vivo 
to the same extent as a panel of virulent control. C. albicans UC820 was inoculated 
into 100 ml of Sabouraud broth and was cultured for 24 h at 37°C. After 3 washes 
with pyrogen-free saline by centrifugation at 1500 g, the number of yeast cells was 
counted in a hemocytometer; occasional strings of 2 yeasts were counted as 1 cfu of 
C. albicans. The suspension was diluted to the appropriate concentration with 
pyrogenfree saline. Microscopy confirmed that the suspension consisted of 
blastoconidia. When necessary, the blastoconidia were heat killed either at 56°C for 
1 hr or at 100°C for 30 min. 
 
 Cells 
Immature DC were generated from human peripheral blood monocytes as described 
previously (Geijtenbeek et al., 2000c). Briefly, monocytes were isolated by adherence 
to plastic and cultured in the presence of IL-4 (500 U/ml) and GM-CSF (800 U/ml) for 
6-7 days. K562 transfectants either expressing DC-SIGN or ALCAM were generated 
by transfection of K562 cells with 10 µg of plasmid by electroporation as described 
previously (Geijtenbeek et al., 2000b; Nelissen et al., 2000). Positive cells were 
sorted several times to obtain stable transfectants with expression levels of DC-SIGN 
and ALCAM similar to immature DC. 
 
Immunofluorescence  
Labeling of Candida cells was performed as follows: yeast cells were resuspended to 
2 x 108/ml in 0.01 mg/ml FITC in 0.05 M carbonate-bicarbonate buffer (pH 9.5). 
After incubation for 15 min at room temperature in the dark, FITC-labeled Candida 
cells were washed twice in PBS containing 1% BSA (PBA buffer), heat killed for 60 
min at 56°C, and subsequently analyzed by flow cytometry. DC were stained in PBA 
with primary Abs and FITC-conjugated secondary Abs and were analyzed by flow 
cytometry using the FACScalibur (BD Biosciences, Mountain View, CA). Isotype-
matched controls were included.  
 
C. albicans binding studies  
DC or K562 transfected cells were stained with anti-CD45-APC prior to exposure to 
FITC-labeled live or heat inactivated C. albicans yeast form. Before adding C. 
albicans, cells were or were not preincubated for 10 min at room temperature with 
mannose (100 mM), EGTA (5 mM), isotype control (mouse IgG1) or a mixture of 
anti-DC-SIGN mAb, AZN-D1 and AZN-D3 (20 µg/ml), in 20 mM Tris pH 8.0, 
containing 150 mM NaCl, 1 mM CaCl2, 2 mM MgCl2, and 1% BSA (TSA buffer) or, 
when EGTA was used, in PBS. Subsequently, FITC-labeled C. albicans were 
resuspended to the appropriate concentrations either in TSA or PBS and added in 
various cell/Candida ratios. After incubation, cell-Candida conjugates were analyzed 
by flow cytometry, and the relative difference in mean fluorescence intensity of the 
double-labeled events in comparison with that of control cells was calculated. Cells 
were labeled with anti-CD45APC to discriminate cells binding FITC-labeled yeast 
particles from yeast aggregates.  
Chapter 6 
 120
Fluorescent beads adhesion assay 
The fluorescent beads adhesion assay was performed as described earlier 
(Geijtenbeek et al., 1999; Nelissen et al., 2000). Briefly, carboxylate-modified 
TransFluorSpheres (488/645 nm, 1.0 µm; Molecular Probes, Eugene, OR) were 
coated with ICAM-3-Fc or ALCAM-Fc, and adhesion was determined by measuring 
the percentage of cells that have bound fluorescent beads, by flow cytometry. In 
inhibition studies, the beads adhesion assay was performed in presence of 0.3 mg/ml 
mannan, 5 mM EGTA, or 20 µg/ml antibodies against DC-SIGN or ALCAM.  
 
Phagocytosis 
Immature DC (5 x 105) were incubated with unopsonized heat-inactivated FITC-
labeled C. albicans (2.5 x 106) in a total volume of 500 µl at 37°C in a water bath 
with orbital shaking at 150 rpm for 60 min. At the end of the incubation period, the 
DC binding C. albicans  were separated from unbound Candida by a Ficoll gradient. 
The samples were then mounted on poly-L-lysine-coated glass coverslips by 
centrifugation at 250 rpm for 3 min. Subsequently, the samples were fixed in 1% 
PFA in PBS for 15 min at room temperature, and permeabilized in cold methanol for 
5 min on ice. After a blocking step in PBS/3% BSA for 60 min at room temperature, 
cells were labeled with mAb (10 µg/ml in PBS/3% BSA) for 60 min at room 
temperature and subsequently incubated with Cy5-conjugated Goat-anti-Mouse 
(Fab’)2 fragments for 30 min at room temperature. Finally, samples were sealed in 
Mowiol and analyzed using a MRC1024 confocal microscope Bio-Rad. 
 
 
RESULTS AND DISCUSSION 
 
Candida albicans is a ligand of the Dendritic Cell Specific ICAM-3 Grabbing 
Non-integrin (DC-SIGN). 
We used the erythroleukemic cell line K562 transfectants stably expressing DC-SIGN 
(K-DC-SIGN) (Geijtenbeek et al., 2000c) to investigate the potential of C. albicans to 
bind DC-SIGN in the absence of any other known C. albicans, receptors. Binding to 
ICAM-3 fluorescent beads is used as a positive control for DC-SIGN function. K562 
cells transfected with the homotypic Activated Leukocyte Cell Adhesion Molecule 
ALCAM (Nelissen et al., 2000) (K-ALCAM), which is expressed by DC but does not 
bind any of the known ligand of DC-SIGN, are used as negative control. The K562 
transfectants stably express DC-SIGN and ALCAM (Fig. 1-A) with expression levels 
similar to that observed for immature DC  (Geijtenbeek et al., 2000c; Nelissen et al., 
2000).Binding studies demonstrate that DC-SIGN clearly mediates adhesion to both 
C. albicans and ICAM-3-Fc-coated beads (Fig. 1-B). In contrast, K-ALCAM cells bind 
neither ICAM-3 nor C. albicans, but do bind ALCAM-Fc beads. Blocking antibodies 
against DC-SIGN significantly inhibit binding of C. albicans by K-DC-SIGN; in addition, 
the calcium chelator EGTA completely abrogates binding (Fig. 1-C). This Ca2+ 
dependence confirms that the C-type lectin domain of DC-SIGN mediates binding to 
C. albicans. Depending on the concentration of C. albicans (Fig.1-D) and on the 
incubation time (Fig.1-E), binding of K-DC-SIGN to the yeast cells increases 
significantly. 
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DC-SIGN binds both live and heat inactivated yeast form of C. albicans. 
In order to exclude that the binding of DC-SIGN to heat-inactivated C. albicans was 
due to artifacts derived from the heat treatment, K-SIGN were allowed to interact 
with both live and heat-inactivated (see Materials and Methods) C. albicans yeast. As 
shown in figure 2, the percentage of binding did not increase significantly upon heat 
inactivation, when compared with binding to live yeast cells. In addition, the blocking 
of binding by Ab against DC-SIGN is not profoundly altered by heat treatment. 
 
 
Figure 2. Live and heat-
killed yeast forms of C. 
albicans are bound by 
DC-SIGN. CD45APC-labeled 
K-DC-SIGN transfectants 
(50x103) were incubated for 
30 min at 37°C with FITC-
labeled C. albicans 
(500X103), both live and 
heat inactivated. A 
representative experiment 
out of two is shown. 
 
 
 
 
 
 
Monocyte-derived DC bind C. albicans  also through DC-SIGN. 
DC are specialized in binding and uptake of antigen (Sallusto et al., 1995) and 
recently it has been published that the interaction between DC and C. albicans is 
mediated by the MR (d'Ostiani et al., 2000; Newman and Holly, 2001). Our findings 
with K-DC-SIGN cells and the observation that C. albicans can be found in areas of 
the body (sub-mucosa) that are highly enriched in DC-SIGN positive cells 
(Geijtenbeek et al., 2000b) suggested that DC-SIGN could contribute to the binding 
of C. albicans to immature DC. 
In figure 3-A, it is shown that human monocyte-derived immature DC are able to 
bind C.albicans, and that this interaction increases in time. This is in agreement with 
previously published work showing that DC rapidly internalize C. albicans: within 10-
20 min of incubation at 37ºC, already 40-50% of the particles are ingested, reaching 
a maximum after 60 min (d'Ostiani et al., 2000; Newman and Holly, 2001).  
To determine the contribution of both MR and DC-SIGN to mediate binding of C. 
albicans, immature DC were incubated with specific inhibitors before interacting with 
the yeast particles. As shown in Fig. 3-B, antibodies against DC-SIGN significantly 
blocked binding, though partially (approximately 25-30%), whereas mannose, which 
is known to specifically inhibits the MR, was responsible for about 65-70% of the 
blocking. Interestingly, mannose did not show any significant blocking of C. albicans 
binding to DC-SIGN on K-DC-SIGN cells (not shown). Moreover, by combination of 
both anti-DC-SIGN Abs and mannose, binding of C. albicans was almost completely 
inhibited (80-85%). This notion is supported by the observation that EGTA blocked of 
C. albicans to DC to a similar level, also indicating that probably no other C-type 
lectins were involved. Furthermore, the finding that binding of C. albicans was 
mediated by DC-SIGN and MR, in a ratio of roughly 1:3, respectively, was in 
agreement with the observation that the expression of MR on the surface of 
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immature DC appears to be higher than DC-SIGN (Fig. 3C). However, no real 
quantitative evaluation can be made. 
In addition, besides DC-SIGN and the MR, DC are known to express high levels of 
the β2-integrin MAC-1, which has already been implicated in the binding of C. 
albicans to lymphocytes [6]. However, we could not detect any blocking when anti-
β2-integrin antibody (NKI-L19) was used, suggesting that MAC-1 is not likely involved 
in C. albicans binding on human immature monocyte derived DC (data not shown). 
Moreover, the use of laminarin, reported to interfere with the interaction between 
another DC specific C-type lectin, Dectin-1, and C. albicans, did not show any block 
either (data not shown). Together, these findings strongly suggest that binding of C. 
albicans to immature DC is predominantly mediated by the C-type lectins DC-SIGN 
and MR. 
 
 
 
 
 
 
 
 
 
DC-SIGN mediates phagocytosis of C. albicans. 
We recently demonstrated that DC-SIGN can act as an antigen uptake receptor and 
facilitates phagocytosis within minutes (Engering et al., 2002b). In order to 
Figure 3. Dendritic cells bind C. 
albicans also through DC-
SIGN. (A) Binding of immature 
DC to C. albicans increased in 
time. CD45-APC labeled DC (50 x 
103) were incubated with FITC-
labeled heat-inactivated C. albicans 
(500 x 103). One representative 
experiment out of two is shown. 
(B) Immature DC bind C. albicans 
through C-type lectins. CD45APC-
labeled DC (50 x 103) were 
incubated with FITC-labeled heat-
inactivated Candida (500 x 103) in 
the absence or presence of anti-
DC-SIGN mAb, (20 µg/ml), 
mannose (100 mM), a mixture of 
anti-DC-SIGN Ab (20 µg/ml) and 
mannose (100 mM), and EGTA 
(5mM). The average of six 
independent experiments is shown. 
The binding to C. albicans in 
absence of inhibitors (with isotype-
matched control) was set as 
100%. * P<0.01 and ** P< 0.001 
percentage of binding in presence 
of blocking agent vs. percentage of 
binding in absence of blocking 
agent. (C) FACS profile of 
immature DC expressing MR and 
DC-SIGN. mAb clone 19.2 and 
AZN-D1 were used to label MR and 
DC-SIGN, respectively. Cells were 
gated on forward-side scatter, and 
the mean fluorescence is shown in 
the top right corner of the 
histograms. 
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determine whether DC-SIGN could contribute also to the internalization of C. albicans 
by immature DC, we incubated DC with FITC-labeled C. albicans particles for 60 min 
at 37ºC to allow phagocytosis. Subsequently, we fixed, permeabilized, fluorescently 
labeled DC with specific Abs against various receptors, and analyzed by confocal 
microscopy. 
In general, we observed that after 1 hour of incubation, about 40% of immature DC 
have ingested C. albicans, ranging from 1 to 9 particles (average of 3) per DC. The 
results in fig 4-A show that DC-SIGN clearly co-localizes with C. albicans particles, 
indicating the involvement of this lectin in binding and uptake of this pathogen. 
By contrast, neither MAC-1 nor ALCAM were found to localize around the yeast 
particles (fig. 4-B and -C).  
Fig. 4-D shows colocalization between MR and ingested Candida. In order to 
determine whether DC-SIGN was able to internalize C. albicans also in presence of 
inhibitors of MR, DC were allowed to phagocytose the yeast particles in presence of 
mannose. As shown in fig. 4-E, vesicles containing DC-SIGN colocalizing with FITC-
labeled Candida can still be clearly observed. To prove that C. albicans were indeed 
ingested, we made Z-scans, unequivocally demonstrating that the yeast particles are 
ingested (Fig. 4-F). The presence of EGTA almost completely blocked phagocytosis 
(data not shown). 
 
 
 
 
 
 
Chapter 6 
  125
 
 
Figure 4. DC-SIGN mediates phagocytosis of C. albicans in DC. Immature DC were 
incubated with C. albicans yeasts at a DC/C. albicans ratio of 1:5 for 1 hr at 37°C to allow 
phagocytosis. Subsequently, samples were fixed and labeled for confocal microscopy: the 
images show FITC-labeled C. albicans (green), Cy5-labeled adhesion receptors on immature 
DC (blue) and  colocalization (merged) (see Materials and methods). (A) Colocalization of DC-
SIGN with FITC-labeled C. albicans  was clearly observed. Labeling of β2-integrins (B) as well 
as ALCAM (C) showed no colocalization in the vesicles containing the pathogen. (D) Labeling 
of MR, the other receptor for C. albicans on immature DC, showed high colocalization with 
the yeast. In addition, DC-SIGN enriched vesicles were observed also in presence of 100 mM 
mannose, inhibitor of the MR (E), and the Z-scan (F) indicates that the yeast particles were 
indeed ingested by the DC 
 
 
CONCLUSIONS 
We showed that next to viruses (HIV-1, SIV, Ebola) (Alvarez et al., 2002; Baribaud et 
al., 2001; Geijtenbeek et al., 2000b) and parasites (Leishmania) (Colmenares et al., 
2002), the C-type lectin DC-SIGN can also bind yeast (C. albicans). These 
observations, together with the discovery that DC-SIGN acts as an antigen uptake 
receptor, provide further evidence that C-type lectins on DC are major pathogen 
recognition receptors (Figdor et al., 2002). Distinct from the Toll like receptors 
(Medzhitov and Janeway, 2000), they mediate antigen uptake rather than activating 
DC.  
Our findings clearly show that C. albicans has two major receptors on human 
monocyte derived DC, DC-SIGN and MR. DC-SIGN is expressed at sites in the skin 
(dermis) and the mucosa (Geijtenbeek et al., 2000b) where C. albicans is known to 
enter the host. Therefore, DC-SIGN positive DC might, trough these C-type lectin 
receptors, form the first encounter with these pathogens and the host immune 
system and after antigen presentation initiate a cellular response (d'Ostiani et al., 
2000; Newman and Holly, 2001). 
It remains to be elucidated whether the destiny of the C. albicans containing vesicles 
enriched in DC-SIGN is different from those enriched in MR. Though we observed 
some vesicles containing both receptors (not shown), it was intriguing that 
colocalization of both C-type lectins with most C. albicans containing vesicles seemed 
mutually exclusive. Therefore, it will be interesting to characterize these vesicles in 
more detail (work in progress) and to investigate if both lectins recognize similar or 
distinct carbohydrate moieties on C. albicans. This is of particular interest because 
MR is known as a recycling receptor, whereas DC-SIGN targets much deeper in the 
endosomal compartments (Engering et al., 2002b). 
Detailed knowledge of the recognition receptors for Candida albicans on DC, together 
with the specific down-stream cellular events initiated by receptor engagement, may 
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increase our understanding of possible immune dysfunctions in patients with 
mucocutaneous candidiasis and may offer new targets for immunotherapy of 
candidal infections and diseases. 
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SUMMARY 
  
The dimorphic fungus C. albicans causes severe opportunistic infections in 
immunocompromised patients. However, the exact mechanism whereby this fungus 
is recognized by the immune cells remains largely unknown. Dendritic cell-specific 
ICAM-3 grabbing non-integrin (DC-SIGN; CD209) is a calcium dependent lectin that 
binds and internalizes several pathogens, including HIV-1 and M. tuberculosis. 
Recently, we demonstrated that DC-SIGN can also recognize C. albicans. In the 
present study, we show that DC-SIGN discriminates among different species and 
morphological forms of Candida. In fact, DC-SIGN predominantly interacts with the 
conidiae and not with the hyphae of Candida species, suggesting a role for DC-SIGN 
in the early recognition of Candida by DCs. By ligand binding assays in presence of 
several pathogen-derived carbohydrates, we demonstrate that DC-SIGN binds to C. 
albicans through the specific recognition of Candida cell wall mannan. Other mannan 
preparations, including S. cerevisiae-derived mannan, reported to inhibit DC-SIGN 
binding, did not affect the interaction with Candida. Further NMR analysis show that 
differences in specificity between C. albicans- and S. cerevisiae-derived mannans 
relate to distinct structural properties. We also show for the first time that a fungal 
glucose-polymer, scleroglucan, selectively interferes with binding to ICAM-3 and HIV-
1 gp120, but not with Candida. Finally, we demonstrate that DC-SIGN binding to 
gp120 or ICAM-3 does not affect binding to C. albicans. Our studies clearly point out 
that a detailed knowledge of DC-SIGN specificity for fungal mannan may be helpful 
to develop efficient DC-based anti-fungal vaccins. 
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INTRODUCTION 
 
The fungus Candida is the most common cause of opportunistic mycotic infections 
worldwide. Usually, Candida infections are superficial and affect skin, urinary tract 
and mucosal membranes. However, in severely immunocompromised hosts, such as 
AIDS or diabetes patients, Candida can cause severe opportunistic mycotic infections 
(Dixon et al., 1996). Although Candida albicans remains the most common agent for 
these fungal infections, the incidence of disease caused by other species of Candida 
increases steadily (Abi-Said et al., 1997; Coleman et al., 1997). Moreover, several 
non-albicans species of Candida, including C. glabrata and C. dubliniensis, have been 
shown to be resistant to commonly used antifungal drugs (Moran et al., 1997).  
During infection, the fungus dimorphic transition from simple yeast form (conidiae) 
to multicellular filaments (hyphae) is thought to play a fundamental role in the 
opportunistic modulation of the host immune defense. While most C. albicans 
organisms are cleared by neutrophils and macrophages (Marodi et al., 1991; 
Thompson and Wilton, 1992), the strategic location of dendritic cells (DCs) at 
mucosal surfaces and in the skin as well as their potent antigen presentation capacity 
suggest that DCs play an important role in initiating protective immunity. This notion 
is supported by the findings that DCs can bind and internalize both conidiae and 
hyphae, thus initiating different T helper cell immunity: a more protective response 
(TH1 cells) to conidiae and a non-protective response (TH2 cells) to hyphae (d'Ostiani 
et al., 2000; Newman and Holly, 2001). 
DCs are equipped with multiple receptors, such as Toll-like receptors (TLRs) (Akira, 
2003) and C-type lectins (CLRs) (Cambi and Figdor, 2003; Figdor et al., 2002), which 
participate in the microbial recognition event. These receptors are referred to as 
pattern-recognition receptors (PRRs) and recognize pathogen-associated molecular 
patterns (PAMPs) displayed at the cell surface of the microorganisms (Medzhitov and 
Janeway, 2002). PAMPs are structurally distinct from molecules expressed on 
mammalian cells, thus serving as recognition molecules for the innate immune 
system (Medzhitov and Janeway, 2002). Whereas TLRs mainly initiate maturation 
and activation of DCs, which leads to migration to the lymph node (Kopp and 
Medzhitov, 2003; Medzhitov and Janeway, 2002), overwhelming evidence now 
shows that C-type lectins, such as Dectin-1 and macrophage mannose receptor 
(MMR), can operate as constituents of the powerful antigen capture and uptake 
mechanism of DCs and macrophages (Brown et al., 2003; Newman and Holly, 2001; 
Stahl and Ezekowitz, 1998). Each PRR interacts with a specific PAMP displayed on 
the Candida cell wall, which is almost exclusively constituted of glycans. These 
glycans are mostly synthesized as polymers of three types of monosaccharides: D-
glucose, which forms glucan, N-acetyl-D-glucosamine, which forms chitin, and D-
mannose, which forms mannan (Masuoka, 2004). While MMR recognizes terminal 
mannose units (Frison et al., 2003), Dectin-1 is the major glucan binding receptor for 
Candida (Brown et al., 2003). Yet living C. albicans yeast cells do not display a large 
amount of glucan on their surface. This becomes accessible only when yeasts are 
heat-killed (like in the zymosan particles) or when the surface coat, predominantly 
made of mannan, is removed (Poulain and Jouault, 2004). In addition, the interplay 
between C. albicans  cell wall glycans and the host induces changes in C. albicans 
morphogenesis based on post-translational modification of essential glycan 
components (Choi et al., 2003; Lowman et al., 2003). 
Recently, we showed that, besides the MMR, DC-SIGN (Dendritic cell-specific ICAM-
grabbing nonintegrin; CD209) is also involved in binding and internalization of C. 
albicans on human DCs (Cambi et al., 2003). This receptor binds and internalizes 
HIV-1 at mucosal sites of initial infection, protecting the virus during the migration of 
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DCs to lymphoid organs, where CD4 positive T cells become infected (Geijtenbeek et 
al., 2000b). In addition, DC-SIGN acts as an adhesion receptor for endogenous 
ligands such as ICAM-3 (Geijtenbeek et al., 2000c) and ICAM-2 (Geijtenbeek et al., 
2000a). In the past three years, an increasing number of microorganisms has been 
found to interact with DC-SIGN (Colmenares et al., 2002; Cormier et al., 2004; 
Geijtenbeek et al., 2003; Pohlmann et al., 2003), and to target this C-type lectin to 
escape immune surveillance (van Kooyk and Geijtenbeek, 2003). 
Several studies have been undertaken to elucidate the carbohydrate specificity of 
DC-SIGN mediated binding. In particular, carbohydrate profiling using soluble 
chimeric DC-SIGN-IgG1Fc fusion proteins in an ELISA format showed that besides 
mannan DC-SIGN is also able to recognize fucose, especially in the LewisX structure 
(Appelmelk et al., 2003). Site-directed mutagenesis studies have demonstrated that 
DC-SIGN has different binding sites for ICAM-3 and the HIV-1 envelope protein 
gp120 (Geijtenbeek et al., 2002b). DC-SIGN binds to gp120 in a distinct but 
overlapping manner with respect to ICAM-2 and –3 (Su et al., 2004). Structural 
studies employing extensive glycan arrays indicate that DC-SIGN has primary and 
secondary binding sites with different affinities for various carbohydrates (Guo et al., 
2004). 
The initial molecular recognition of pathogens by DCs is decisive in the type of 
immune response that is initiated. At the same time, constant sampling by DCs for 
self-antigens in peripheral tissues is crucial for tolerance induction. To understand 
how C-type lectins expressed on DCs discriminate between endogenous and 
pathogen-associated antigens, a detailed knowledge of the specific carbohydrate 
structures recognized by these receptors is required. 
In the present study, we investigated the carbohydrate specificity of DC-SIGN in the 
recognition of the dimorphic fungus C. albicans. We show that DC-SIGN 
discriminates among Candida species and morphological forms. We demonstrate that 
the recognition between C. albicans and DC-SIGN occurs via the fungal cell wall 
mannan and that distinct mannan structures interact differently with DC-SIGN. Our 
results highlight the importance of identifying the specific carbohydrate structures on 
the pathogens interacting with DC-SIGN to design compounds that selectively 
interfere with binding of DC-SIGN to one type of ligand and to develop efficient anti-
fungal vaccines. 
 
 
MATERIALS AND METHODS 
 
Reagents and antibodies.  
Fluorescein isothiocyanate (FITC) was from Fluka. Zymosan, mannan (from 
Saccharomyces cerevisiae), LewisX, fucose, and D-mannose were from SIGMA 
Chemical Co., St. Louis, MO. α1-3,α1-6-mannotriose was purchased by Dextra 
Laboratories LTD. IL-4 and granulocyte macrophage colony stimulating factor (GM-
CSF) used for culturing monocyte-derived dendritic cells were from Schering-Plough 
(International, Kenilworth, USA). Recombinant gp120 was from R&D. ICAM-3Fc and 
ICAM-1Fc were produced as described in (Bleijs et al., 2000). The following Abs were 
used: AZN-D1 (mouse IgG1, anti-DC-SIGN (Geijtenbeek et al., 2000c)); the directly 
APC-conjugated mAb against CD45RO was from Becton Dickinson (Mountain View, 
USA); Alexa647-conjugated goat-anti-mouse IgG was from Molecular Probes (Leiden, 
Netherlands). 
 
Carbohydrate polymers 
The mannan from S. cerevisiae (SC-mannan) was purchased from Sigma (Lot 
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16H3842) and used as received. The mannan from C.albicans (CA-mannan) was a 
kind gift of Dr. Grigorij Kogan (Institute of Chemistry of Slovak Academy of Sciences, 
Bratislava, Slovakia) and was isolated as previously described (Kogan et al., 1988). 
Glucomannan was also a gift of Dr. Grigorij Kogan and was isolated as already 
published (Chorvatovicova et al., 1999). The CA-mannan contained no nitrogen as 
determined by elemental analysis. Glucan derived from C. albicans (CA-glucan) was 
isolated and characterized by the methods of Lowman et al. (Lowman et al., 2003). 
Scleroglucan was isolated and characterized as described by Pretus et al. (Pretus et 
al., 1991). Table 1 shows the carbohydrates used in this study. 
 
 
Table 1. Characteristics of fungal cell wall isolated glycans used in this 
study.  
 
 
Candida culture conditions. 
C. albicans, strain UC820, a clinical isolate that has been well described (Forsyth and 
Mathews, 1996), was maintained on agar slants at 4°C. Previous experiments 
showed that strain UC820 can develop hyphae and pseudohyphae in vitro and in vivo 
to the same extent as a panel of virulent controls. C. albicans UC820 was inoculated 
into 100 ml of Sabouraud broth and was cultured for 24 h at 37°C. After 3 washes 
with pyrogen-free saline by centrifugation at 1500 g, the number of yeast cells was 
counted in a hemocytometer; occasional strings of 2 yeasts were counted as 1 cfu of 
C. albicans. The suspension was diluted to the appropriate concentration with 
pyrogen-free saline. Microscopy confirmed that the suspension consisted of 
blastoconidia. Clinical isolates of C. albicans, C. dubliniensis, C. tropicalis, C. glabrata, 
and C. parapsilosis were used as potential additional DC-SIGN ligands. C. albicans 
and C. dubliniensis hyphae were grown from 1x106/ml blastoconidia, during 24 hours 
at 37ºC in RPMI 1640 adjusted to pH 6.3 using hydrochloric acid. We used a well 
characterised isolate of Aspergillus fumigatus (strain 4215: MYA-1163; American 
Type Culture Collection, Manassas, Va.). The strain was grown on Sabouraud glucose 
agar supplemented with penicillin/streptomycin for 4 to 7 days at 35oC. Abundant 
Polymer Structure Source 
 
Mannan 
 
 
 
 
 
Glucan 
 
 
 
Glucomannan 
 
 
 
 
 
Scleroglucan 
 
 
a polymer containing [1-6]-linked mannosyl 
units with side chains of [1-2]-linked 
mannosyl units phosphate diester linkages, 
and [1-3]-linked mannosyl units at the end of 
the side chains 
 
a polymer containing [1-3]-linked glucosyl 
repeat units with a [1-6]-linked glucosyl unit 
side chain 
 
a polymer containing [1-4]-linked mannosyl 
repeat units terminated at the reducing 
terminus with [1-4]-linked glucosyl repeat 
unit(s) that also possibly contains branched 
mannosyl and/or glucosyl units 
 
a polymer containing [1-3]-linked glucosyl 
repeat units with a [1-6]-linked glucosyl unit 
side chain every third backbone glucosyl unit 
 
S.cerevisiae and C.albicans 
 
 
 
 
C.albicans 
 
 
 
Candida utilus 
 
 
 
 
 
 
Schlerotium glucanicum 
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conidia were elaborated under these conditions. Conidia were harvested by gently 
scraping the surface of the slants and suspending them in phosphate buffered saline 
with 0,05% Tween 80. To remove hyphae and debris the conidial suspension was 
filtered through 8 layers of cheesecloth. A. fumigatus conidia were then killed by 
autoclaving (120oC for 25 min) to prevent fungal overgrowth in the cell cultures. 
Conidial suspensions were kept frozen at –80oC till use.   
 
Cells 
Immature DC were generated from human peripheral blood monocytes as described 
previously (Romani et al., 1994). Briefly, monocytes were isolated by adherence to 
plastic and cultured in the presence of IL-4 (500 U/ml) and GM-CSF (800 U/ml) for 6-
7 days. The DCs obtained were analyzed for their immature phenotype as already 
described (48). K562 transfectants expressing DC-SIGN (K-DC-SIGN) were generated 
by transfection of K562 cells with 10 µg of plasmid by electroporation as described 
previously (Geijtenbeek et al., 2000c). Positive cells were sorted several times to 
obtain stable transfectants with expression levels of DC-SIGN similar to immature 
DC. 
 
Candida binding studies  
Binding of DCs or K-DC-SIGN cells to Candida conidiae (or hyphae, or A. fumigatus 
or zymosan) was measured by flow cytometry using the FACScalibur (BD 
Biosciences, Mountain View, CA), as already described (Cambi et al., 2003). Before 
adding FITC-labeled live Candida conidiae (or hyphae, or heat-killed A. fumigatus, or 
zymosan), APC-labeled cells were or were not preincubated for 10 min at room 
temperature with either mannose (150µg/ml), or fucose (150µg/ml), or α1-3,α1-6-
mannotriose (150µg/ml), or LeX (150µg/ml), or CA-mannan (50 and 150µg/ml), or 
SC-mannan (50 and 150µg/ml), or CA-glucan (150µg/ml), or glucomannan 
(150µg/ml), or scleroglucan (150µg/ml), or EGTA (2 mM), or soluble ICAM-1Fc 
(50µg/ml), or soluble ICAM-3Fc (50µg/ml), or recombinant gp120 (50µg/ml), or 
isotype control (mouse IgG1), or anti-DC-SIGN mAb AZN-D1 (20µg/ml) in 20 mM 
Tris pH 8.0, containing 150 mM NaCl, 1 mM CaCl2, 2 mM MgCl2, and 1% BSA (TSA 
buffer) or, when EGTA was used, in PBS. Subsequently, FITC-labeled yeast cells 
were resuspended to the appropriate concentrations either in TSA or PBS and added 
in a cell/yeast ratio of 1/5. After 30 min incubation at 37ºC, cell-yeast conjugates 
were analyzed by flow cytometry, and the relative difference in mean fluorescence 
intensity of the double-labeled events in comparison with that of control cells was 
calculated.  
 
Fluorescent beads adhesion assay 
The fluorescent beads adhesion assay was performed as described earlier 
(Geijtenbeek et al., 1999). Briefly, carboxylate-modified TransFluorSpheres (488/645 
nm, 1.0µm; Molecular Probes, Eugene, OR) were coated with ICAM-3-Fc or the HIV-
1 envelope protein gp120, and adhesion was determined by measuring the 
percentage of cells that have bound fluorescent beads, by flow cytometry. In 
inhibition studies, the beads adhesion assay was performed in presence of the same 
inhibitors described above for the Candida binding studies. 
 
Phagocytosis 
Iimmature DC (5 x 105) were allowed to adhere onto fibronectin and subsequently 
incubated with unopsonized FITC-labeled C. albicans or C. dubliniensis conidiae (2.5 
x 106) for 60 min at 37°. At the end of the incubation period, the samples were 
washed to remove unbound conidiae, fixed in 1% PFA in PBS for 15 min at room 
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temperature, and permeabilized in cold methanol for 5 min at 4º. After a blocking 
step in PBS containing 3% BSA and 20 mM glycine for 60 min at room temperature, 
cells were labeled with mAb AZN-D1 (10 µg/ml in PBS/3% BSA) for 30 min at room 
temperature and subsequently incubated with Alexa647-conjugated Goat-anti-Mouse 
(Fab’)2 fragments for 30 min at room temperature. Finally, samples were sealed in 
Mowiol and analyzed using a Bio-Rad MRC1024 confocal microscope. 
 
NMR Spectroscopy 
The proton and carbon-13 NMR spectra were collected on a JEOL Eclipse+ 600 NMR 
spectrometer in 5-mm OD NMR tubes at 70 ºC in D2O. Internal chemical shift 
reference was provided by trimethylsilyl-2,2,3,3-d4-propionic acid (TSP) (Cross, 1977; 
Hoffman, 1988; Huckerby, 1983; Kath, 1999) at 0.0 and -2.78 ppm for 1H and 13C 
spectra, respectively. Individual solutions of SC-mannan and CA-mannan were 
prepared at mannan concentrations of 24 and 15 mg per 1 mL of solvent, 
respectively. 
 
GPC/MALLS methodology 
The molecular weight distributions of the mannans were established as described 
previously (Muller et al., 1995).  Briefly, the mannans were dissolved (3 mg/ml) in 50 
mM sodium nitrite mobile phase and filter sterilized (0.45 micron). The mannans 
were analyzed by gel permeation chromatography (GPC) with online multi-angle 
laser light scattering photometry (MALLS). The chromatograms were analyzed with 
Wyatt Astra software (v. 4.9) and the data reported as weight average molecular 
weight. 
 
 
RESULTS 
 
DC-SIGN discriminates among species and morphological forms of 
Candida. 
We previously demonstrated that in addition to viruses and bacteria DC-SIGN binds 
fungi such as C. albicans (Cambi et al., 2003). Although C. albicans remains the most 
common agent for nosocomial fungal infections, several non-albicans species of 
Candida have been isolated with increasing frequency in patients suffering of 
candidiasis and have been shown to be resistant to several commonly used 
antifungal drugs (Abi-Said et al., 1997; Barchiesi et al., 1993; Coleman et al., 1997; 
Moran et al., 1997). Therefore, we analyzed the capacity of DC-SIGN to recognize 
and bind different Candida species. As shown in Fig. 1 A, besides C. albicans, K-DC-
SIGN cells were able to strongly bind to C. dubliniensis and C. glabrata, while binding 
to C. parapsilosis and C. tropicalis was very weak. 
In addition, DC-SIGN showed high binding to A.fumigatus, in agreement with a 
recent report by Serrano-Gomez et al. (Serrano-Gomez et al., 2004), as well as to S. 
cerevisiae derived zymosan particles. All interactions were highly specific for DC-
SIGN, as shown by the significant block exerted by the anti-DC-SIGN Ab. In addition, 
DC-SIGN-mediated binding was Ca2+-dependent as indicated by the inhibition by the 
Ca2+-chelating agent EGTA. 
These observations demonstrate that DC-SIGN recognizes a variety of distinct fungal 
species. 
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Figure 1. DC-SIGN discriminates among different fungi and preferentially binds to 
conidiae. A) K-DC-SIGN cells were incubated with FITC-labeled conidiae of different fungi 
for 30 min at 37°C, in presence or absence of DC-SIGN blocking antibody AZN-D1 (20µg/ml) 
or EGTA (2mM). The percentage of binding was calculated by flow cytometry. The average of 
three independent experiments is shown. B) K-DC-SIGN cells were incubated with FITC-
labeled conidiae or hyphae of two different strains of C.albicans (V13-12 and V18-17) and 
two strains of C.dubliniensis (4247 and 3588) for 30 min at 37°C, in presence or absence of 
DC-SIGN blocking antibody AZN-D1 (20µg/ml) or EGTA (2mM). The percentage of binding 
was calculated by flow cytometry. One representative experiment out of two is shown. C) 
Immature DC expressing DC-SIGN were incubated with FITC-labeled conidiae of C.albicans 
and C.dubliniensis for 30 min at 37°C, in presence or absence of DC-SIGN blocking antibody 
AZN-D1 (20µg/ml). The percentage of binding was calculated by flow cytometry: basal 
binding was set as 100%. The average of three independent experiments is shown. D) 
Immature DC were incubated with C.albicans and C.dubliniensis conidiae at a DC/Candida 
ratio of 1:5 for 1 hr at 37°C to allow phagocytosis. Subsequently, samples were fixed and 
labeled for confocal microscopy: the images show FITC-labeled Candida (green) and Cy5-
labeled DC-SIGN (red). Scale bar is 5µm. 
 
 
An important factor in fungal virulence is the dimorphism. During the infection, 
Candida species undergo a morphogenic transformation from unicellular yeast form 
(conidiae) into filamentous forms (hyphae) that plays an important role in its 
pathogenicity (Odds, 1994). Figure 1 B shows that K-DC-SIGN cells strongly bind to 
the conidiae of two different strains of C. albicans and C. dubliniensis in a DC-SIGN-
dependent manner, whereas binding to the corresponding hyphae was almost 
absent. Similar data were obtained when conidiae and hyphae of A. fumigatus were 
used (data not shown). This clearly indicates that DC-SIGN is able to discriminate 
between the conidiae and the hyphae of these two Candida species, suggesting the 
involvement of DC-SIGN in the early recognition of Candida. 
We already demonstrated that on DCs besides the MR DC-SIGN also contributes to 
the binding and internalization of C. albicans (Cambi et al., 2003). Therefore, we also 
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investigated the role of DC-SIGN in the interaction with C. dubliniensis on immature 
DCs. As indicated in Fig. 1 C, about 50% of the binding of DCs to C. dubliniensis is 
mediated by DC-SIGN, thus even higher than what is observed for C. albicans. This 
correlates with the stronger binding of K-DC-SIGN to C. dubliniensis (Fig. 1 A). 
Moreover, on DCs, DC-SIGN was able to internalize conidiae of C. albicans as well as 
C. dubliniensis that were found in DC-SIGN enriched vesicles (Fig. 1 D). Besides DC-
SIGN, only the MMR contributed to the binding of DCs to C.dubliniensis. No 
involvement of Mac-1 or Dectin-1, which have also been described to bind to 
Candida, was observed (data not shown).  
Altogether, these results demonstrate that the affinity of DC-SIGN varies for various 
Candida species as well as for the different infectious stages, and that DC-SIGN is 
involved in uptake of different non-opsonized Candida species on DCs. 
 
 
DC-SIGN specifically recognizes Candida-derived mannan. 
As PRR, DC-SIGN is able to recognize specific PAMPs that include the high mannose 
carbohydrate moiety on the HIV-1 coat protein gp120 (Geijtenbeek et al., 2000b), 
but also less complex mannose-containing carbohydrates such as mannose and α1-
3,α1-6-mannotriose (Feinberg et al., 2001), LewisX antigen (van Die et al., 2003), 
and ManLam (Geijtenbeek et al., 2003). To get insight in the PAMP that is recognized 
on C. albicans by DC-SIGN, we compared the capacity of S. cerevisiae - derived 
mannan (SC-mannan) to inhibit binding of DC-SIGN to various known ligands and to 
Candida (Fig. 2 A). Surprisingly, while binding to zymosan, A. fumigatus, ICAM-3-, 
and gp120-beads is significantly blocked by SC-mannan, the interaction of DC-SIGN 
with Candida was clearly not inhibited by SC-mannan. 
Therefore, to better define the carbohydrate moiety recognized by DC-SIGN on 
Candida conidiae, we analyzed the carbohydrates purified from the cell wall of 
Candida (Table 1). While SC-mannan was inactive, C. albicans-derived mannan (CA-
mannan) specifically inhibited DC-SIGN mediated binding to both C. albicans and C. 
dubliniensis in a concentration-dependent manner (Fig. 2 B). In contrast, C. albicans-
derived glucan (CA-glucan) has no effect on the interaction (Fig. 2 B). The inhibition 
by CA-mannan on DC-SIGN-mediated binding is more pronounced for C. albicans 
than for C. dubliniensis. Since glycosylation differences between these two Candida 
species are documented (Hazen et al., 2001), these most likely account for this 
different sensitivity to mannan inhibition. 
Similar to K-DC-SIGN, also binding of DCs to Candida is strongly blocked by CA-
mannan but not by SC-mannan or CA-glucan (data not shown), further supporting 
the notion that mannan rather than glucan of C. albicans cell wall plays a major role 
in the initial interaction with DCs. 
These data clearly demonstrate the finely tuned recognition of carbohydrate moieties 
by C-type lectins like DC-SIGN. The inhibiting effect SC-mannan on DC-SIGN binding 
to zymosan suggests that SC-mannan might better represent the structure of the cell 
wall mannan after the treatment to derived zymosan from S. cerevisiae. This 
observation also highlights the importance of using live microorganisms to determine 
the recognition of specific PAMPs. 
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Figure 2. DC-SIGN specifically recognizes mannan of C.albicans cell-wall. A) K-DC-
SIGN cells were incubated with different ligands of DC-SIGN including ICAM-3- and gp120-
coated fluorescent beads, FITC-zymosan, and FITC-conidiae of A.fumigatus, C.albicans, and 
C.dubliniensis, as described in Materials and Methods. Binding assay was performed in 
presence or absence of anti-DC-SIGN blocking antibody AZN-D1 (20µg/ml), SC-mannan 
(100µg/ml), and EGTA (2mM). The percentage of binding was calculated by flow cytometry. 
The average of three independent experiments is shown.  B) K-DC-SIGN cells were incubated 
with FITC-conidiae of C.albicans and C.dubliniensis, in presence or absence of AZN-D1 
(20µg/ml), SC-mannan (100µg/ml), CA-mannan (50 and 100 µg/ml), CA-glucan (100 µg/ml), 
and EGTA (2mM). The percentage of binding was calculated by flow cytometry: basal binding 
was set as 100%. The average of three independent experiments is shown. 
 
 
Differences in specificity between CA- and SC-derived mannans relate to 
distinct structural properties. 
To explain the differences between CA- and SC-mannan in their capacity to block 
DC-SIGN – Candida interaction, we initiated a thorough structural analysis comparing 
the two different mannans by NMR. Fungal cell wall mannans consist of a backbone 
of [1-6]-linked mannosyl repeat units with side chains of [1-2]-linked mannosyl 
repeat units connected to the backbone by a [1-2]-linkage as well as phosphate di-
mannosyl esters and [1-3]-linked mannosyl units at the end of the side chains 
(Shibata et al., 1995). The α-anomer glycosidic linkage configuration is the major 
conformation found in mannans with a low level of β-anomer glycosidic linkage 
configuration possible (Kath, 1999; Masuoka, 2004). The major differences in the 
mannan isolates in this study are differences in structural features, purity of the 
isolated mannan, and molecular size. SC-mannan was isolated by a procedure 
involving acetolysis which results in the selective cleavage of [1-6]-linkages in the 
backbone (Kobayashi, 1992; Kocourek and Ballou, 1969; Kogan, 1991). CA-mannan 
isolation did not involve acetolysis. 
The proton NMR spectrum of CA-mannan (Figure 3A, bottom) exhibited additional 
resonances compared to the spectrum of SC-mannan (Figure 3A, top) in the spectral 
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region outside of the carbohydrate spectral region (which is generally between 3.2 – 
5.7 ppm). Structural characterization of the mannans indicated that CA-mannan is a 
more intact mannan than SC-mannan, therefore better resembling the native 
mannan from the cell wall (Vinogradov, 1998).  
 
 
 
 
Figure 3. NMR spectra of the carbohydrate spectral region for mannans from S. 
cerevisiae and from C. albicans. A) Comparison of the complete proton NMR spectra of 
SC-mannan (top) and CA-mannan (bottom). B) Expansion of the proton NMR spectra from 
panel A, showing the anomeric proton spectral region for SC-mannan (top) and CA-mannan 
(bottom). C) Comparison of the complete carbon-13 NMR spectra of SC-mannan (top) and 
CA-mannan (bottom). The abbreviation ppm indicates parts per million. 
 
 
Differences in the structural details between SC-mannan and CA-mannan are evident 
on examination of the anomeric proton spectral region (Figure 3B). The spectrum for 
SC-mannan shows evidence for [1-6]-α-linked mannosyl backbone repeat units with 
attached side chains (peak at 5.075 ppm), [1-2]-α-linked internal mannosyl units in 
the side chain (peak at 5.28 ppm), a [1-2]-α-linked mannosyl unit next to a [1-3]-
linked non-reducing terminus (NRT) (peak at 5.06 ppm), and [1-3]-α-linked 
mannosyl unit at the side chain NRT (peaks at 5.11 and 5.16 ppm) (53,59,62). These 
assignments are consistent with a partially degraded mannan isolated by acetolysis 
(Kath, 1999). The spectrum for CA-mannan shows evidence for [1-6]-α-linked 
mannosyl backbone repeat units with attached side chains (peak at 5.075 ppm), [1-
2]-α-linked internal mannosyl units in the side chain (peaks at 5.26 and 5.29 ppm), 
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[1-3]-α-linked mannosyl unit at the side chain NRT (peak at 5.11 ppm), α-mannosyl 
units at the reducing terminus (RT) (peak at 5.37 ppm), phosphate-mannosyl esters 
(peak at 5.56 ppm), and [1-2]-β-linked mannosyl units at the end of the side chain 
(peak at 4.93 ppm) (53,59,62). 
The SC-mannan molecular size is clearly smaller than that for CA-mannan as 
evidenced by comparison of the C-13 NMR (Figure 3C) resonance linewidths. The 
molecular weight distributions of the mannans were established by GPC/MALLS 
analysis (see Materials and Methods). SC-mannan has an average molecular weight 
of 37,000 g/mol, while CA-mannan has an average molecular weight of 490,000 
g/mol. Therefore SC-mannan is designated as Low-Molecular-Weight (LMW) 
mannan, and CA-mannan as High-Molecular-Weight (HMW) mannan. This molecular 
weight difference is supported in the resonance linewidths observed in the C-13 NMR 
spectra (Fig. 3C). The molecular motions of the LMW SC-mannan are faster in 
solution resulting in narrower C-13 NMR resonance linewidths (Figure 3C, top). The 
larger molecular size of HMW CA-mannan results in slower molecular motion in 
solution and broader linewidths in the NMR spectrum (Figure 3C, bottom). Schematic 
representations of these structural features characterized from NMR and GPC/MALLS 
analysis are given in figure 4. All together our data indicate that the specificity of DC-
SIGN towards SC-mannan and CA-mannan in fungal recognition is due to both 
differences in the molecular weight and differences in structure of the mannans. 
 
 
 
Figure 4.  Schematic presentation of the structural features reported for the low- 
and high-molecular weight mannans. M indicates a D-mannopyranose unit. LMW 
indicates Low Molecular Weight mannan (SC-mannan), HMW indicates High Molecular Weight 
mannan (CA-mannan). The side chain sequences are not specific, but indicate the nature of 
the structural features and differences between the two structures suggested by the proton 
NMR spectra (Figure 3B). Mannose units within parentheses in the (1-6)-linked polymer 
backbone indicate that they may be present or absent in the polymer chain. Brackets 
connecting the phosphate group to the chain of four M units indicate general bonding of the 
phosphate to a chain(s) of M units. Likewise, the phosphate group is bound to the reducing 
terminus of any one of several mannose chain configurations. This schematic presentation 
follows the model of Shibata et al. (Shibata et al., 1995). 
 
 
The Candida binding site on DC-SIGN differs from that of gp120 and ICAM-
3. 
The difference in mannan specificity observed for DC-SIGN in binding to Candida 
with respect to the other ligands prompted us to investigate a broader spectrum of 
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purified microbial glycans (see Table 1). Interestingly, as depicted in the overview of 
Fig. 5 A, carbohydrates like LewisX, mannose, fucose, and α1-3,α1-6-mannotriose 
did not inhibit either of the ligands tested, although they have been reported to bind 
to DC-SIGN (Appelmelk et al., 2003). Different combinations of these carbohydrates 
were equally unable to block DC-SIGN binding to Candida (data not shown). 
Strikingly, glucomannan (see Table 1) specifically blocked binding of DC-SIGN to 
ICAM-3 and gp120 but not to C. albicans and C. dubliniensis. Unexpectedly, 
scleroglucan (see Table 1) exclusively inhibited binding to ICAM-3 and gp120. Other 
fungal cell wall components, such as purified chitin and chitin-glucan complex, were 
examined and did not show any inhibition of DC-SIGN-mediated binding to Candida 
(data not shown).  
 
 
 
 
Figure 5. DC-SIGN binds to Candida in a distinct manner with respect to HIV 
gp120 and ICAM-3. A) Comparison of binding of K-DC-SIGN cells to ICAM-3- or gp120-
coated fluorescent beads, or FITC-conidiae of C.albicans and C.dubliniensis. Binding assay 
was performed in presence or absence of different blocking agents. The percentage of 
binding was calculated by flow cytometry. One representative experiment out of three is 
shown. B) K-DC-SIGN cells were incubated with ICAM-3- or gp120-coated fluorescent beads, 
or FITC-conidiae of C.albicans, in presence or absence of AZN-D1 (20µg/ml), soluble ICAM-
1Fc (50µg/ml), soluble ICAM-3Fc (50µg/ml) and EGTA (2mM). The percentage of binding was 
calculated by flow cytometry: basal binding was set as 100%. One representative experiment 
out of two is shown. 
 
 
Based upon these observations and previous studies, indicating that gp120 and 
ICAM-3 bind to DC-SIGN in a distinct yet overlapping manner (Su et al., 2004), we 
investigated whether the ligands would reciprocally affect their recognition by DC-
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SIGN. Figure 5 B indicates the effect of soluble ICAM-3Fc and gp120 proteins on DC-
SIGN-mediated binding. While binding of K-DC-SIGN to ICAM-3- and gp120-coated 
beads was mutually inhibited by the recombinant forms of both proteins (similar 
results were obtained using DCs, data not shown), binding to Candida was totally 
unaffected. Addition of ICAM-1Fc did not show any specific block of DC-SIGN 
mediated binding.These results strongly indicate that the interaction between DC-
SIGN and Candida may occur in a distinct fashion with respect to other known 
ligands and could involve additional regions within the carbohydrate recognition site 
of DC-SIGN.  
 
 
DISCUSSION 
Infections of the fungus C. albicans cause significant morbidity and mortality among 
immunocompromised indivuals, such as HIV patients, transplant recipients and 
cancer patients (Dixon et al., 1996). Therefore, a better understanding of the specific 
receptors involved in the interactions between invading fungi and immune cells is 
necessary. 
We previously demonstrated that DCs bind and internalize C. albicans also through 
the C-type lectin DC-SIGN (Cambi et al., 2003). Here we show that besides C. 
albicans, DC-SIGN binds to other fungal species, including the C. albicans closely 
related C. dubliniensis as well as A. fumigatus, and is also able to bind with high 
affinity to zymosan particles (Fig. 1 A).  
Fungal dimorphic transition from simple yeast form (conidiae) to multicellular 
filaments (hyphae) is supposed to play a fundamental role in the opportunistic 
immunomodulation of the host defense (Calderone and Fonzi, 2001).  We 
demonstrate that DC-SIGN discriminates between conidiae and hyphae of the same 
fungus, preferentially binding to the conidial form, and contributes to binding and 
internalization of Candida conidiae, on immature DCs (Fig. 1 B-D). Accordingly, DC-
SIGN could not mediate binding of DCs to fungal hyphae (data not shown). Previous 
reports indicate that internalization of Candida hyphae by DCs is mainly mediated by 
non-lectin receptors such as CR3, FcγRII, and FcγRIII (Romani et al., 2002). This is 
in agreement with our recent observation that, unlike neutrophils and 
monocyte/macrophages, DCs are poor in both intracellular killing and damaging of C. 
albicans hyphae (Netea et al., 2004). This suggests that DCs might be important at 
early stages of fungal infection, in the recognition of the conidial form, rather than at 
later or chronic stages of fungal infection when multicellular filaments of Candida 
have been formed.  
Interactions between host and fungal pathogens occur at the level of the cell-wall 
(Calderone, 1993), which is composed of glycoproteins embedded within a 
polysaccharide matrix. Therefore, carbohydrates are the first components to contact 
host tissues. Unfortunately, detailed characterization of these initial interactions at a 
more structural level is lacking. The findings in this paper demonstrate that the 
interaction between DC-SIGN and C. albicans is mediated by mannan rather than 
other fungal cell wall components such as glucan, chitin, or chitin-glucan complex 
(Fig. 2 and data not shown). CA-mannan, purified from C. albicans cell wall, could 
specifically inhibit binding of this fungus to DC-SIGN (Fig. 2 B). Interestingly, the SC-
mannan, purified from S. cerevisiae cell wall, was not able to block the interaction 
between DC-SIGN and Candida (Fig. 2 A). This observation together with the 
structural data obtained by the NMR and GPC-MALLS analysis indicate that SC-
mannan and CA-mannan differ in terms of their binding efficiency, molecular weight, 
and secondary structure, and they can be referred to as LMW- and HMW-mannan, 
respectively (Fig. 4). Clearly, these structurally distinct mannans interact differently 
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with DC-SIGN. This observation emphasizes the importance of understanding these 
structural differences and the need for further studies that include structurally well-
characterized mannans, if details of mannan binding to receptors as a function of 
structure are to be well understood. In this respect, it is known that the composition 
of fungal cell wall varies between conidiae and hyphae, especially regarding the ratio 
between the three major components, glucan, chitin, and mannan (Cassone et al., 
1978; Chattaway et al., 1968). Moreover, the mannan present on the hyphae cell 
wall may be structurally different from the mannan on the conidiae cell-wall, and this 
could account for the inability of DC-SIGN in binding to Candida hyphae. This has 
been already reported for another fungal cell wall carbohydrate, the β(1,3)-glucan 
isolated from conidiae and hyphae of C. albicans: by NMR analysis, these glucans 
were shown to differ in terms of molecular weight, degree of polymerization, and 
structural composition (Lowman et al., 2003). Therefore, structural data concerning 
fungal carbohydrates are an essential prerequisite to better understand the 
relationships between structure and function of fungal cell wall carbohydrates during 
recognition by immune receptors. 
Our findings concerning DC-SIGN selective recognition of structurally different 
mannans  further extend and substantiate previous observations concerning DC-
SIGN selective recognition of the mannose caps of lipoarabinomannan from different 
Mycobacterium species (Maeda et al., 2003) as well as DC-SIGN specific interaction 
with LewisX/Y-expressing phase-variant of Helicobacter pylori (Bergman et al., 
2004). Use of specific glycosylation mutants of C. albicans in binding assays with DC-
SIGN expressing cells may shed light on the exact mannan structural features 
important for recognition by DC-SIGN. 
The complexity of carbohydrate-DC-SIGN interaction is further highlighted by the 
observation that scleroglucan and glucomannan only affect the binding to gp120, 
ICAM-2, and ICAM-3 but not to Candida (Fig. 5 A). So far, DC-SIGN has been 
demonstrated to preferentially interact with mannose- and fucose-containing 
polymers, but not with glucose-containing polymers such as glucans. To the best of 
our knowledge, this is the first time that a pure glucose-containing polymer, in this 
case sleroglucan, can block DC-SIGN-mediated binding. However, the inability of CA-
glucan to inhibit DC-SIGN binding suggests that scleroglucan might have a different 
primary or secondary structure that allows scleroglucan to be specifically recognized 
by DC-SIGN. Furthermore, other carbohydrates, such as LewisX and α1-3,1-6 
mannotriose, which are recognized by DC-SIGN (42), have no effect on binding to 
gp120, ICAM-2, -3, and Candida, indicating that they bind to different regions of the 
CRD or that binding occurs with a lower affinity. 
We also demonstrate that while gp120 and ICAM-3 mutually inhibit the interaction of 
DC-SIGN with coated beads, these recombinant proteins do not affect binding to C. 
albicans (Fig. 5 B). Recently, Su et al. (Su et al., 2004) demonstrated that gp120 and 
ICAM-3 bind to DC-SIGN in a distinct yet overlapping manner, therefore it is 
conceivable to hypothesize that Candida may bind to DC-SIGN in yet a distinct 
manner. 
Based on the different blocking capacity exerted by the LMW- and HMW-mannan on 
the interaction between DC-SIGN and its ligands, we propose a model to summarize 
our observations (Fig. 6).  
Since increasing evidence shows that the CRD contains more than one binding site, 
the HMW-mannan may be able to occupy multiple binding sites on the CRD, whereas 
the LMW-mannan cannot. This would explain why the binding of DC-SIGN to the cell 
wall of Candida, which contains HMW-mannan, cannot be inhibited by the LMW-
mannan. 
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Figure 6. DC-SIGN interacts with carbohydrates using multiple binding sites. Model 
showing the distinct blocking capacity of the HMW- and LMW-mannan in the interaction of 
DC-SIGN with various ligands. The CRD of DC-SIGN contains more than one binding site, 
therefore the HMW-mannan may be able to occupy multiple binding sites on the CRD better 
than the LMW-mannan. In this way, binding of DC-SIGN to the cell wall of Candida, which 
contains HMW-mannan, cannot be inhibited by the LMW-mannan. However, LMW-mannan is 
able to interact with DC-SIGN at the overlapping binding sites of both ICAM-3 and gp120, 
thus preventing these ligands to come in contact with the CRD. 
 
 
Interestingly, LMW-mannan inhibits the interaction of DC-SIGN with zymosan. This 
might be due to the fact that the structure of the mannan that is still present on the 
degraded cell wall of zymosan may resembles that of the LMW-mannan. LMW-
mannan is able to block DC-SIGN binding to both ICAM-3 and gp120, which interact 
with DC-SIGN at distinct but overlapping sites, suggesting that LMW-mannan might 
be able to simultaneously occupy these overlapping sites on the CRD (Fig. 6). Since 
the exact carbohydrate moieties recognized by DC-SIGN on HIV-1 gp120 and the 
self-proteins ICAM-2 and ICAM-3 have not been characterized, subsequent mutation 
analysis of DC-SIGN is required to better understand the interaction of DC-SIGN with 
its ligands at the molecular level. In this respect, it is of interest to note that the 
recently discovered secondary binding site on the CRD of DC-SIGN might also play a 
role in the recognition of ligands other than high-mannose or fucose moieties (Guo et 
al., 2004). Finally, a further level of complexity in the interaction of DC-SIGN with 
large carbohydrate structures, such as HMW fungal mannan, may be provided by the 
tetramerization of DC-SIGN molecules (Feinberg et al., 2001). The way in which 
several CRDs are spatially arranged is an important determinant for specificity. 
Finally, the organization of DC-SIGN in microdomains at the cell membrane may 
further increase the valency for the interaction with arrays of glycans presented at 
the pathogen surface (Cambi et al., 2004). In this way, clusters of DC-SIGN 
molecules could serve as multivalent scaffolds to simultaneously engage multiple 
interactions with large carbohydrate structures derived from the fungal cell wall.  
It is now becoming clear that the carbohydrate recognition profile of DC-SIGN is 
broader than originally thought. This differential binding capacity may enable DC-
SIGN to discriminate between endogenous and pathogen-derived antigens, therefore 
inducing distinct functions in DC. The results of this study also indicate that pathogen 
recognition by C-type lectins, such as DC-SIGN, is tightly controlled. Through the 
engagement of distinct pathogen recognition receptors, DCs are equipped with a 
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delicate sensing system that is able to recognize and discriminate fungal species and 
life forms. After recognition, DCs can initiate immune responses and influence the 
outcome of a fungal infection (d'Ostiani et al., 2000). Better insight in the 
carbohydrate recognition profile of C-type lectins on DCs could ultimately lead to the 
development of new drugs targeting specific fungal cell wall antigens in a DC-based 
vaccination against opportunistic fungi. Our studies demonstrate that a detailed 
knowledge of DC-SIGN specificity for fungal mannan may be helpful to selectively 
target DC-SIGN on DCs without preventing other important cellular function of this 
C-type lectin.  
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GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
The plasma membrane is a specialized microenvironment, where finely orchestrated 
interactions among proteins, carbohydrates and lipids take place. These complex 
interactions mediate many fundamental processes that occur at the cell-cell or cell-
pathogen interface. Insight in the cell surface organization of immune receptors like 
the β2 integrin LFA-1 and the C-type lectin DC-SIGN will undoubtely contribute to the 
development of novel strategies that specifically modulate leukocyte adhesion and 
migration during inflammation or inhibit interactions with life-threatening pathogens 
like HIV-1 or Mycobacterium. 
 
 
Organization of immune receptors in microdomains 
The continuous mobility of the immune cells from tissues to blood and lymph and 
vice versa is guaranteed by the expression of appropriate adhesion receptors on the 
cell surface of each immune cell. Also, the wide arsenal of pathogen recognition 
receptors (PRRs), located on organelles in the cytoplasm, at the cell surface , or 
secreted, provide immune cells with effective tools for sensing invading pathogens.    
Monocytes can readily differentiate into antigen-presenting DCs (Banchereau and 
Steinman, 1998) upon reverse transmigration of endothelial monolayers (Randolph 
et al., 1998) or when cultured in vitro in presence of GM-CSF and IL-4 (Romani et 
al., 1994). The plasma membrane of monocyte-derived DCs displays a specific set of 
cell surface molecules that must change dynamically along with the specific 
alterations occurring in the development from precursors towards DC. Some of these 
molecules already present on monocytes are preserved also on DCs, while the 
expression of new DC specific molecules represents one of the major phenotypic 
changes during DC development. The expression of DC-SIGN is one of the 
phenotypical modifications occurring during monocyte differentiation and the 
presence of this receptor on the cell surface seems to be fundamental for the 
acquirement of new adhesive properties on immature DC with respect to their 
precursors (Geijtenbeek et al., 2000a). In contrary, LFA-1 is expressed at comparable 
levels on monocytes and on immature DCs (Chapter 3).  
Interestingly, despite the fact that these receptors belong to completely different 
families, they share similar characteristics such as binding to ICAM-2 and ICAM-3 and 
requirement of divalent cations for adhesion (Bleijs et al., 2001).  
We observed that LFA-1 and DC-SIGN, while having an overlap in ligand repertoire, 
were active at distinct stages of DC development (Chapter 3 and 4). By high 
resolution transmission EM we showed that remarkable changes in the cell surface 
distribution pattern of these receptors strongly correlate with changes in the 
adhesive properties. While LFA-1 organization in sub-micron sized microdomains on 
monocytes changes into a random distribution on immature DCs, DC-SIGN molecules 
follow a clear opposite trend. In fact, at early stages of DC development, DC-SIGN is 
randomly distributed and becomes organized in well-defined 200 nm microdomains 
at the cell membrane of immature DC (Fig. 1). However, the impact that these 
changes in receptor microlocalization have on adhesive properties is different for 
LFA-1 with respect to DC-SIGN. In fact, while the disassembly of LFA-1 
microdomains has a clear correlation with the acquisition of an inactive conformation 
(lacking the NKI-L16 epitope) that prevents binding to the ICAMs molecule, DC-SIGN 
is able of binding to ICAMs and HIV-1 gp120, as well soluble as coated on a 1µm 
bead, even when its distribution pattern at the plasma membrane is random 
(Chapter 4). However, the organization in microdomains on the cell surface of DCs 
confers to DC-SIGN the capacity of binding to viral particles more efficiently than 
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when DC-SIGN molecules are present as single features on the cell membrane 
(Chapter 4). 
Also the localization of LFA-1 and DC-SIGN with lipid rafts shows an opposite trend: 
while LFA-1 resides in lipid rafts on monocytes and becomes gradually excluded from 
these domains during DC development, DC-SIGN has a strong affinity for a lipid raft 
environment both when randomly and clustered distributed (Chapter 3 and 4). 
Neither DC-SIGN nor LFA-1 have on their molecules a post-translational modification, 
such as palmitoylation, that may mediate association with lipid rafts. Therefore, 
further studies are required to understand how the recruitment of these two 
receptors in the lipid raft fraction of the plasma membrane is regulated.    
The capacity of C-type lectins like DC-SIGN to sense microorganisms is highly 
dependent on the density of the PAMP present on the microbial surface as well as on 
the degree of multimerization of the lectin receptor. In fact, the arrangement of 
several CRDs in multimers projects the binding sites in a common direction, in order 
to allow interactions with the arrays of carbohydrates on microbial surfaces. 
 
 
 
 
 
Figure 1. LFA-1 and DC-SIGN distribution at the cell surface during DC 
development. 
 
 
The soluble collectins, also belonging to the C-type lectin family, form trimers that 
may further assemble into larger oligomers. Also transmembrane C-type lectins have 
developed several strategies to increase the interaction strength with PAMPs. The 
extracellular portion of the MMR is composed of several CRDs, of which at least three 
are required for high affinity binding and endocytosis of multivalent glycoconjugates. 
Thus, several CRDs with only weak affinity for single carbohydrates are clustered in 
one single molecule to achieve higher affinity binding (Taylor et al., 1992). 
Biochemical studies using soluble recombinant fragments of DC-SIGN and its liver 
homolog  L-SIGN  indicate that the extracellular domain of each molecule is a 
tetramer stabilized by an α-helical neck and that the individual CRDs have high 
affinity for mannose-containing oligosaccharides (Mitchell et al., 2001). The 
organization of DC-SIGN in microdomains may add a further level of complexity in 
the recognition of large carbohydrate moieties present at the cell surface of 
microorganisms (Chapter 7). It is tempting to speculate that the affinity of DC-SIGN 
towards certain carbohydrates might be influenced by changes in DC-SIGN 
distribution pattern. 
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Adhesive properties are regulated by subtle differences in ligand structure. 
LFA-1 and DC-SIGN recognize different binding sites on the ICAMs: the I domain of 
LFA-1 specifically interacts with the first NH2-like domain of ICAM-2 and –3 (as well 
as of ICAM-1) in a Mg2+-dependent manner (Binnerts and van Kooyk, 1999), 
whereas DC-SIGN binds to mannose carbohydrate structures present on the second 
NH2-like domain of ICAM-2 and –3 and requires binding of Ca2+ ions to the 
carbohydrate recognition domain (CRD) of this lectin (Geijtenbeek et al., 2002a). 
Recently, Jimenez et al. demonstrated that presence or absence of specific N-linked 
high mannose glycans at the extracellular domains of ICAMs determines the 
recognition by LFA-1 or DC-SIGN (Jimenez et al., 2004). More specifically, these 
authors showed that the absence of high mannose glycans on ICAM-1, which is the 
high affinity counter-receptor for LFA-1, does not allow binding to DC-SIGN (Jimenez 
et al., 2004). 
Particularly studied is the carbohydrate specificity for C-type lectins. Recent findings 
indicate that CLRs recognize subtle differences in the arrangement and branching of 
the carbohydrate residues. For example, MMR recognizes end-standing single 
mannose moieties, whereas DC-SIGN has higher affinity for more complex mannose 
residues in specific arrangements (Mitchell et al., 2001). Despite the fact that several 
C-type lectins share a CRD and bind mannose-containing structures, different 
branching and spacing of these structures create unique sets of carbohydrate 
recognition profiles for each receptor. A good example are the different modifications 
of Lewis blood-group antigen that bind to completely different C-type lectins. In fact, 
while DC-SIGN recognizes the unsialylated form of Lewis-X and Lewis-A (Appelmelk 
et al., 2003), P- and E-selectin have high affinity for sialylated Lewis-X and Lewis-A 
(Fukuda et al., 1999). In addition, both E- and L-selectin have been shown to 
interact with sulphated forms of Lewis-X and Lewis-A (Green et al., 1992; Yuen et 
al., 1992), while DC-SIGN strongly binds to sulphated Lewis-A but not to sulphated 
Lewis-X (Appelmelk et al., 2003). The MMR does interact with sulphated 
oligosaccharides of Lewis-X, but this interaction occurs via the cysteine rich domain 
rather than the CRD (Leteux et al., 2000).  
The complexity of carbohydrate  structures and the need to establish binding 
specificity for C-type lectins stimulated the development of several techniques to 
decipher the “glyco-code”. 
Oligolysine-based oligosaccharide clusters are chemically defined compounds that 
have been used in combination with surface plasmon resonance to identify ligands 
selectively recognized by various C-type lectins. In particular, dimannoside clusters 
have been shown to be recognized by the MMR with high affinity and by DC-SIGN 
with very low affinity; conversely, Lewis clusters show higher affinity for DC-SIGN 
than for the MMR (Frison et al., 2003). 
Alternatively, glycodendrimers, based on a hyperbranched polymer functionalized 
with different carbohydrates, have been used to interfere with biological processes 
where carbohydrates are involved. For example, mannosyl glycodendritic structures 
have been used to inhibit DC-SIGN-mediated infection of Ebola virus in cis and in 
trans (Lasala et al., 2003). 
Soluble chimeric DC-SIGN-IgG1-Fc  fusion proteins have been used in an ELISA 
format to screen for a panel of synthetic glycoconjugates containing mannose or 
fucose. This allowed the identification of new distinct carbohydrate structures that 
interact with DC-SIGN. Based on this information, it could be predicted that 
pathogens  could be recognized by this receptor (Appelmelk et al., 2003). 
Identification of carbohydrate moieties specific for particular lectins provide new 
perspectives for the design and development of drugs to prevent (chronic) infections 
by pathogens. Therapeutic manipulations of carbohydrate-protein interactions 
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require detailed knowledge of the specific spectrum of carbohydrate structures 
recognized by each lectin. Oligosaccharide microarray technologies are currently 
developed  to  facilitate a more rigorous, systematic, and high-throughput analysis of 
protein-carbohydrate interactions. 
One of the best examples is the neoglycolipid technology that generates lipid-linked 
oligosaccharide arrays from glycoproteins, glycolipids, proteoglycans, 
polysaccharides, whole organs, or chemically synthesized oligosaccharides (Feizi and 
Chai, 2004). By glycan array profiling discrimination of high and low affinity 
carbohydrate ligands for the murine C-type lectins SIGN-R1, SIGN-R3, and langerin 
have been determined (Galustian et al., 2004). 
Alternative glycan arrays are also documented. Recently, Guo and colleagues showed 
that DC-SIGN and its homolog  L-SIGN have distinct ligand-binding properties (Guo 
et al., 2004).  While  L-SIGN was only able to bind to mannose-containing ligands, 
DC-SIGN reacted with many more glycans, including those containing blood group 
antigens (Guo et al., 2004). The observation that DC-SIGN and  L-SIGN differ in their 
carbohydrate binding profiles was also  demonstrated by the work of van Liempt and 
colleagues. By examining Schistosoma mansoni egg antigen and various mutants of 
DC-SIGN and L-SIGN, they demonstrated that the difference in one single amino acid 
at the binding site is responsible for the fucose-specificity of DC-SIGN (Van Liempt et 
al., 2004). 
In this thesis, I demonstrated that besides virus and parasites DC-SIGN is also able 
to bind and internalize fungi such as Candida albicans (Chapter 6). Subsequently, I 
investigated the carbohydrate specificity of DC-SIGN in the interaction with fungal 
cell wall (Chapter 7). Our observation that Low Moleculr Weight and High Molecular 
Weight mannans have a different effect on DC-SIGN-mediated binding to Candida 
further highlights the complexity of DC-SIGN/glycans interactions. In fact, until now 
DC-SIGN has been generally reported as a ‘mannan-binding’ lectin. The structural 
studies performed by NMR and shown in Chapter 7 clearly indicate that differences in 
the mannan structure, in terms of molecular weight and branching, may also affect 
the spoecificity of DC-SIGN for high-mannose moieties. 
Detailed knowledge of the carbohydrate specificity of this family of receptors will 
contribute to the further understanding of the functional roles of the C-type lectins in 
glycan recognition of pathogen and carbohydrates expressed at the cell surface. 
 
 
Networks of immune receptors 
Accumulating evidence suggests that many integrin-mediated functions occur 
through physical interaction of integrins with other associated proteins (Brown, 
2002). Interactions in cis with different partners at the cell surface may influence the 
recruitment of LFA-1 into lipid rafts as well as its adhesive properties. Cooperation 
between integrins and Fc-Receptors or integrins and members of the tetraspannin 
family has been demonstrated to influence and modify integrin-mediated events such 
as cell migration and antigen presentation. Cross-talk between different integrins has 
also been demonstrated. Engagement of the integrin α4β1 with VCAM-1 increases 
binding between LFA-1 and ICAM-1 (Chan et al., 2000). This α4β1-mediated 
enhancement of LFA-1 adhesiveness requires the presence of urokinase receptor 
(uPAR; CD87) as activation transducer on leukocytes cell membrane (May et al., 
2000). This GPI-linked receptor can, besides its role in the fibrinolytic system, 
upregulate cell adhesion by forming a multimeric receptor complex where tyrosine 
kinase as well as β2 integrins localize (Bohuslav et al., 1995). In this way, the α4 
integrin which mediates rolling also stimulates the β2 integrins to initiate firm 
adhesion and transmigration. In general, the involvement of integrins in membrane 
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supramolecular complexes constituted by proteins as well as specific lipids is an 
emerging area of research particularly important in the immune system. 
A similar model emerges for C-type lectins and other PRRs, in which microbial 
recognition is not the result of one microbial component interacting with a single 
PRR, but rather a complex network of interacting receptors and ligands. Depending 
on the type of the receptors involved, and also the organization of the receptors at 
the cell surface, the outcome can be completely different. It can result in simple 
resolution of the pathogen but also lead to a vigorous adaptive immune response or 
lead to tolerance induction. Increasing evidence suggests that TLRs and C-type 
lectins communicate with each other, and that this cross-talk is critically important 
for the balance between immune tolerance and immune activation. In particular, the 
β-glucans receptor, Dectin-1, has been shown to mediate binding and  phagocytose 
of yeast and fungal-derived zymosan, resulting in the production of inflammatory 
cytokines by macrophages (Brown et al., 2003). In contrast, mycobacterium-derived 
mannosylated lipoarabinomannans  (ManLAM) have been shown to bind to DCs via 
DC-SIGN, thereby inhibiting TLR-mediated IL-12 production and stimulating IL-10 
production (Geijtenbeek et al., 2003). Blocking antibodies against DC-SIGN were able 
to restore IL-12 production, demonstrating that ManLAM triggers anti-inflammatory 
signaling via DC-SIGN (Geijtenbeek et al., 2003). 
The cross-talk between C-type lectins and TLRs controls the toggle between 
tolerogenic and activating immune responses. Recently, both TLR-2 and TLR-4 have 
been shown to be recruited into lipid rafts (Soong et al., 2004; Triantafilou et al., 
2002). At the apical surface of airway epithelial cells, TLR-2 is enriched in caveolin-1-
associated lipid raft microdomains after bacterial infection and its signaling 
capabilities are amplified by its association with the lipid raft ganglioside GM1 (Soong 
et al., 2004). TLR-4 was found to mobilize into lipid rafts together with other 
bacterial recognition immune receptors (such as CD-14) upon LPS-induced cell 
activation (Triantafilou et al., 2002). The observation that several C-type lectins and 
some TLRs may associate within lipid rafts suggests the possibility of spatially 
confined interactions between these two families of receptors. Especially for those C-
type lectins lacking signaling motives in their cytoplasmic domain, residing in a 
signaling platform such as a lipid raft increases their chance to activate components 
of the cell’s endogenous signaling machinery. 
The present challenge is to unravel the interactions among these receptor 
microdomains and define exact networks involved in important cellular processes 
such as cell migration, cell adhesion, and pathogen recognition. 
 
 
Importance of high-resolution imaging 
Our view of the cell membrane as a simple two dimensional homogeneous structure 
has changed radically in recent years by demonstrations of lateral heterogeneities 
and the existence of protein domains in the membrane (Jacobson et al., 1995; 
Kusumi and Sako, 1996; Yechiel and Edidin, 1987). Accumulating evidence points to 
a direct relation between the lateral organization of these supramolecular complexes 
and their specific cellular function (Simons and Ikonen, 1997; Simons and Toomre, 
2000; Vereb et al., 2003). Similarly, a large body of evidence indicates that the size 
of many of these membrane domains ranges from 30 to 800 nm (Vereb et al., 2003). 
Part of the controversy regarding the existence of membrane domains lies on their 
physical size, being smaller than the diffraction limit of light, and thus not resolvable 
by optical means. Moreover, there is increasing evidence that the assembly and 
disassembly of such complexes is a rather dynamic process (Vereb et al., 2003). 
Finally, biochemical and biophysical approaches aimed at the study of protein 
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domains have lead in many cases to contradictory results (Sharma et al., 2004; 
Subczynski and Kusumi, 2003). So far, lipid or protein microdomains can be ‘seen’ 
only by either extracting them from the cell membrane after detergent treatment or 
by inducing artificial patches with Ab to increase their size, thus making them 
visible/detectable by light microscopy. There is therefore need for new high 
resolution methodologies capable of directly imaging domains within the plasma 
membrane of intact cells. 
Fluorescence microscopy has become one of the most prominent and versatile 
research tools used in modern cell biology (Stephens and Allan, 2003). Light-based 
microscopy allows the study of living specimens in their native environment in a non-
invasive manner. Additionally, fluorescence microscopy offers chemical specificity by 
exploiting polarization, lifetime and spectral contrast (Michalet et al., 2003). 
Furthermore, progress in detector technology has recently pushed fluorescence 
microscopy to its ultimate level of sensitivity: the detection of individual molecules 
(Moerner and Orrit, 1999; Tsien, 1998). 
NSOM is a technique that preserves the advantages of the evanescent type of 
illumination, while providing simultaneously lateral resolution beyond the diffraction 
limit of light (see Chapter 2). The lateral resolution, down to tens of nanometers, is 
essentially defined by the size of the aperture and the sample-to-probe distance. The 
probe illuminates the sample with an evanescent field that is strongly localized at the 
vicinity of the aperture and decreases very rapidly away from the probe’s end face. 
Due to the exponentially decaying character of the illumination field, NSOM is a 
surface sensitive technique, and it is therefore ideal for studying the cell membrane 
(Laurence and Weiss, 2003). Despite its apparent advantages, the application of 
NSOM to biology has witness a modest progress. Successful examples on cell 
membrane studies include the co-localization of proteins within the membrane of 
malaria parasite-infected red blood cells at a resolution of ~100 nm (Enderle et al., 
1997), mapping the clustering of major histocompatibility complexes I and II in 
fibroblast cells (Nagy et al., 2001), identification of membrane lipid and proteins on 
fibroblast (Hwang et al., 1998) and the study of ion channel clusters in cardiac 
myocyte membranes (Ianoul et al., 2004).  
To demonstrate the potential of NSOM as a high resolution optical technique to study 
the organization of proteins on the cell membrane, we have investigated the 
distribution of the C-type lectin DC-SIGN expressed on DCs (Chapter 5).  
These findings confirmed and extended our previous observations that DC-SIGN is 
not randomly distributed as individual molecules but rather clustered in domains 
(Chapter 4). It also demonstrates that NSOM is equally capable (as compared to 
electron microscopy, EM) to resolve the static heterogeneity of the cell membrane 
with high resolution. Moreover, as surface scanning technique, NSOM is able to 
follow the cell topology thereby excluding any possible artifacts due to membrane 
structure or folding, in contrast to EM which is exclusively a 2D technique. Finally, 
the combination of topography and fluorescence intensity also allows the 
determination of the absolute position of the fluorescent spots on the membrane. 
We have now demonstrated that NSOM can be reliably operated in physiological 
conditions using a simple concept, opening the way to high resolution live cell 
imaging. However, one must be aware that as scanning probe technique, NSOM is 
inherently slow, being less suitable for monitoring lateral diffusion processes of 
membrane complexes. On the positive side of the balance, its excellent axial 
resolution should allow for the monitoring of ex-and endo-cytosis processes with high 
speed and sensitivity.  
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Co-localization studies, a common application of far-field fluorescence imaging in cell 
biology, when performed with NSOM should provide unprecedented detail and 
accuracy which are impossible to obtain by diffraction-limited imaging techniques. 
We demonstrated that high-resolution microscopic techniques such as EM and NSOM 
provide us with detailed information about receptor organization and 
microlocalization at the nanometric level (Chapter 3, 4, and 5). 
 
 
 
FUTURE PROSPECTIVES 
The application of high-resolution microscopy techniques allowed to gain detailed 
information regarding cell surface distribution pattern of membrane receptors at the 
nanometric level. However, this information relies on static snapshots of events that 
in living cells are instead highly dynamic. Moreover, the investigations were limited to 
the study of one receptor at the time. Therefore, the future challenge is to study the 
cell surface organization of a receptor at high resolution in time and space as well as 
the role of a receptor within a specific network.  
Novel genetically-encoded reporter constructs derived from fluorescent proteins 
together with innovative fluorescent semiconductor nanocrystals (Quantum Dots) are 
becoming powerful tools in fluorescence imaging. This in combination of 
Fluorescence Resonance Energy Transfer and Fluorescence Lifetime imaging 
microscopy will allow to unravel the intriguing dynamics in time and space of 
membrane receptors. 
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Dendritic cells (DCs) are the sentinels of the immune system and act at the interface 
between innate and acquired immunity. During their life-time, DCs establish several 
dynamic interactions: they recognize invading microorganisms or nascent tumor 
cells, migrate on extracellular matrix, roll on and adhere to endothelial cells, and 
instruct lymphocytes to eliminate dangerous antigens. 
All these interactions are mediated by specific membrane receptors, among which 
the β2 integrin LFA-1 and the C-type lectin DC-SIGN. Interestingly, these receptors 
have two common ligands, ICAM-2 and ICAM-3. While LFA-1 is present on 
monocytes as well as on monocyte-derived DCs, DC-SIGN expression is quickly 
upregulated during differentiation of monocytes into DCs. However, LFA-1-mediated 
adhesion rapidly decreases during DC development, and while on DCs binding to 
ICAM-1 is completely lost, interaction with ICAM-2 and ICAM-3 become exclusively 
DC-SIGN dependent. 
Besides sharing common ligands, DC-SIGN and LFA-1 are both transmembrane 
proteins expressed at the cell surface. 
The cell plasma membrane plays a crucial role: it defines boundaries and maintains 
different environments between cytosol and extracellular environment. In the model 
proposed by Singer and Nicolson about 30 years ago (Singer and Nicolson, 1972), 
the plasma membrane was described as a neutral lipid bilayer forming a two-
dimensional solution where proteins were homogeneously distributed and free to 
move laterally as well as rotationally. However, in the last decade experimental 
results have been obtained that challenged the Singer-Nicolson view, providing 
increasing evidence that the plasma membrane of eukaryotic cell is far from being 
homogeneous, but is rather a mosaic of differently originated microdomains. 
The aim of this thesis was to investigate the relationship between function and cell 
surface organization of LFA-1 and DC-SIGN at high resolution. 
In Chapter 1, a general introduction is given about characteristics and properties of 
DCs and their monocytic precursors. In addition, several receptor families important 
in diverse DC-mediated interactions, such as integrins, C-type lectin receptors 
(CLRs), and Toll-like Receptors (TLRs), are described. Finally, an overview of the 
various molecular microdomains that compose the cell membrane (like lipid rafts, 
caveolae, tetraspannins, and TCZs) is presented.  
The nanometric size of these plasma membrane heterogeneities, ranging from 700 
to 50 nm, has made difficult if not impossible any investigation by conventional 
microscopy. However, in the last two decades, several novel microscopy techniques 
were developed to overcome this problem. Chapter 2 describes several high-
resolution microscopies and their applications in cell biology. In particular, the 
Transmission Electron Microscopy (TEM) and Near-field Scanning Optical Microscopy 
(NSOM) are discussed in details. In fact, in this thesis, both these techniques were 
applied to study the organization of membrane receptors at the cell surface of 
immune cells. 
In Chapter 3, we show that LFA-1 activation state changes during development of 
monocyte-derived DCs along with major modification of its organization within the 
cell membrane. Human monocytes express high levels of the ICAMs-binding LFA-1 
and exploit it to bind to endothelial cells and to extravasate into the underlying tissue 
upon inflammation. As precursors of DCs, microenvironmental factors can induce 
monocytes to differentiate into immature DCs. Interestingly, these DCs do express 
significant levels of LFA-1 but, unlike monocytes, we observed that binding to ICAM-
1, ICAM-2 and ICAM-3 through LFA-1 is completely lost. The loss of ligand binding by 
LFA-1 during DC development directly correlates with a gradual exclusion of LFA-1 
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molecules from cholesterol rich micro-domains. TEM on whole-mount samples of 
monocytes and DCs mapped the cell surface distribution of LFA-1 at sub-micron 
level, showing that while on DCs LFA-1 is randomly distributed, on the precursor 
monocytes LFA-1 is organized in well-defined 100-150 nm sized microdomains. 
These microdomains were heterogeneous regarding their activation state, as 
demonstrated by expression of the activation reporter epitope recognized by NKI-L16 
mAb. Live imaging of monocyte and T cell interactions shows that only active NKI-
L16 positive LFA-1 microdomains are dynamically recruited at the cellular interface to 
form large micron-sized macroclusters. These findings show that in addition to 
affinity regulation, LFA-1 function is tightly controlled at the cell membrane by 
surface distribution at least three levels: random distribution of inactive molecules, 
pro-active ligand-independent nanometric microdomains, and  ligand-triggered 
micron-sized macroclusters.  
In Chapter 4, the distribution of DC-SIGN in well-defined microdomains at the cell 
surface of immature DCs was is described. DC-SIGN facilitates binding and 
internalization of several viruses, including HIV-1, on dendritic cells, but the 
underlying mechanism for being such an efficient phagocytic pathogen-recognition 
receptor is poorly understood. During development of human monocyte-derived DCs, 
DC-SIGN becomes organized in well-defined microdomains, with an average 
diameter of 200 nm. Biochemical studies and confocal microscopy indicate that DC-
SIGN microdomains reside within lipid rafts. Finally, the organization of DC-SIGN in 
microdomains on the plasma membrane is shown to be important for binding and 
internalization of virus particles, suggesting that these DC-SIGN assemblies act as a 
docking site for pathogens like HIV-1 to invade the host. 
Chapter 5 is the result of a challenging multidisciplinary project involving biologists 
and physicists. Within this project the distribution of DC-SIGN in microdomains on 
DCs was determined by NSOM, which for the first time imaged sub-micron sized 
microdomains on whole cells under liquid conditions. NSOM is a relatively new 
technique that combines ultra high optical resolution, down to 70 nm, with single 
molecule detection sensitivity. As such, the technique holds great potential for direct 
visualization of domains at the cell surface. Yet, NSOM operation under liquid 
conditions is far from trivial. However, we show that the performance of NSOM can 
be extended to measurements in liquid environments using a diving bell concept. For 
the first time, individual fluorescent molecules on the membrane of cells in solution 
are imaged with a spatial resolution of 90 nm.  
DC-SIGN is an exquisite virus-uptake receptor and it can interact with other types of 
pathogens as well, including bacteria and parasites. In Chapter 6, we demonstrated 
that DC-SIGN is also able to recognize fungi such as C. albicans. The binding was 
shown to be time- as well as concentration-dependent, and live as well as heat-
inactivated C. albicans were bound to the same extent. Moreover, immature DC 
internalize C. albicans in specific DC-SIGN enriched vesicles, distinct from those 
containing the mannose receptor, the other known C. albicans receptor expressed by 
DC. 
Both CLRs and TLRs interact with pathogen by recognizing specific Pathogen-
associated Molecular Patterns (PAMPs) expressed at the microbial cell surface. In the 
case of the CLRs, to which DC-SIGN belongs, these PAMPs are primarily 
carbohydrate moieties. In Chapter 7, the PAMP recognized by DC-SIGN on the cell 
wall of C. albicans has been identified. In this study, we showed that DC-SIGN 
discriminates among different species and morphological forms of Candida. In fact, 
DC-SIGN predominantly interacts with the conidiae and not with the hyphae of 
Candida species, suggesting a role for DC-SIGN in the early recognition of Candida 
by DCs. By ligand binding assays in presence of several pathogen-derived 
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carbohydrates, we demonstrate that DC-SIGN binds to C. albicans through the 
specific recognition of Candida cell wall mannan. Other mannan preparations, 
including S. cerevisiae-derived mannan, reported to inhibit DC-SIGN binding, did not 
affect the interaction with Candida. Further NMR analysis show that differences in 
specificity between C. albicans- and S. cerevisiae-derived mannans relate to distinct 
structural properties. We also show for the first time that a fungal glucose-polymer, 
scleroglucan, selectively interferes with binding to ICAM-3 and HIV-1 gp120, but not 
with Candida. Finally, we demonstrate that DC-SIGN binding to gp120 or ICAM-3 
does not affect binding to C. albicans. Our studies clearly point out that a detailed 
knowledge of DC-SIGN specificity for fungal mannan may be helpful to develop 
efficient DC-based anti-fungal vaccins. 
Finally, in Chapter 8, general discussion and future prospective on the topics 
described in this thesis are given. 
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Dendritische cellen (DCs) zijn de poortwachters van het immuunsysteem en 
functioneren in het grensgebied tussen ‘innate’ en ‘acquired’ immuniteit. Tijden hun 
levenscyclus hebben DC een groot aantal dynamische interacties: ze herkenden 
invasieve microorganismen of tumorcellen, migreren door extracellulair matrices, 
rollen over en adhereren aan endotheelcellen, en instrueren lymfocyten om 
gevaarlijke antigenen te elimineren. 
Al deze interacties zijn gemedieerd door specifieke membraanreceptoren, waaronder 
de β2 integrine LFA-1 en de C-type lectine DC-SIGN. Interessant is dat deze 
receptoren twee gemeenschappelijke liganden hebben: ICAM-2 en ICAM-3. Terwijl 
LFA-1 op zowel monocyten als DC tot expressie komt, is de expressie van DC-SIGN 
tijdens de differentiatie van monocyten in DC snel verhoogd. Echter, LFA-1 
gemedieerde adhesie vermindert snel tijdens de ontwikkeling van DC. Terwijl op DC 
is de binding aan ICAM-1 totaal verloren gaat, wordt de interactie met ICAM-2 and 
ICAM-3 totaal DC-SIGN aanvankelijk. Naast het feit dat DC-SIGN en LFA-1 
gemenschappelijke liganden hebben zijn ze ook allebei transmembraan eiwitten op 
het plasmamembraan. 
Het plasmamembraan spelt een cruciale rol: het definieert grenzen en handhaaft de 
verschillende milieus tussen het cytosol en de buitenwereld. In het model dat Singer 
en Nicolson 30 jaar geleden voorstelden (Singer and Nicolson, 1972) werd het 
plasmamembraan beschreven als een neutrale dubbellaag van lipiden waarbinnen 
eiwitten homogeen gedistribueerd zijn en vrij kunnen bewegen. Echter, in het 
afgelopen decennium werden steeds meer resultaten verkregen  die het Singer-
Nicolson voorstel corrigeerden en steeds meer suggereerden dat het 
plasmamembraan van eukaryotische cellen helemaal niet homogeen is, maar 
eigenlijk een mozaïk van verschillende microdomeinen vormt. 
Het doel van dit proefschrift is om de relatie tussen functie en organisatie van LFA-1 
en DC-SIGN op het cel oppervlak door middel van hoge resolutie te bestuderen. 
In Hoofdstuk 1 wordt een algemeen introductie gegeven over eigenschappen van 
DC en hun voorlopers, de monocyten. Daarnaast zijn een aantal families van 
receptor beschreven die betrokken zijn bij verschillende DC-gemdieerde interacties. 
Hiertoe behoren bijvoorbeeld de integrinen, C-type lectinen (CLR), en Toll-like 
receptoren (TLR). Uiteindelijk word een overzicht gepresenteerd van de verschillende 
moleculaire microdomeinen die het celmembraan vormgeven, te weten: ‘lipid rafts’, 
‘caveolae’, ‘tetraspannins’, en ‘transient confinement zones’. 
De afmetingen van deze plasmamembraan microdomeinen, variërend tussen 50 en 
700 nm, heeft het moeilijk, zo niet onmogelijk, gemaakt om door conventionele 
microscopie te worden bestudeerd. Echter, in de afgelopen paar decennia werden 
verschillende nieuwe microscopische technieken ontwikkeld om dit probleem op te 
lossen. Hoofdstuk 2 beschrijft verschillende hoge-resolutie microscopische 
technieken en hun toepassing in de celbiologie. In het bijzonder zijn de Transmissie 
Elektronen Microscopie (TEM) en Nabij-veld Scanning Optische Microscopie (NSOM) 
tot in detail bediscussieerd. Beide microscopische technieken werden gebruikt om de 
organisatie van membraanreceptoren op het oppervlak van afweer cellen te 
bestuderen. 
In Hoofdstuk 3 laten we zien dat tijdens de ontwikkeling van DC zowel de activiteit 
van LFA-1 als zijn organisatie op het celmembraan verandert. Humane monocyten 
brengen ICAM-bindend LFA-1 hoog tot expressie en gebruiken het om aan 
endotheelcellen te binden en naar ontstoken weefsels te migreren. Meerdere 
factoren kunnen monocyten induceren om in onrijpe DC te differentiëren. DC 
brengen significante niveaus van LFA-1 tot expressie. Echter, we observeerden dat, 
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in tegenstelling tot monocyten, de binding van DC aan ICAM-1, -2, en -3 helemaal 
verloren is. Het verlies van ligand binding door LFA-1 correleert direct met het 
verdwijnen van LFA-1 moleculen uit cholesterol-rijke microdomeinen. TEM heeft de 
verdeling van LFA-1 op het celoppervlak van intacte monocyten en DC op een 
submicron niveau in kaart gebracht. Dit onderzoek toont aan dat op DC LFA-1 
willekeurig verdeeld is, terwijl op de monocyten LFA-1 in goed gedefinieerde 100-150 
nm microdomeinen tot expressie komt. Deze microdomeinen waren heterogeen ten 
aanzien van hun activiteit, zoals aangetoond door de expressie van het activiteit-
afhankelijk epitoop herkend door monoclonaal antilichaam NKI-L16. Levende beelden 
van interacties tussen monocyten en T cellen laten zien dat alleen actieve NKI-L16- 
positieve microdomeinen naar de contactplaats tussen de cellen gedirigeerd worden. 
Deze bevindingen laten zien dat de bindingscapaciteit van LFA-1 niet alleen door de 
affiniteit maar ook door zjin verdeling op het celmembraan nauw gereguleerd is. Dit 
gebeurt op drie manieren: 1) verdeling van inactieve moleculen, 2) aanwezigheid van 
pro-actieve ligand-onafhankelijke microdomeinen, en 3) van ligand-geïnduceerde 
macroclusters. 
In Hoofdstuk 4, is de distributie van DC-SIGN in goed gedefinieerde 
microdomeinen op het cel oppervlak van onrijpe DC beschreven. DC-SIGN 
vergemakkelijkt de binding en internalisatie van verschillende virussen, zoals HIV-1, 
door DC. Echter, het onderliggende mechanisme die verklaart waarom DC-SIGN als 
zo’n efficiente pathogeen herkennings receptor functioneert, is onduidelijk. Tijdens 
de ontwikkeling van DC uit humane monocyten, organiseert DC-SIGN zich in 
microdomeinen met een gemiddelde diameter van 200 nm. Biochemische studies en 
confocale microscopie tonen aan dat deze microdomeinen deel uitmaken van ‘lipid 
rafts’. Ten slotte wordt beschreven dat voor de binding en internalisatie van virale 
partikels, de expressie van DC-SIGN in microdomeinen op het plasma membraan 
heel belangrijk is. Dit suggereert dat deze DC-SIGN clustering optreedt als een 
‘docking site’ voor invasieve pathogenen, zoals HIV-1. 
Hoofdstuk 5 is het resultaat van een uitdagend multi-disciplinair project waarbij 
zowel biologen als natuurkundigen betrokken zijn. Voor de eerste keer werd binnen 
dit project ook door NSOM de distributie van DC-SIGN in microdomeinen op sub-
micron niveau en op intacte cellen in vloeistof beschreven. NSOM is een relatief 
nieuwe techniek die ultra hoge optische resolutie, zelfs tot 70 nm, combineert met 
een gevoeligheid die afzonderlijke eiwitten kan herkennen. Door deze eigenschappen 
heeft NSOM veel te bieden voor het visualiseren van celmembraan domeinen. Tot op 
heden is het gebruik van NSOM op cellen in medium nog ver van routine. Echter, wij 
laten zien dat met behulp van een ‘duikersklok’de prestatie van NSOM vergroot kan 
worden tot het meten onder vloeibare omstandigheden. Voor de eerste keer konden 
met een resolutie van 90 nm individuele fluorescerende moleculen op het 
plasmamembraan van cellen in vloeistof gemeten worden. 
DC-SIGN uitstekende opname receptor voor virussen, maar het kan ook een 
interactie aangaan met andere soorten pathogenen zoals bacterien en parasieten. In 
Hoofdstuk 6, beschrijven we dat DC-SIGN ook schimmels zoals C. albicans kan 
herkennen. Deze binding bleek zowel tijd- als concentratie-afhankelijk te zijn, en 
leven en hitte-geinactiveerde C. albicans werden even goed gebonden. Daarnaast 
internaliseerden immature DC C. albicans via specifieke DC-SIGN verrijkte ‘vesicles’. 
Deze vesicles waren van andere origine dan diegene die vooral de mannose 
receptor, de andere receptor voor C. albicans op DC, bevatten. 
Zowel CLR als TLR interacteren met pathogenen door herkenning van specifieke 
pathogeen-geassocieerde moleculaire patronen (PAMPs) die op het pathogeen 
oppervlak aanwezig zijn. In het geval van de CLR, waar DC-SIGN bij hoort, zijn deze 
PAMP meestal koolhydraat groepen. In Hoofdstuk 7 is de door DC-SIGN herkende 
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PAMP op op het oppervlak van C. albicans beschreven. In deze studie laten we zien 
dat DC-SIGN tussen verschillende species en morfologische vormen van Candida 
discrimineert. In feit interacteert DC-SIGN alleen met de conidiae en niet met de 
hyphae van Candida species, wat suggereert dat DC-SIGN een rol speelt in het 
vroege herkenning van Candida door DC. Mede door ligand bindings assays in 
aanwezigheid van verschillende koolhydraten geisoleerd uit pathogenen, tonen we 
aan dat DC-SIGN C. albicans via een specifiek celmembraan-geassocieerd mannan 
bindt. Andere mannans, inclusief de DC-SIGN-blokkerende mannan van S. cerevisiae,  
konden de interactie met Candida echter niet beïnvloeden. Verdere NMR analyse liet 
zien dat de verschillen in specificiteit tussen mannans van C. albicans en S.cerevisiae 
gerelateerd zijn aan verschillen in structurele eigenschappen. Verder laten wij ook 
voor de eerste keer zien dat een glucose polymeer uit schimmels, het scleroglucaan, 
in een selectieve manier de binding van DC-SIGN aan ICAM-3 en HIV-1 gp120, maar 
niet aan Candida, beïnvloedt. Uiteindelijk tonen we aan dat gp120 of ICAM-3 de 
interactie tussen DC-SIGN en Candida niet kunnen blokkeren. Onze studies 
benadrukken dat een gedetailleerde kennis van de specificiteit van DC-SIGN voor 
mannan heel behulpzaam kan zijn om een efficiënt antischimmel vaccin te 
ontwikkelen. 
Tenslotte worden in Hoofdstuk 8 een algemene discussie en een aantal 
toekomstige perspectieven over de onderwerpen van dit proefschrift gegeven.  
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